var title_f18_22_18784="Pancreatic abscess CT";
var content_f18_22_18784=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F73456&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F73456&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pancreatic abscess",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 309px; height: 238px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT scan in a patient with abdominal pain, fever, and jaundice shows air (thin arrow) in the central pancreas, which is necrotic and largely replaced by an acute fluid collection (thick arrows), leaving only a small residual pancreatic head (P).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan Kruskal, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_22_18784=[""].join("\n");
var outline_f18_22_18784=null;
var title_f18_22_18785="Etamsylate: International drug information";
var content_f18_22_18785=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Etamsylate: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F1978741\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Altodor (DE);",
"     </li>",
"     <li>",
"      Dicinone (BR, CH, ES);",
"     </li>",
"     <li>",
"      Dicynene (CH, GB, IE);",
"     </li>",
"     <li>",
"      Dicynone (BE, CH, FR, HR, HU, IT, LU);",
"     </li>",
"     <li>",
"      Eselin (IT);",
"     </li>",
"     <li>",
"      Ethamsyl (IN);",
"     </li>",
"     <li>",
"      Hemo 141 (ES);",
"     </li>",
"     <li>",
"      Hemoced (FR);",
"     </li>",
"     <li>",
"      Impedil (AR)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list synlist drugH1Div drugBrandNames\" id=\"F1978722\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Index Terms",
"    </span>",
"    <ul>",
"     <li>",
"      Ethamsylate",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1978727\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Hemostatic Agent",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F1978730\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prevention and treatment of capillary hemorrhages; treatment of menorrhagia or metrorrhagia",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F1978725\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Preoperative: 250-500 mg 1 hour before surgery",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Postoperative: 250-500 mg every 4-6 hours as risk of bleeding persists",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Menorrhagia: 500 mg 4 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.M., I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Preoperative: 250-500 mg 1 hour before surgery",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     During and after surgery: 250-500 mg repeating every 4-6 hours as risk of bleeding persists",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821180\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F1978729\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justified;\">",
"     Injection, solution: 125 mg/mL (2 mL) [contains sodium bisulphite]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justified;\">",
"     Tablet: 250 mg, 500 mg",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10378 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-122.72.76.133-D6EAFC90AA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_22_18785=[""].join("\n");
var outline_f18_22_18785=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978741\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978722\">",
"      Index Terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978727\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978730\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978725\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821180\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978729\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10378\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10378|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_22_18786="Bee and insect stings";
var content_f18_22_18786=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Bee and insect stings (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?18/22/18786/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/22/18786/contributors\" id=\"au2980\">",
"       Theodore Freeman, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?18/22/18786/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/22/18786/contributors\" id=\"se920\">",
"       David B Golden, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?18/22/18786/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/22/18786/contributors\" id=\"de128\">",
"       Anna M Feldweg, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?18/22/18786?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Being stung by a bee, wasp, hornet, or yellow jacket can be both painful and scary. Some people have serious or even life-threatening reactions to stings, requiring quick treatment.",
"    </p>",
"    <p>",
"     This article will review the most common types of stings, reactions to stings, and recommended treatments. More detailed information about stings is available by subscription. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/1/12313?source=see_link\">",
"      \"Bee, yellow jacket, wasp, and other Hymenoptera stings: Reaction types and acute management\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      INSECT TYPES",
"     </span>",
"    </p>",
"    <p>",
"     The insects that cause the most serious sting reactions include the following:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Honeybees (",
"       <a class=\"graphic graphic_picture graphicRef79579 \" href=\"UTD.htm?15/7/15472\">",
"        picture 1",
"       </a>",
"       ) and bumblebees.",
"      </li>",
"      <li>",
"       Yellow jackets (",
"       <a class=\"graphic graphic_picture graphicRef79706 \" href=\"UTD.htm?17/11/17585\">",
"        picture 2",
"       </a>",
"       ), yellow hornets, white faced hornets, and paper wasps (",
"       <a class=\"graphic graphic_picture graphicRef70439 \" href=\"UTD.htm?4/2/4128\">",
"        picture 3",
"       </a>",
"       ).",
"      </li>",
"      <li>",
"       Fire ants, harvester ants, bulldog ants, and jack jumper ants. Fire ants are discussed separately. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?18/44/19138?source=see_link\">",
"        \"Patient information: Fire ants (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      INSECT STING REACTION",
"     </span>",
"    </p>",
"    <p>",
"     After being stung, you should remove the stinger from your skin as soon as possible to prevent any more venom from being released into the skin. However, all the venom is released from the stinger within the first few seconds, so this is only helpful if done quickly. You do not need to use any special technique (eg, flicking or scraping) to get the stinger out.",
"    </p>",
"    <p>",
"     Most people who are stung by an insect will develop a local reaction (an area of swelling and redness). Some people will also develop a severe allergic reaction, called anaphylaxis.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Local reaction",
"     </span>",
"     &nbsp;&mdash;&nbsp;Immediately after being stung, most people have:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Sharp or burning pain",
"      </li>",
"      <li>",
"       Skin swelling and redness (",
"       <a class=\"graphic graphic_picture graphicRef81060 \" href=\"UTD.htm?22/47/23280\">",
"        picture 4",
"       </a>",
"       )",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     The swelling and pain usually improve within a few hours.",
"    </p>",
"    <p>",
"     Approximately 10 percent of people develop severe redness and swelling after a sting; this is called a large local reaction. The area may become large (4 inches or 10 cm) over 1 to 2 days, then slowly resolve over 5 to 10 days.",
"    </p>",
"    <p>",
"     Having a large local reaction does not mean that you will have a severe allergic reaction (anaphylaxis) if you are stung again. Only about 5 to 10 percent of people who have a large local reaction will have anaphylaxis if stung in the future. If you have a large local reaction, talk to your doctor or nurse to determine what steps, if any, you need to take if you are stung again.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h3\">",
"      Local reaction treatment",
"     </span>",
"     &nbsp;&mdash;&nbsp;To reduce pain and swelling after an insect sting, you can try the following:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Apply a cold compress (a cold, damp washcloth or damp cloth wrapped around an ice pack) to the area.",
"      </li>",
"      <li>",
"       If you develop itching, you can take a nonprescription antihistamine, such as cetirizine (Zyrtec&reg;).",
"      </li>",
"      <li>",
"       A pain reliever, such as ibuprofen (sold as Advil, Motrin, and store brands), may help reduce pain.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     If nonprescription treatments do not help or your pain or swelling gets worse, call your doctor or nurse.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Allergic reaction",
"     </span>",
"     &nbsp;&mdash;&nbsp;Insect stings cause allergic reactions in some people. Symptoms of an allergic reaction usually develop quickly, and include:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Skin symptoms, such as hives, redness, or swelling of skin away from the area that was stung (for example, the face or lips may swell after being stung on the hand)",
"      </li>",
"      <li>",
"       Belly cramps, nausea, vomiting, or diarrhea",
"      </li>",
"      <li>",
"       Hoarse voice, shortness of breath, and difficulty breathing",
"      </li>",
"      <li>",
"       Lightheadedness, dizziness, passing out",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Severe allergic reactions are called anaphylaxis. You can have an anaphylactic reaction the first time you are stung.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h3\">",
"      Severe allergic reaction treatment",
"     </span>",
"     &nbsp;&mdash;&nbsp;Severe allergic reactions are a medical emergency that can lead to death if not treated quickly. If you develop any symptoms of anaphylaxis, you need to get emergency care as soon as possible. When possible, ask someone else to call for emergency care (call 911 in the United States).",
"    </p>",
"    <p>",
"     Do not drive yourself to the hospital and do not ask someone else to drive you. Calling 911 is safer than driving for two reasons:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       You can get treatment from the paramedics as soon as the ambulance arrives. If you drive to the hospital, you cannot get treatment until you arrive in the emergency department.",
"      </li>",
"      <li>",
"       Dangerous complications may occur (eg, you may stop breathing) on the way to the hospital, which would increase the chances of having a motor vehicle accident. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?40/14/41186?source=see_link\">",
"        \"Patient information: Anaphylaxis treatment and prevention (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     The first and most important treatment for a severe allergic reaction is a shot of epinephrine. Epinephrine is available by prescription in prefilled syringes, called epinephrine autoinjectors. Instructions for using epinephrine are available in a separate article. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/30/28134?source=see_link\">",
"      \"Patient information: Use of an epinephrine autoinjector (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H8\">",
"     <span class=\"h1\">",
"      AM I ALLERGIC TO STINGS?",
"     </span>",
"    </p>",
"    <p>",
"     If you had",
"     <strong>",
"      any",
"     </strong>",
"     symptoms of an allergic reaction or anaphylaxis after being stung, you should make an appointment to see an allergy specialist. At this visit, the allergist will try to determine if you are allergic to stings. If you are allergic to stings, the allergist will teach you how and when to use an epinephrine autoinjector. He or she will also help you decide if you need allergy shots (called immunotherapy) to reduce your risk of anaphylaxis in the future.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Allergy testing",
"     </span>",
"     &nbsp;&mdash;&nbsp;Testing can be done to determine if you are allergic to insect stings. Blood and skin tests are available, and both are needed in some cases. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/30/14824?source=see_link\">",
"      \"Diagnosis of Hymenoptera venom allergy\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     If allergy testing shows that you are allergic to insect stings, there is a good chance that you will have a serious allergic reaction (anaphylaxis) if you are stung again. Allergy shots can greatly reduce the risk of anaphylaxis.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Allergy shots (immunotherapy)",
"     </span>",
"     &nbsp;&mdash;&nbsp;Allergy shots, also called venom immunotherapy, can reduce your chance of having a serious or life-threatening reaction to a sting. When you are stung by an insect, the stinger injects venom into your skin, which causes the allergic reaction. Allergy shots usually contain purified venom. The first few allergy shots contain very small amounts of venom, and the amount is gradually increased until you can tolerate the amount of venom in two or more stings without having allergic symptoms.",
"    </p>",
"    <p>",
"     Allergy shots are often recommended if you had:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       A serious allergic reaction (anaphylaxis) after being stung,",
"       <strong>",
"        AND",
"       </strong>",
"      </li>",
"      <li>",
"       Allergy testing shows that you are allergic to bee, wasp, yellow jacket, or hornet venom",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Allergy shots are usually given in an allergist's office one to three times per week for a few months, and then once per month for at least three years. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/34/16936?source=see_link\">",
"      \"Hymenoptera venom immunotherapy: Efficacy, indications, and mechanism of action\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Some people continue to get allergy shots for three to five years while other people get them for longer. Most experts recommend that you continue getting allergy shots indefinitely if:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       You had a life-threatening reaction to a past sting",
"      </li>",
"      <li>",
"       You have a reaction to the allergy shot since this is a sign that you are very sensitive to the venom",
"      </li>",
"      <li>",
"       You are so fearful of having a severe allergic reaction that you cannot enjoy normal outdoor activities",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     As a result of immunotherapy, your risk of having a serious allergic reaction after a sting becomes much lower. You should still carry an epinephrine autoinjector. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/59/13239?source=see_link\">",
"      \"Hymenoptera venom immunotherapy: Determining duration of therapy\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Epinephrine",
"     </span>",
"     &nbsp;&mdash;&nbsp;Epinephrine, sometimes called adrenaline, is a medicine that can treat the symptoms of a serious allergic reaction. Epinephrine is available in pre-filled syringes so that you can give yourself a shot, if needed. If you had anaphylaxis after an insect sting in the past, you should always carry at least one epinephrine autoinjector (even in the winter).",
"    </p>",
"    <p>",
"     However, one or even two injections of epinephrine may not be enough to stop a life-threatening reaction. This is why it is important to talk to an allergist about allergy shots if you have had a serious allergic reaction after a sting. You should also seek emergency medical care after using an epinephrine autoinjector, because the symptoms of allergic reactions sometimes come back after initially improving.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H12\">",
"     <span class=\"h1\">",
"      AVOIDING STINGS",
"     </span>",
"    </p>",
"    <p>",
"     Bees and wasps that are away from their nest are not aggressive and only sting when threatened (after being hit, stepped on, or swatted). Wearing brightly colored clothing or perfume does not increase the risk of being stung. Wearing white or light-colored clothing may reduce the chance of being attacked if you are near a nest.",
"    </p>",
"    <p>",
"     When eating outside, keep food and drinks covered and wipe up food and drink spills quickly. Watch for yellow jackets inside drink containers. Do not walk outside without shoes.",
"    </p>",
"    <p>",
"     If you find a wasp nest near your home, do not try to get rid of the nest yourself. Instead, call a pest control professional. If you have a sting allergy, avoid activities that may disturb a nest, such as mowing the lawn or pruning a hedge.",
"    </p>",
"    <p>",
"     If a stinging insect is near, slowly back away and do not flail your arms. If you are being swarmed or stung, cover your mouth and nose with your hand and run inside a building or an enclosed vehicle.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H13\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1785001102\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H23445150\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?14/51/15155?source=see_link\">",
"      Patient information: Insect bites and stings (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/42/25250?source=see_link\">",
"      Patient information: Insect allergy (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?10/16/10498?source=see_link\">",
"      Patient information: Spider bites (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H23445167\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?18/44/19138?source=see_link\">",
"      Patient information: Fire ants (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?40/14/41186?source=see_link\">",
"      Patient information: Anaphylaxis treatment and prevention (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/30/28134?source=see_link\">",
"      Patient information: Use of an epinephrine autoinjector (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/1/12313?source=see_link\">",
"      Bee, yellow jacket, wasp, and other Hymenoptera stings: Reaction types and acute management",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/30/14824?source=see_link\">",
"      Diagnosis of Hymenoptera venom allergy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/36/7752?source=see_link\">",
"      Entomology and control of imported fire ants",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/59/13239?source=see_link\">",
"      Hymenoptera venom immunotherapy: Determining duration of therapy",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/34/16936?source=see_link\">",
"      Hymenoptera venom immunotherapy: Efficacy, indications, and mechanism of action",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/5/39000?source=see_link\">",
"      Hymenoptera venom immunotherapy: Technical issues, protocols, adverse effects, and monitoring",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/22/32104?source=see_link\">",
"      Scorpion stings in the United States and Mexico",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/51/7994?source=see_link\">",
"      Stings of imported fire ants: Clinical manifestations, diagnosis, and treatment",
"     </a>",
"     <br/>",
"    </p>",
"    <p>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/insectbitesandstings.html\">",
"        www.nlm.nih.gov/medlineplus/insectbitesandstings.html",
"       </a>",
"       )",
"      </li>",
"      <li>",
"       American Academy of Allergy, Asthma, &amp; Immunology",
"       <br/>",
"       <br/>",
"       (",
"       <a class=\"external\" href=\"file://www.aaaai.org/patients/publicedmat/tips/stinginginsect.stm\">",
"        www.aaaai.org/patients/publicedmat/tips/stinginginsect.stm",
"       </a>",
"       )",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?18/22/18786/abstract/1-5\">",
"      1-5",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 2, 2013.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?18/22/18786?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18786/abstract/1\">",
"      Severino M, Bonadonna P, Passalacqua G. Large local reactions from stinging insects: from epidemiology to management. Curr Opin Allergy Clin Immunol 2009; 9:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18786/abstract/2\">",
"      Freeman TM. Clinical practice. Hypersensitivity to hymenoptera stings. N Engl J Med 2004; 351:1978.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18786/abstract/3\">",
"      Bil&oacute; BM, Rueff F, Mosbech H, et al. Diagnosis of Hymenoptera venom allergy. Allergy 2005; 60:1339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18786/abstract/4\">",
"      Bonifazi F, Jutel M, Bil&oacute; BM, et al. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice. Allergy 2005; 60:1459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18786/abstract/5\">",
"      Golden DB, Moffitt J, Nicklas RA, et al. Stinging insect hypersensitivity: a practice parameter update 2011. J Allergy Clin Immunol 2011; 127:852.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f18_22_18786=[""].join("\n");
var outline_f18_22_18786=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           INSECT TYPES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           INSECT STING REACTION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H8\">",
"           AM I ALLERGIC TO STINGS?",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H12\">",
"           AVOIDING STINGS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H13\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          PICTURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?15/7/15472\" title=\"picture 1\">",
"           Honey bee",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/11/17585\" title=\"picture 2\">",
"           North American yellow jackets",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/2/4128\" title=\"picture 3\">",
"           North American paper wasps",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/47/23280\" title=\"picture 4\">",
"           Simple local reaction",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f18_22_18787="Impetigo crusted lesions";
var content_f18_22_18787=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F82281&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F82281&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Impetigo",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Crusted lesions in a patient with impetigo.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_22_18787=[""].join("\n");
var outline_f18_22_18787=null;
var title_f18_22_18788="Delivery rates by diagnosis";
var content_f18_22_18788=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F52891&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F52891&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 532px\">",
"   <div class=\"ttl\">",
"    Cumulative delivery rates after oocyte donation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 512px; height: 373px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Life-table analysis of women undergoing oocyte donation denoting success rates for live births per embryo transfer over five cycles according to the primary diagnosis. The thick white line represents the mean rate of success.",
"    <div class=\"footnotes\">",
"     POF: premature ovarian failure; IVF: in vitro fertilization.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Paulson, RJ, et al. Cumulative conception and live birth rates after oocyte donation: implications regarding endometrial receptivity. Hum Reprod 1997; 12:835.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_22_18788=[""].join("\n");
var outline_f18_22_18788=null;
var title_f18_22_18789="Determining body composition in adults";
var content_f18_22_18789=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Determining body composition in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/22/18789/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/22/18789/contributors\">",
"     George A Bray, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/22/18789/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/22/18789/contributors\">",
"     F Xavier Pi-Sunyer, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/22/18789/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/22/18789/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/22/18789/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 25, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Methods for determining body composition have improved over the past 20 years, greatly increasing the accuracy and ease of making these measurements [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18789/abstract/1-4\">",
"     1-4",
"    </a>",
"    ]. Body composition measurements may be useful in undernourished patients, or for identifying patients who do not have an increase in overall body fat, but who have an increase in visceral fat. This latter circumstance is associated with a substantially increased risk of heart disease and diabetes. Measurement of body composition is also instructive for assessing body changes associated with growth and development, aging (sarcopenia), and in certain disease states (eg, HIV, diabetes) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18789/abstract/5-11\">",
"     5-11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Certain measurements, such as height, weight (to calculate body mass index), and waist circumference are the minimal clinical criteria for evaluating the overweight patient. This topic will review body composition and critique most methods available for its measurement. Other considerations when evaluating the overweight patient are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/20/12615?source=see_link\">",
"     \"Screening for and clinical evaluation of obesity in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MODELS OF BODY COMPOSITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Body composition can be viewed from five perspectives (",
"    <a class=\"graphic graphic_figure graphicRef79699 \" href=\"UTD.htm?22/36/23105\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18789/abstract/1,12\">",
"     1,12",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Atomic",
"     </li>",
"     <li>",
"      Molecular",
"     </li>",
"     <li>",
"      Cellular",
"     </li>",
"     <li>",
"      Tissues",
"     </li>",
"     <li>",
"      Whole body",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Atomic composition",
"    </span>",
"    &nbsp;&mdash;&nbsp;A reference human weighing 70 kg contains 61 percent oxygen, 23 percent carbon, 10 percent hydrogen, 2.6 percent nitrogen, 1.4 percent calcium, and less than 1 percent all other atoms (phosphorous, sulphur, potassium, sodium, chlorine, magnesium, and various trace elements). Thus, six elements - oxygen, carbon, hydrogen, nitrogen, calcium, and phosphorous - account for more than 98 percent of body mass, while less than 2 percent is contributed by the other 44 elements that are present [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18789/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Molecular composition",
"    </span>",
"    &nbsp;&mdash;&nbsp;The molecular model is the most common form in which body composition is expressed. More than 100,000 chemical compounds can be identified in the human body, ranging from simple to very complex; water, lipid, and protein are the major components (",
"    <a class=\"graphic graphic_figure graphicRef79699 \" href=\"UTD.htm?22/36/23105\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18789/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Water comprises 60 percent or more of the reference male (and 50 percent of the reference female), of which approximately 26 percent is extracellular and 34 percent intracellular.",
"     </li>",
"     <li>",
"      Body fat ranges from under 10 percent in well-trained athletes to slightly over 50 percent in obese patients. Two to 3 percent of lipids in fat are essential structural lipids; the remainder are fat stores.",
"     </li>",
"     <li>",
"      Protein comprises 15 percent of normal body composition.",
"     </li>",
"     <li>",
"      Mineral comprises 5 percent of normal body composition.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, water, lipid, protein, and minerals account for 99.4 percent of the molecular constituents of the body.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Cellular composition",
"    </span>",
"    &nbsp;&mdash;&nbsp;The body is composed of cell mass, extracellular fluid, and extracellular solids. The 10(18) cells in the body of an adult can be divided into four major categories: connective tissue cells, epithelial cells, neural cells, and muscle cells. Fat cells, osteoclasts, osteoblasts, and the cellular elements of blood are components of connective tissue. Muscle cells include skeletal muscle, smooth muscle, and cardiac muscle. Epithelial cells include the cells lining a hollow viscus. The body content of potassium, measured as the naturally occurring isotope (40K) or as exchangeable potassium (42K), is the most widely used indicator of body cell mass because potassium is the principal intracellular cation [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18789/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Extracellular fluid is approximately 94 percent water. It is distributed into two main compartments, the plasma in the intravascular space and the interstitial fluid in the space outside of the vascular compartment. Plasma and interstitial fluid account for approximately 5 and 20 percent, respectively, of body weight in the reference human.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Tissue and organ components",
"    </span>",
"    &nbsp;&mdash;&nbsp;Body weight represents the sum of the muscle tissue, connective tissue, epithelial tissue, and nervous tissue. Bone, adipose tissue, and muscle make up 75 percent of body weight (",
"    <a class=\"graphic graphic_figure graphicRef79699 \" href=\"UTD.htm?22/36/23105\">",
"     figure 1",
"    </a>",
"    ). The majority of body fat (80 percent in men, 90 percent in women) is subcutaneous. However, fat also accumulates around the abdominal organs (visceral fat). Visceral adipose tissue is more difficult to measure [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18789/abstract/13\">",
"     13",
"    </a>",
"    ]. Visceral adiposity is associated with a greater risk of metabolic and cardiovascular disorders including insulin resistance, type 2 diabetes mellitus, hypertension, and coronary heart disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/35/30266?source=see_link\">",
"     \"Health hazards associated with obesity in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Whole body",
"    </span>",
"    &nbsp;&mdash;&nbsp;The whole body represents the final perspective on body composition. There are at least 10 different components of the whole body that may be measured, including stature, segment lengths, circumferences, skinfold thicknesses, body surface area, body volume, body weight, body mass index, and body density.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     METHODS OF MEASURING BODY COMPOSITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several methods for determining body composition. Each provides a different view of the body's components. The various methods include two compartment models (fat and non-fat, aqueous and non-aqueous), three compartment models (fat, lean, bone mineral), or four compartment models (body density, weight, water, and bone mineral mass) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18789/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. They differ in ease of determination, cost, accuracy, use of radiation, and utility for assessing regional body fat (",
"    <a class=\"graphic graphic_table graphicRef69462 \" href=\"UTD.htm?3/63/4093\">",
"     table 1",
"    </a>",
"    ). The most useful techniques are described below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Anthropometric measurements",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Height and weight are the most commonly measured and can be determined with great accuracy. They are important in making clinical decisions regarding treatment of obesity [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18789/abstract/16\">",
"       16",
"      </a>",
"      ]. Weight can be related to height by several methods, but the most widely used is the body mass index (BMI), which is weight (in kilograms) divided by the height (in meters) squared (",
"      <a class=\"calc calc_patient\" href=\"UTD.htm?41/23/42366?source=see_link\">",
"       calculator 1",
"      </a>",
"      and",
"      <a class=\"calc calc_patient\" href=\"UTD.htm?36/47/37630?source=see_link\">",
"       calculator 2",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/20/12615?source=see_link\">",
"       \"Screening for and clinical evaluation of obesity in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Waist circumference is another essential anthropometric measurement. It is measured with a flexible tape placed on a horizontal plane at the level of the iliac crest as seen from the anterior view (",
"      <a class=\"graphic graphic_figure graphicRef77584 \" href=\"UTD.htm?14/15/14577\">",
"       figure 2",
"      </a>",
"      ). Increasing central adiposity, as measured by waist circumference, is associated with an increased risk of morbidity and mortality. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/20/12615?source=see_link&amp;anchor=H8#H8\">",
"       \"Screening for and clinical evaluation of obesity in adults\", section on 'Waist circumference'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/11/32954?source=see_link\">",
"       \"The metabolic syndrome (insulin resistance syndrome or syndrome X)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Measurements of skinfold thickness are considerably less accurate than measurements of height or weight, particularly in obese subjects. Thus, they have little practical clinical value and are primarily used in epidemiological studies.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Dual-energy X-ray absorptiometry",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dual-energy X-ray absorptiometry (DXA) is one of the more commonly used methods for determining body composition. This method is based on the attenuation of signals from two energy sources to provide a three compartment model of body composition.",
"   </p>",
"   <p>",
"    In a study comparing DXA with a four compartment model of body composition, estimates of mean percent body fat were similar between the two methods [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18789/abstract/15\">",
"     15",
"    </a>",
"    ]. However, there was considerable intraindividual variability, ranging from -3.0 to +4.0 percent, with DXA. Thus, DXA is good for cross-sectional measurements, but is less reliable for individual measures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Isotopic measurement of body water",
"    </span>",
"    &nbsp;&mdash;&nbsp;Isotopic dilution with a tracer that measures body water (D20; 3H20) also provides an accurate assessment of body fat. In a study of children, three methods (DXA, isotopic measurement of body water, and densitometry) provided a similar estimate of body fat relative to a more complicated four-compartment model of body composition [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18789/abstract/1,14\">",
"     1,14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Body density and whole body plethysmography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Partitioning fat and fat-free components of the body can be done with hydrodensitometry (underwater weighing) or whole body plethysmography (Bod Pod). The first technique weighs the individual on dry land and then after complete submersion, preferably with a simultaneous measurement of lung volume. In contrast, whole body plethysmography uses air displacement rather than water displacement to measure body fat. It is similar in principle to hydrodensitometry or underwater weighing, but does not require submersion. In a study that compared air displacement (Bod Pod) versus water displacement (underwater weighing), the two methods were highly correlated (r = 0.94) with a standard error of the estimate of 0.0073 [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18789/abstract/17\">",
"     17",
"    </a>",
"    ]. Air displacement appears to be an important new instrument for measurement of body fat.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Impedance measurement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Impedance measurement is widely used but has significant limitations. Impedance is measured by applying electrodes to one arm and one leg or by standing on the foot plates of a special scale. Impedance is proportional to the length of the conductor and inversely related to the cross-sectional area of the conductor. Accuracy in placement of electrodes is essential because even small variations can cause relatively large errors in the measurement of impedance and corresponding errors in the estimate of body water.",
"   </p>",
"   <p>",
"    A variety of formulas have been developed to convert impedance, which measures body water, into an estimate of fat [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18789/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. Most formulas for estimating fat from bioelectric impedance analysis underestimate body fat [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18789/abstract/14\">",
"     14",
"    </a>",
"    ]. As an example, in a study comparing two bioelectric impedance devices with DXA for the measurement of body fat, percent body fat measured with both bioelectric impedance devices was 2 to 6 percent lower in men and women with normal BMI [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18789/abstract/18\">",
"     18",
"    </a>",
"    ]. Among the overweight individuals, the values were lower in women but similar in men. When using bioelectric impedance devices, it is important to use validated formulas to estimate body fat [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18789/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Imaging techniques",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patterns of body fat distribution can be reliably determined by either computed tomography (CT) or magnetic resonance imaging (MRI) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18789/abstract/1,20,21\">",
"     1,20,21",
"    </a>",
"    ]. The most common technique is to obtain a single cross sectional image at the interspace between the fourth and fifth lumbar vertebrae. The image is used to quantitate subcutaneous and visceral fat. Images obtained between the second and third lumbar vertebrae provide similar information [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18789/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      CT uses X-radiation and computer analysis to determine the structure of internal organs. It is possible to obtain an accuracy of less than 1 percent margin of error for body fat using a series of scans. To minimize radiation dose, however, a single cut at the L4-5 position is used clinically.",
"     </li>",
"     <li>",
"      MRI requires the use of a powerful magnet that surrounds the subject. It has no risks, but takes considerably longer to perform than CT. Movement will blur the images.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The estimates of subcutaneous and visceral fat obtained by these two methods may differ in absolute terms, but the relative ranking of subjects is similar.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Careful measurement of height, weight, and waist circumference are the minimal measurements needed to begin evaluation of overweight patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/20/12615?source=see_link\">",
"     \"Screening for and clinical evaluation of obesity in adults\"",
"    </a>",
"    .) If there is concern about whether fat is increased, particularly visceral fat, DXA may be beneficial. Although impedance measurements are used in many clinical settings, they do not contribute more than the methods outlined above.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Heymsfield SB, Shen W, Wang Z, et al. Evaluation of Total and Regional Adiposity. In: Handbook of Obesity, Bray GA, Bouchard C (Eds), Marcel Dekker, New York 2004. p.33.",
"    </li>",
"    <li>",
"     Jebb SA, Johnstone AM, Warren J, et al. Key Methodologies in Obesity Research and Practice. In: Obesity: Science to Practice, Williams G, Fruhbeck G (Eds), Wiley-Blackwell, Chichester, UK 2009. p.45.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18789/abstract/3\">",
"      Levitt DG, Heymsfield SB, Pierson RN Jr, et al. Physiological models of body composition and human obesity. Nutr Metab (Lond) 2007; 4:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18789/abstract/4\">",
"      Lee SY, Gallagher D. Assessment methods in human body composition. Curr Opin Clin Nutr Metab Care 2008; 11:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18789/abstract/5\">",
"      Chomtho S, Wells JC, Williams JE, et al. Associations between birth weight and later body composition: evidence from the 4-component model. Am J Clin Nutr 2008; 88:1040.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18789/abstract/6\">",
"      Loomba-Albrecht LA, Styne DM. Effect of puberty on body composition. Curr Opin Endocrinol Diabetes Obes 2009; 16:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18789/abstract/7\">",
"      Dey DK, Bosaeus I, Lissner L, Steen B. Changes in body composition and its relation to muscle strength in 75-year-old men and women: a 5-year prospective follow-up study of the NORA cohort in G&ouml;teborg, Sweden. Nutrition 2009; 25:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18789/abstract/8\">",
"      Gallagher D, Kelley DE, Yim JE, et al. Adipose tissue distribution is different in type 2 diabetes. Am J Clin Nutr 2009; 89:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18789/abstract/9\">",
"      Heshka S, Ruggiero A, Bray GA, et al. Altered body composition in type 2 diabetes mellitus. Int J Obes (Lond) 2008; 32:780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18789/abstract/10\">",
"      Scherzer R, Shen W, Bacchetti P, et al. Comparison of dual-energy X-ray absorptiometry and magnetic resonance imaging-measured adipose tissue depots in HIV-infected and control subjects. Am J Clin Nutr 2008; 88:1088.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18789/abstract/11\">",
"      Newman AB, Lee JS, Visser M, et al. Weight change and the conservation of lean mass in old age: the Health, Aging and Body Composition Study. Am J Clin Nutr 2005; 82:872.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18789/abstract/12\">",
"      Wang ZM, Pierson RN Jr, Heymsfield SB. The five-level model: a new approach to organizing body-composition research. Am J Clin Nutr 1992; 56:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18789/abstract/13\">",
"      Gallagher D, Kuznia P, Heshka S, et al. Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue. Am J Clin Nutr 2005; 81:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18789/abstract/14\">",
"      Bray GA, DeLany JP, Volaufova J, et al. Prediction of body fat in 12-y-old African American and white children: evaluation of methods. Am J Clin Nutr 2002; 76:980.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18789/abstract/15\">",
"      LaForgia J, Dollman J, Dale MJ, et al. Validation of DXA body composition estimates in obese men and women. Obesity (Silver Spring) 2009; 17:821.",
"     </a>",
"    </li>",
"    <li>",
"     National Institutes of Health. National Heart, Lung, and Blood Institute. North American Association for the Study of Obesity. The Practical Guide: Identification, Evaluation and Treatment of Overweight and Obesity in Adults. NIH Publication Number 00-4084, October 2000. file://www.nhlbi.nih.gov/guidelines/obesity/prctgd_c.pdf (Accessed on November 16, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18789/abstract/17\">",
"      Ginde SR, Geliebter A, Rubiano F, et al. Air displacement plethysmography: validation in overweight and obese subjects. Obes Res 2005; 13:1232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18789/abstract/18\">",
"      V&ouml;lgyi, E, Tylavsky, FA, Lyytik&auml;inen, A, et al. Assessing body composition with DXA and bioimpedance: effects of obesity, physical activity, and age. Obesity 2008; 16:700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18789/abstract/19\">",
"      Fakhrawi DH, Beeson L, Libanati C, et al. Comparison of body composition by bioelectrical impedance and dual-energy x-ray absorptiometry in overweight/obese postmenopausal women. J Clin Densitom 2009; 12:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18789/abstract/20\">",
"      Shen W, Punyanitya M, Wang Z, et al. Visceral adipose tissue: relations between single-slice areas and total volume. Am J Clin Nutr 2004; 80:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18789/abstract/21\">",
"      Machann J, Thamer C, Stefan N, et al. Follow-up whole-body assessment of adipose tissue compartments during a lifestyle intervention in a large cohort at increased risk for type 2 diabetes. Radiology 2010; 257:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18789/abstract/22\">",
"      Bray GA, Jablonski KA, Fujimoto WY, et al. Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Am J Clin Nutr 2008; 87:1212.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5381 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-221.179.173.170-7B5B02C4AA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_22_18789=[""].join("\n");
var outline_f18_22_18789=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MODELS OF BODY COMPOSITION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Atomic composition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Molecular composition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Cellular composition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Tissue and organ components",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Whole body",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      METHODS OF MEASURING BODY COMPOSITION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Anthropometric measurements",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Dual-energy X-ray absorptiometry",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Isotopic measurement of body water",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Body density and whole body plethysmography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Impedance measurement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Imaging techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/5381\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/5381|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?22/36/23105\" title=\"figure 1\">",
"      Body composition",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/15/14577\" title=\"figure 2\">",
"      Waist circumference measure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/5381|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/63/4093\" title=\"table 1\">",
"      Instrumental methods measuring body composition",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_patient\" href=\"UTD.htm?41/23/42366?source=related_link\" title=\"calculator 1\">",
"      Calculator: Body mass index for adults (Patient information)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_patient\" href=\"UTD.htm?36/47/37630?source=related_link\" title=\"calculator 2\">",
"      Calculator: Body mass index for adults (Metric, Patient information)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/35/30266?source=related_link\">",
"      Health hazards associated with obesity in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/20/12615?source=related_link\">",
"      Screening for and clinical evaluation of obesity in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/11/32954?source=related_link\">",
"      The metabolic syndrome (insulin resistance syndrome or syndrome X)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_22_18790="Micrograph of VAIN";
var content_f18_22_18790=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F68837&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F68837&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vaginal intraepithelial neoplasia II compared to normal vaginal epithelium",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 439px; height: 231px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADnAbcDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6NJ46dDTS20E846dM1zfxI8TL4Q8FatrX7tpreI+Qr9HmY7UHUcbiM+2ax/g/4xufF3h68OrPZNrGm3ktndfY23ROQfldOTlSpGD3wa3b1sYW6nejofpTc9ecgd/WgNgY5x0H0pcn15x6UCSuNI7d+OvSgjPOTS5zkHoKQ4A55H5UFWGYx6kj3oPHqOepNLnrihsnpigLDVJHc07uv+NIpP1H+e1Lk46j1phyiA+vvSKSVOSRx9aUkHGcUnQdc0BYGB6c/WlJwxwcY/Ck3ZPJHv2pCcH5jgelAWA52nBPT0puQehOfXNLu9MZ9aAykDAH/wBagVhCcN6igMeMHvilB+YjI60h5weP6imSGR2JpcjuSePXrTQw49SaUH8elAh5OCTn04oJHTnJOOe9NOQnUccHFHfIoGxQSSRz1/Ok+pPSlHc/xUDpnI59aGS0Ix5p3bvz70wdCMZ+nFLkD69aBD885yRyM10dc10YHjHHaulrKoa0eplawcTJ/u8fXNUNucegq/q5xMnb5f615h8YPFeq+GbbQBomzztR1BLN91q1wwUqx+SMMpZuBxkZpLYiSvJnoB6j8enrTMnPfp1Fcn8KPEt54r8F2+oat9nTUlllt7qKJWTy5Ecjaytkq2MEjJ6116/d7Z9aZNrMaeo/WlH3e9Kex6Dpim9M+1IYvIGemKRiCDjI7UrN1zjFID78/rQA0cAAnBA7E08cnknG2lwDgEZHtR0PX8qpu5SQ4EZA9abwOOnNBboMDjtij+H2/GlcoOh4FMLDPB/rTyTnn9OlNboQcA1SGCn35z1o7ZPAzQGwACe+elIWyc+nNUOwE8DPemsemM89aNxHXrn0oPIH8qENKwhYEexz0pGbIz0A5JJrL1zXtL0DTze63qFtp9rg4eeTG8jqFA5Y+yg15n4g8VeIdT8Qwt4f1O7t9CmhH2RbLT0lmuSRnzJPNViiYOBkL0Bx66wg5a9BpXfLFf1+h6Zq3iDTNKlEN5dqLlgGW3iBlmYeuxcnHucD3rx74peItc8RQJpmlLLbQy5P2JPmllUYIkmYfIqggjYW9znOBAfDXiKy14AeIYo7KYhp55HF1qFy2RlZMAYHUDJAAUetXJ9S0/Vri40mynnjEZKvLas7lMA4EkyqYx/ugn05NW0o/Dr5/wBf16HfhMPGMlOpq+3T8d328+5jaNH4hsLq1ji0u1kkdF+13zyCGGJW6pEnsOMY5Par+qX2tprls2hadeXnloI5kS3Coykk4aZjgepAHGBzUXiSd9L0G3Gm6hM0zSiKN4oUlcEe0jjk8DceldrawTPp8C6gbgXAhU7JJNoQkcnYCyg9ecmoTtaVlb+v60PQqzTbV9f6+b87/iReG9KtLO3kXSLODTbmf55vIUOpPoGzznnkHvxXOeKZ7288aWdkNa+yxO6Ri2ggkAU4yAD0LEZw3Q9OtXtT1q+tbieP+w7iXSrGLzpLreyySNkBduMA/MeevAJwMCrN34v0t9GsNUsIN95ctJF5jxiJ4gD86mQjgZPAHWtKalfmavf5/wCZx1ZK6Sext7tUOrQpa6YGtrdfKeW7lCySYB6nr17DiiixmfWtKgaW2vrRZF5AuDFINp4xIuDg8HPcUUuVPcyc5La39fM7jXtA0zX47SLWLZbmK1uUu4kZmCiVc7SQDhsZPynI9qh0nwxo+j6tqGpaXYx2t3qCxi5MTEK+wYT5M7RgE8gA+ua1+gHFKB13fnisGtTzRQTkgY496D1IPPqaAF74Pfp3owCDgAmlYqwe36ZowQv+eKbnHToKQsqgk7QB3PFDQ0ri44pWz3OeP1qv9pg3Y3hiM9FJxUc17FEuXjn2/wB4QMRU3SLVKbdrFnknHA96O/OM1m/2tbkDyo55Nx/gjLdfWlOohWx9ivP9lhHkGjmRosPU2aNA8nAxmmgkjg8Y6n09ax7y9gvrWa0DyWlxIrLH5ilDnGeOOfwrkbDSpXjjY6vEkka4IjdgeB1PvntUynZ6HTQwCnFucuW3kz0cct0HvQx+cnjFcaNPt2x/aOuCS1jXG0Sbee5Jq9c+JtC02IRx3MThRtEcI3cUKa66ETwUm1GleT8kzoj90nI54FC5x8uOBXIv480ZFDH7Rycf6r/69XbXxZoVygkN2sHtMpQ5pqpG+5E8uxUFzSpv7joeTnO0H86GGF5IwTnFYq+JdFlRZF1CHDDgsGHt6cUyLxNoz7tt8hYNjGw5/l0p88X1MXg6/wDI/uZtZORg4ANP3EgHj86yv7XtJGTYs7BuhFu+PryKqXviTTrV1W4S7QEDDNbsB+Zp8yFHCV5PlUHc6HkKOh4oGM+hz27VzLeKrCVGGnCW5m6KojI/Opf7YvSiiHS3lmI5Td933IHSlzot4Cuvijb10/M6ENxyRjrSkkjtgc1y8F/4kmGP7HiQ+pYAfq1WCPETJuENqj44DSAkH8Bijn7IcsFJaSnH/wACRv5OAOOnHvSZ/vbTjn8a5O81DUbZBHqqvbswP+qIJYdCRjPr3p8Wq280QENxcs64G57lVycd80vaIby6pa6d/TVfedUT645xXT15XdXN+CfJuAQOCvmI+fbPFeqVMpJkvDuik273MnWCPOTJGAvOfrXKeJ/DOk+J4LWPXLZ5xaSieAxzyQtHIAQGDRspzye9dXq4zcR9Pu/1qhgFeAMYoRxy+Jmd4b0LTfDumJYaLapa2qMz7FJYsx5LMzElifUkmtI9icfWm9BnA49f505cMRkZ/KnYQOSCfu/0pvYnjAHrRKSpbAJbsAM5oAwAXXDYzg+tACgZyFx2oHf86FAOTznHSlAGenfpigaQi8/3cfzp/Hr24NNxwTt+v0pCCOoOAM4NBaVh2OmcdKTIzjPGetG3H/1qQYx2GaAAEE84z703OAcYxmmtJk7I1DkHkDt/n+tVdSv7bTLGa8vpVhgjBZiefoABySeAAOSTiqWuhWxbB4yADzUF5dW1lF515c29tCTjzLiVY1J64yxArxrVvi3qWra7JonhLT1tZUOJ728gef7Nxk7wuFTHTktzwaiu/DOgeKrqK+vIz4huox5U1017hAwG4/JvwOTnaoHB6Vt7Lka53Y3p4epUjzRVl5noOtfEHw/p1hc3kdy+pQ24G46cvn8ngAEfKenOCcd8Vy174813xH4fmm8I2Euk3O3EQ1G33zv0BZVJCKADncd3TpxRbWUlk0K6PPBpmkKuPLslEZXPJ2uDgd+eTmor240ux1BNLlvpIricK4klzMCW6FiTk/y9qqLj9lf16G6wqj8buY3hjw/LqMfn+JLwalrqHzJrvUEW4MaY/wBUmflA79SMk1L4y1lAn2e2i1a9tHfZJ/ZlwIgWwf8AWFSCcntkHjrXSafZS2q3K3T3l/ETh3li8tYyMdvb6097aBbf7Lp9wsSEk/Z4LdsMSevb9c0c7cryN7RgrQRzlnveDTD4e+x6foCD97F9mcyqcncNp6HOeScknk+uxDY3cGoFZZmuPNEzRyuylkRjuEYUHDKDjAKkjaOmKTUYVa9Wa3l1BZ1IG63QnzG6HIH+Pal1SFZpoby+jms2RxseNl69vof0qW7mtr2RnaZbaFHq8waCO8vribfLPcW65aVRwuFGAB2yMnuTV/TNUEupT2t3bvZ/MdnmybjI3OeMcAflVqawkvZhPbXkVqoIaSR4yZNnfbjGT6ZIqvqekXl1qcEtlryrbow/0R0ZfMUdR6MxyM988indPdktJadSzY/bo79obnURdNNkRw7OCuOrE4ABB6c8Vh/ZPFcF4YoNA06201gBO0cqo6Mzf62PJ28Dnpk469q0LLUIZvE9xJc6TrGny2y5V54g1u4xgESKSv0H6VZ1bVdOsLnGo3draPKPNCzHyeG5/jA5weR+lVZp2aJ1duUz7XUdS0G6+wGGTVRI5ZrlsiVhg4AA44xyep/CitS/0ye8ghkMl3CIUEkEkHUq3HGDyMHrnFFaaPVGHup2kz1Ic9qczAMRxkVlX+r2dnIqSTxB25AY7R+tUk1X7U48m4yuMgQKGJ49z9elccppGNPCVJLmtZG/JIqRlnZVXAGWNZtxrlssywwEXE7H5URh19+1cB4k1p5bgWqO0zAkMiu7lef4gBjPsKgtNKjmCiWW7lyuXWHT5QV+jEgZ46msHVb0iezSyeEIKdeW/l/X6HdanqktvKgmubeB24WFA0krHpwo5z+QqjcSa55YkstKacN977WERiP9nD59eD+dYkOmWVhI0lvogjmZcJJe3uZWOP8AnmhJP04/CqU1i7GR8XEQ5QtaEmNTxlc7sfXmk5Nm1LC0lpG3zS/SX6kl14rdr1rdCsDrw73crpGp74SLP6k0k+oRKA099BiTjf8AYbgR/UHeCaZoFneWweKzbTLFHO55pMSyueMDgk/yrbuNK1K7ZTd69IkI+83leWpHoATk/pUpNrU65vD0pqK0X3v/ANJf3XMs6gttE8kF5pr7FziPUZrc/wDfMgPP41lweKDfAbLe1jkGAZp72QSZPHDAge9bB8MW8rs8ct7dFeQ7Rgg89Ae341bs2t5CbXVdLN4Tklim2fH+0hIJ+qE0uV9dCufDxTkouT+5/don+BnP4p1K2RrPU7S31CN1C7TLtkPPHIGG9QwqfT59VvkYf2NN5UmNocgFx/tMAM/Xio5vDujzO39m6gEQHLWk7bWUd+vI79RTotJ2yFILpI4gMBhqDBSPTGeTTtLqS/qyjemuV9bpr8L/AJBdaRrNwpNrokNqRjgMP1O6sO60nxFEjSS27NEnJDBNuPY9/pWpq3h6/UoNK1eCO4yd0XmyT7vTAHI/Grllo+pGFEvtQX7YPmaMfeDf3sSEce/NDhcqnilBJ80WvR3/ADZzL6ZcO8cms2cttGQFEnlCJR79MHt6VJPb6VbQbbdb25AwqttUAk9uv155rbXT9eM74vzcgZ+RV8wDPc8bQfqakiSfT5hLNZzm4X789rd7pMd8jBUfSkoGzxTe0k/JO356/cczEulLFtnhuFlc54jyPbB3c/iK0LDT4ZfKE739jbyfcbBbd6Y24wD+NdPDqVuC0qC6uYyD5hlfEh9iysQR14IH1pgNpelzoVjKsrnL28nltC59SpbrnnI79qagjnqY2ck04ted9vv2+5nOL4YuY3ludJ1XzYJJNsaXClmkbuFGcge/4mreqaRrKSLFOLtrfGWXzfPPtwvaursdL1lgDdtZ2bEEEwJkhT/DhcDr6k1DbeEdB02V7iGIw30gO66D/vSSc9OmM84xWns7o4P7T5J6yUn5K/46fqcZbweQhV7LyJf+ekkzqufZcZz7Vr2tvNHCJFuHsm3cBopBGfqSC2T+HSuiZdcaXbZ3cMsYGPOlhMZHpyev4VXl8PXFy6JqGr3ckr5OIoiUUe5Pb60lT7FVMwjL+JJL73+DRytze641y8c98Y4kbDMZtgbjtk5/SnRw6vcQbXW5c/wYeTJz3HHP5108NlHoPyx3emmQc/vYAsh/EEn9Kv2V3ean5nlyQMASCN7An324yAfWlyd2E8eormpwXL31X6HJ6Vdw2czrf3GoWUpwDJCSN3puzk/pVqf+zbqUi2G9unmTlFLn/ZHBNdTPp8MiYvtKilwPvJ856epwagn02wmtzFHp9vFGRnfIdpx6jBzVcj2ucv1+nKXPZp+qt/Xlc4+bSbKyZ3vEZs8q0cmAPYjGf1r3WvGby308bljM9xL0MiTMwyOnOMfnXs1SlYzzGo6ig2313+Ry/i3XdJ0i8t49U1K0tJJUJRZ5QpIHU/SsBPG/hYgf8TywXPyhndkBz/tMAKg+LCXjX9udMtLWe48jk3IIXG44AI757fSvPtV1yxihi0vUrVp724Ch7O1jMgDMM43cZyO9dVOCklp+P/APK+r82vN+H63PVLXxNoN4F+y65pMpIyAl5GcZ6Hr7H8q1Iis8Qmh2SR7ch0YMMfUcV5A+iabpvmy2Xh+FmkQboUyHOO+GJAPbIFZ2l+GtB1yyWabSX0lopML5VwYsHrngDPPrVckHrd2+X+YLCTto/wCvxPdQrAgFDwecimnqwGCV4Yeh9/SvHb/SPsmkeR4bZ4rmIF4kF1MyNnORnf79M4zSeAYtbi055b5ZtJu4ZBIQlwzpODwSwct2GOc9BjuKPZRab5v6+8mWGqK1v1/yPZeMKBt5YAc4yfQetIe+Aqk+teV67YWOo3kWoeJ717uCDJgEtwoijyPvAKoGfcc1e1LUtR1W0EXhzxXBa/ZwFbZEkkr4HALHOM+pwTwfWl7OLt734afr+QvYVd+X+vw/M9Hxxg4/PpSDrjjpXnehx+JYrbF94puZpE4Xdawlcf7R2FifXJqxMPEc4U2niKWSVeWXyoFAz3OUA464wRSdNXtzL8f8h+zqW+H8v8zvGXd0AI6e30rM1nWbDRmgTUJtlzcNsht442lmkP8AsxqCxAxycYGOTXL3mmzm4e9vNSle6aH7MZFvhEHTOSoSIAZzzn684rnrrw74SuXMMupzQTyYjnS1vZGMmBwHIbLY6DPAzTjCF9X+H/B/QtUJv0/ryE1D4rXTeJho2keHNTiVpikt7e2jKsQ/v7MgbeM5LdO1Y3ixvE6avDeaXY2OrXZ3Ib29uNq26MRlI48gIh9QM+pNd5pmmw22mRWEGP7PjUKkc82XYc8ndkk9cEnpVG5hnjtJI08y1lVW8qcx5wfXJ/pWntIp+7H89f67bHVRoRj1u/6+X6mTfTNFpEcutQz/AGiQZmj05Hu0YnjGCuSCMdsckVR8P6Laz6RJbWmjXej6dv3fNGLYykgZOOvIABJweg7Va0jTbxr1ZBftMQ+R9naQzHHbLMBg98huO2aXxXaa7M0C6POtpPK5WRJXjjx0w2BliPvE49KltX5U/wDI7IuXX/gmrFZWdjCsCW6JCibliRCxx1yB3J/U0kEFhqMA1OO1MVypAUvB+9OOmCeBj6VOk93pOm21oon1B45DE95LGqgOBnJ/uoPz57Vz14utx6imp6xLbtbwkt54RZkcEY2xhQSfrxipinrZkX5nYvW03iAahLFZ2ttBZKfneedppZlz8xVQcZOewHPWqGtafAusi91PXNY2E74tNFx5Uajr8wTBI4/vfnWnpVydU0+Z7a3m0+2DbmduA2R1yT09s8c4p02jwatbFLZsyJGEW4gKylB69fXtVc1n2Dl5XqyaW4lhgXz5gkbqDHuYkBfUAcbcdzXP36eKLRZjc26zwvhmt0iiddh6Yycn15Kn0ra/si20zQbldbv55oN/mu5iJVW7KhyTzg5965RNf8Lwtruq2ej6jdX15MJr+4uhvZjnhEQHCqOcZwR+AxVNatpX+QnrZLTubqeIrXSrS2hvYEidslltssG9iWJ6e369asXOtaYWFvc3unxyyIpiEkIZ1B+6A3PHPeq2m3zX+nQ3NpBLBHKMpA6bGAHAzntxwfTBrH1JtQmmKanpGnX0JKsoa1WVhk854DKw9SSD6iiMVcuS2bL9nBq9rqV+lw97qMDsAZ0iQxKCm4OF37yM4U5AOT6c1kWMVx4ku2g1qDSNT0+LcsJcgMjE/dUcEcdc/rWpHrVhCX0vzIYx8yg2CnOVGN6gDKkcdOOelc/qPiC+06+s4Ydc029Xchmn1CHYzRPjYxkCkFcZ5yMHHetoKT1S1/r+tzN2jpJ6f1/Wxv6La6fotwdB8Pme1uAxnhju0Z0QEfMI2P8ACQM+mfeiuha4uFvI4v3UChfmCx70Jx0HORz60VEpMjc628sdKhgaTVDBIwAY9gPYAdfqeT61h6jcQm0KaTYQfZ3OJZIbbzDGvYg9M/jV+0tLiJ1a7ubKS4kYvHH5e/Z9FGBn3qa+EsqNHe3kaxkfdaQRD67Rz+tcEtfI9ClanJc0ub77fJWMnR7nS9LSVLK5SF5cbpP9dO31I+Vfp269aXVLuJkDyXsWCMRLLI1w/wD3zkLn86z3sNNifMEVxeAnjy28qLPsc5NT3VpLGoMWl2Nq2PmXzhIzfgQeaz9TudOnzqd3d97frr+DDR/DcNkkko1FLRLjmQQ4DOPc54/A1rWVppqhYLET3wQEYWQhEHvjisFbTV7hw0WnxIh4/eRopz+WKbcWOoRSqrWl6ko/5apIcH8U6infyFOm6jfNVV/K36a/idSfDweJhGfs4PdJGOD6A561ai8OrEweG9nSbH3mRZFzj0auWsdT1qAiO3UzBsgb33Y/MZzXTW8+rywq8qtHL/zzSNW/DO4dqpOL2R5+Ip4mnpKorev/AA5VvLfVYL2KW/ukktugkt8xkemR6/jVe6i1O/Z4Va3vYgcqlyNrLjurjBzVq9mZ0VL6+urRSeDJaBVz6ZzgmqaJNbuZILo3jY+40GAw9Mg9fek9zWk3ypu11to7fkvzKbQXFrMqa/bTrCPuXHEoT6P1/OrUul+GgjSSXTuxGRmQqMn2GKz18SavYyPCbcSQk8RyZbA9M96fdi61mBJJNG8iEDmWBQT0646/lUp9jrdOqmnOXKu8Wvyev4kGk39vbrJbTz6kLcMdn2fGCvbJAzV8HS52LjSLqaIf8tGd2b9TWW9lY6aQ9nq002Rlo9w3J+H+e9bun65beWqi8LOeMPDjP0xRHswxK/5eUU3f1X5Iri40uEbYptSgX73lMhdQPQj0/GrR8RxQps064gkYdEMLJkemQetSTavZqMzpKisCC6Rtjr9P1qOyn8NkMHmhYyHJ3qF/n0q/RnFJJq9SnJ/j+n6lqK4sLxFfVrBbeRutwqnZ+Ei4IP1pG0XTLoZjvUaPsMrI6/Riciq8ml2ryGTQtaazk/uowkjOR6E1nS2EzPs1nULONgxxJ9jGGHT7wwPzob7kwhGTvTqOPlZ3Xys/zNKbSbC0UP8A2vIGX5Qks5wf++SD/OnCS0EbCLSJrxyOCnmMD/wJwMCqNohsCP7JvtPuJhkZ+zqHI9jzj+Va9vdajPGB5F62PvFpIkBPqCeaEzOrGUdXK/q3H8LIqzG+jUfZYdTtm64VJJFXnphs06OWzlLDVdTu3kByY5FMGOnbjj9K0msryVNz3Btz3xKzkfj8orNfToUn8x9WQueczvux+BYinaxjGpTkrN2fktfvsyWPUtJhDR6dZvPIegit/MOfc8ms24W3uyHazltZ8ffSNoyT34yPz6VsJd3FtGdk1pOoP3UhZQR6/LkfpWQ/ju1+0LCkluHLYIVmYjnk4wP50dNSqUaid6UW/O//AAB9taXaQoE083KAcSzXjYyfbdiqsyfZp8XggiYfME2lwPc5PSrU+qPGHliacg/eEUIUE+vf16023h1O7Pm/ZjJFjI+0BQSDjp3/AMaSSNHKpZyk0vm/1Zp29o6ohQR4KgjYBg55z0NejV5w8F+VCiK3/wDAlgR36fhXo9Nnm1W27t3PK/i5oxvtb0y8jvL+1khjwGt5AFPzHqCRnr71zWpX8Gm3Dtc26vceXtFwibZQvswGB3468npmpPjtrOm6P4y0yTUJblpWs1EUI2xxE73ILSHOCcdMduTiotK1S2u4rQS2ckQmQGMSkFlJ6A9D2/8ArV0qElBN7F02rW3LEFpDcWaxXAupJWKtA8jqrfQcg559azfGl3YW1vDZeITqtuzttjkEG7LDnHUqxx754rO8VWr65rNlaWeoWMc8CYksXuAoWTOchnGH47Ed/bNdFoNlrNppMlrqdw3kpxEElDcf3Ax6gevb0qtElJv5GmtypoVhHo1jNLbS3V7B0Cyja27ryOc1Jq2nReIdI2XtzLp8RO9XUYYkeqdx+PbvVO31jxGq3Go39jGIYxstLS2fIBJ++xHHHUknOTjpUdo11rOkyxatG8UJVQt6dykEHIJz1wQO+DyPeh3vzMtJtWRd0Ow0iTRZNPtbt76DPmyPI2z5s5LAIeB6Dp1qxocWlwNNFopiDAhXmBMjHH+0euPbpSaJo0Wk28om1GW9MqhWZ4/mwP6c/wD6qvCxtdNSS8ZQqEAt0Xd1GT3x171MpatJiUV13IAY7O+c3WuwMWG0W7tyD9AMg1oEfahIkELsLhRmZTg+vGRgHisiG70m9sZr20ijv2jXb5WzcVPHIOeRgj061fEj3FnBJdCa3L4CInyqUx0C/wAP4cVLVtx/G9DPstBtPCcN89hFfXcs2ZHgS5EjtjOFAbAHp178msu317U55nTVdA/4RvTGjJfUrzUYY5WY8DAAwTjJ4HH0rV023v4p3nvphHbMwWC2trfOM9Gd+vb/ABxSa3Fomsox1TShqqwyYiRgy7n4zj1HPLdOeM1UXd+9qVL3Xqyr4a0DSYLs6nYaxcaoTlQ0t4zxE+4GQTkdz3rahjbTmuJ5NUlInkPy3E6qI/8AZAIGP51weqQ6dLeWGmeEdcvdANtI3lx2a+ZbPIRkiRT9/kHrkdsV0PiLT9F1WzsrTxZE95KFGye2iZCX6MVKngE9ufpTlHa738tbf15he90jT8Sy6mdNEnhmw0y5vgyBk1J2QNk8kMNvOccE4IPrwcvSItUGkynULbQ7DX5nZIxp8hfemAMc5Prkjjp9K171ZbDTY9Og+zWk7IIbLZLIcouAdzY+8fzqvoqF7hLmbUTqAdXiEsSAIMkcZJOcEBcgnJOCBmovpYuMdOa5zPi7R7C+udLsfE9xqcd/DGkLNANsG1m+98zDLZ4JAP4V32l6NqUVwsc0kMVkoKRQQZaJIl4jOW53FQCcE4J6nrXlPhTT9HtPFmoxaJe+J45tOck2Mk22JxkBtoIJ+UkcEZwc5Ndvr/jPSdIitBdy35juw5jdIQViK9Q3IAI5yPpWs03aC1I5Xv3MnWft90dQs/EuLDQbYmZL5syLuGNsW3dufdnJAAwR3HFZtsqHwjLJo2piK3acNcy3cfkiZ9vypGFyQoHXPOTz2Fbwtdbt5nbxBLp99pi/MzToQoQ4K/LtDA89MmuoiuNIAguBpJ1N3XbGLa2V0gQEfKEJ+X16ZNPmskl/wCb296xyfh6D+y9HzqFytz9vOwLbxs0S5PzcNjg/THPFZfiC4u9NvU07TWjh2YLJEmQGI6Fjy3XrXXap4mgfUL6K2sofKsI2lkEX+tbpwccD9cD6Vg6FqMev6pJc3GnR2lzbLjzU3FN5B2/MeH6nkYxjpRG7vJo0U3otrkWuam+m25Vr6ys5ZCA0tyyqpfbkAFjwvYnnHXBrShN1LptvM0dlPqo+YLHdBQU7Ybo/8vrmuR+JWkwa3LpOkTu1pLIP3VyiFgXycqSOByAcnH1re0m4tND0zSbeSWCbS2hKfb8/N5oAO3yyM4OTgg5XuuOatxXImtyXK7d9DOSz0rWL2D+1tGutI1M9GRg6yeuB1B4ztGD3wat3+lwSxXMOow22oWEI2svKvH2yrDkA/UZz3pPGFte/2XFq2gYuLu3dXfyY/NR17tswSfTj5h25FLb20mtyaJr0dy2m3qRbpoTHu3IDhkIOMjOVyeoIJGRVX0Ur2/Qzb3i0TSa/peiaTazwxXc+nEC3gW1ImKqo43lmDdsdT2op2rz3EEC33h+CGS23lLm28kNz2O0ZJ5PbpwemRRVwjFrb8TNyd9PyZ3pEMEyy3NxBaOQAEYjcB6bf4f1pwn0/JeNQQfvXDxBicdlyMDFZv9o6TMhRGkctziC1Vcn64Lfjmpm/s+UwxRwXNrvO1Z7hjtT3weuen868i/Y9p0nvNP8AT/P8yG7YNIZIpACBwJAJD179APoKispHa4IuL9YgT91CiE/Q9vpW4dLVYj5cGnXgx8ruSGOPc5qpE/2mb7KtpY25wQ2IwxHHXjgUuUarRlFqKv8Ad/w4s1wbLc9nqSyoMcTDcCfY/wCHpVhBqlygkd4o1OMADqPpzU9rb3628lvLcwOmcbWi4xjGPQisiUahZStHDOqIvQBcgA9sHoPxqmrb7GELVLqNr93/AMMi1La6mjCVpF8zPGFyCPfHWtCz16NHWPUQLWVQBu6oSenPb6GqcV5qkiKR9jmXvHkox/pWDrN1IAw1KzlgLYAOfl56DOcVN+XWJUcP9YfJUS+W/wBx3s11Zm3djPDIhHQOGB/CufstKjuLmQKrrESWBDlcY9MGqnhzS9PvgGinlDdQEfac9sCrem669zFqMNnDPcx20pi85h5bHBI+6evSr1lZsx9m6HNTpN3630I4bS4S6aTZNPYxHDBpNzqfpjmuotmh8pTA67AMqQegrn9M1cqjqljdSMWLEKuMHgd/wqC53zagPKim08yDc6zYUSe496E1FXQq1KdaTjPS39bD/Fk0Hlo3kLO6PkFVBOOuDXP3FjPfmS503DIoOIlbawOMgYPSuvt7a2sYmmuXSdwBzkNj6e9cn4vj1K+X7TocVpLdiQYW4mMKmPvhxjn6/r0qZK71OnCVlBckdl1e33DvBGtavqNzdWTuo+yYLG4jLcdMbuOfbmuteC5DZn06xulx/wAssB/yYc/nWSE0iyQSQSTLcBfvwSYbPp6P+IpIfEUk77La4QqAQZXgZcfUc5NUpJaGFelOrN1KULL0a/Isajb6HqUZguFisLgZwSggkT+WR074rPttGZbwwwNFqlsvLNLM6que3GQfw/SrcIs7y/V59Yd7jGESWBF+uAw5rRudGnKg216IHByrx2yKfx24zRa+pn7V0P3fO1fvfR+WiZBF4agEUkTOqGQk4hhVAo9BuBP61n/8I9FZXDOdUiG4f6ueMt19Pm61alh1CJtt/eXkkecmS3Ix+IA3CoDdaFp6kfbXMhJZh5j7y3fPem0tghOvrablfsriyaZay4aO4vmJHPk27Y/AcU4WGqR4NlNcsCcAXGyMfzJGPpVFvENkwKwPdxkDht7ucewqneanZSSBLa51G5lY/MXJCj1G0ck/lU3XQ3jQxEnaSfzV/wArfmbUsGpRJ5mpazDbIudwSUg4+vb8qybHTo4L43VrNYLv+bzJxvY98gdRUNpHbxTR3FxbyzMD/wAvHQfUHj9asXniQOSihYwMf6pMsBjscUrrqaexqpuNNXvvokvu1/E2re+1F7VZbh1gYgkILR2z16nisx3DM6z3sdvHu3g+TsZj64z09Kzl8TbZZIn097hgMu08hwAB37dxxV25vLzynaJ7KJANwSCPd29abehzRw8oTaslf0/4L+8kPkzKcX0ssYOGKIic+gJ5r16vE9PS+umMzqHiQkuAArH24GcV7ZS3OXHR5JKN7/18vyPKfijbG88YafHFHEHjtBLJK8KMWXeQEDHnqScduTXO3czw31nvvrcRJlpt5zI5PBA9P6V3vj2Fm1WGVYyR5AQkdeWOAK8s1yGwgW+v5opPtMKggMflZzhVOTxjGeM44+tdVP3rJmcPh0IrbwzZ2EbLpii+uwHJF9MRgHrtAwN2O55xW5PfWtzp9s907C1lhxLBKpcOmMMnYgjkfrWdoUn2zUbO7EwikurP7SLNgSY2/hJXpjIBAJGQfSpZ7u3Vra31aKe8vFYLGx+U3Wec5Uc9ge2aud29WaxS2Mzwr8ObXwn4sutQ07Vrs2MgBWyIP7sMM4dv48cc4BAyCT1rS1aLxJJqkX9n31tcaX8qzl1+aM5O4nJ446DgVZ177ReWgh06URSsyszITuALEduwBC8dT9at2l9JYQyC0mlkubMC3k80bfOfDELkn5icH5euDRKcpPmlqSlZWQmi6tZ6ppttfadcXM8UKfv7Z4vs7oVyCWQn5SpHIBOe2aZ4kuLUwzWWsanp0CXce0RSzqk3PAOD06jrjPSsrwR4i0zWNY1Oyj0k291EnnyujkqxX+FgRxzjj+lUW8Ixxz3es65M2q27XLmGONVG52+9vcZYrgYxwOnXpRyKM/e0HzNruJpcOl+Aryd9T1kS/aYAqwwW2DtPQgKcEf7Q69O9adjqFp4ime70zXf9HjA8xZYjEkIHZyT8vcepNX9S0LS9WVNRuNNge+ljVIFuV3RwYA/d7OhOMYJFZXivQLG60i10uxns9MuLiRLpYxagRSsAV2yIOSeQR+FU2pPXcI6bG3cmD7crpqd5HbuYxGtsPOUoDk4YEfe7t7YwKlkvFh86HUZ5biO4kxGsYO+3UjB5z0PHHWsiBW02ez0m1tY5beziRXuHPQYB3nJxjnPP55qlqfiG1XULjS5l1LS9TGJImltg6SgjrGwOHUjkkGoUbuyNJJdypZaTe6XrE82nQZ8iORzDsJjkycJhwc7SCMr6857V0UGo3rWCTX1tFYukfmPGSGUnHzAcZ6Y79+tc/e6tqAt30zU4Pst+m1jPFnyriJvuyocZ25OGHVT1FP1K+nttO07TdQsY71bxJILmHPzPEx2bEI6Eg5JGcZBI7hyTk1fcaS5dDoo9PtLZhIskz2bujCFoDIqMACOvIJDYIIGffis/QPCmm+ETP/Ycc6pMzMsE826F5MEKATwvBIyeSMckiq/h/T4fB9rBp0eq3N7crvS0W5cLvDbhDCcnB28gAHqc4AwKr6P4nudSa3uY9OurG3ivBbajZsCQVkYgSKQAcKwGQRkZpKMteV6Cvffc1NO1eHWmZL6C50XUnJjVh947TjG4enOD0PvWzfWyXlhDZX8BvUgcSKZ7EFZGUfwscqCffBqtF59v4gvhJZSm0eErY6gJVbzUkTcVAAGGVxt+bqCOcVzPhfXdZ0bxBd6JrM8MkGoIJbCWxglbyewdyw29V5QnPXBIIylFu9ugSaaTRXW11K31hr/xHevHYypILmDzfP8AP+U7FSMdDkg5OMEcHmukuIb+2iis9KmjsLKPa0zPKDKzHkg45/DpmmW8uqW1s8+qWdnc3iNG0clm7EOXTLyeWygxkHnGW6nGMVj3bQ63fjTVu54bq2lyHfrPH/Fhu7DOOaq/MOKNrUNZsdNeJ5IZ2MqiYzQAAHtudRywxxjrV2Ozs2014Fso4hzJttzlJlPIIPrjsfSuYuLySOK+ufElssWnW6Yhj2bGU8AKrZ5HBJJrS0HUtM1fTYrpc2sabolmkKyIQO20/eHPX9aqzS0IcVcsaVZ2rX7yrNJLCp+aG5XbLE6j5WGenAAIxhseorDs9N06x1K4sGk+eZdy2UkgVj6MgJxKB2KfNz0OcV1DG5S+tHt3jk08LtWMW+WiOchxkkkewPHSsjV7C81ZXtpNAsLkxNvVLnbLAzcnMZOHhY46H5TTi3cTstUZ+l6nqWk6iEv7dxavnlBk7umQxAz26jnkHBFRa14ntLbUb2KRZDBHBvCqQpWRsYjB6AnA/Kk/4SHULC9gttSt4YJbtz5dtcbo5HI67HQMkgGRnof51X8XHSJWhjutP1GZUL3BisiVVycBtxO3cRjpkEDkVpGK5tV9wpydr3Ohsre2mso7rS5Hgju0SQyDLk/UevXOKK5G4ki16Cxurb+2NHhtV8mGGazdEYYPzrg9ccYOe3NFV7Pu/wACFKO1i3petGC7mjguYg8R2MYH2jdk8kfeB7H1rs9O1241dBYNexSNt5hZghcegJ6niofGX9kfa4rU+HIbqNyJ4bq3udqMg6scDgrzx0rjtY0yXw/rDrb3aXNtPJ5tjKDksnJIBHHFePzKTaufYKnTrxT5bN6q9n+TdvTQ9MtbDS5ZGg82W0uV+/C5QEewPQ1bu449JtDcX/2JrRThVA2THJx8vqfYVzcGoWd1p6ebZypqEKgnG3bn1wecf/Xq1rkVpqemQPPbvHPvBhRifKB43FO3pxweKqPKeZVpVLpTbtfX/gdbG5ps+n307CzvJoY2XKAyYDn23f09K0rnSpZcj7dMMcjcqk5+uOaxl02P7DFbak9xBGoBRgEKAfguV69DTxZ3+nRmawvZLi0xnaGBIX1GeD+FV6o5JRV7wnZ+ev42GT3F7pmxbhYmHOJMfKfofX2qLUbu21Cyex1a2lSKQqyyAn5WGMMCP5VdfWYmsfMnMd3ATsII2uM/7J4OMdQaz9Et4dRnkjN60cJGVjV8Mc/w89Pwqb2fus3UU4OdWNrdV+hPY6PpsUGLa/heUDdmZgP0BBqjA0dpczlrowzscOqglZD2OcnP1z3rrv7N02xAL2lsoxz+7ByfXkf5zWLLcWMeoRSiOK3t1487yiEP+znGAeKJxM6GI9pzbyXyIbLxKLR/La2SfcMZil+Y9s4NX57pdWiEVwY4YsAtG42vn6EVYv7uyvmjQrJ5uN0Ukce7aeoIxWVe3cmpSR2VzaxicZCzEEZ9xnnn0ou1pcmMYzkpqHK+rv8Ajqaken6IkPzw275HJIyfr7VzrLpkF84Aluo85Ea7nHt9B9a0L7R763sWAktAOMhNwYD0yal022uLyyASQ2MagKwh65HqffH6UPV2sVSmqcXN1HJPzI7WGx1cokhgtYhx5asBK3oM9h+taP8AZa6aoNheNbrnO2YeYvv71z1zBbw6PqEbQwXGpRoxi3pjzH7HPX0PWqmiwT2ujwPfXENxeuM/ZpQ5YemCp/mKa03JqQc3aM3a+1r389fzZ09x4ettTAN7fzXGMgBCgUA9cDH0568VT1DSF0mCJrXVb6KDeA0JlLHHqgqpY2epyxsU0uyiUdPO3AnnpweKt6JYITIZNRa3uS53Rx43R+gDNk47Ub9CG5U/iqXS6WT/ACvb7jJ1rVtE06AKbe7kun5Usj7ifUlu1ZNgkl3EwBSGFvnkmMQ3gZ4G45wAewx3rqtdh0q2C/2g9xf3AJeOOeYsMnjJAwFBqjpTaBBEqTXcdxcFcNkMwUn0GMAdqUldnXQrKFFyjGT+V/uKGvS29ho1mmi2NpfXbzqlzJO53LFn5nznOfYe9NuZ9LjE/wDZMlzEd2FaMlQ3PfPNX9b1VAstmENtacAwrCVYr1yfRSe3WseEpJKEtbRzn5lfBzn2FKUleyNsPSly8829ddX+f/ANO3ZW0/feNYh3HztOxlkwTjOD39hVLT7ySzif7MkeTldxjGGHPcnjjtVlrXThZJ5LST3+dzKAcDHUEY6UyG2097GUm6SOZh8oyTtbPGfWi21jNTjaXMm032/QjRzdXIuLuSME8ESRFh+A4Fb9nc2hCq2opGnQhUC7fzzXP3M0MNiolu3lnK7RGDgDPB5x06fn2p9uY50WYo25eDh1CntnB709jOrTjUjfVL5fqixZ6hZXWoyQXE95FG+V8wjaPbPHNe114iYVkkQXDtFCBlSqgk+4P1r26i9zy8fBRcbO5yPjnSk1YG2uI4ri2mhMbwOSN3J6EEfz7V5lrSrBNolh/ZN1f6dLMIHmRtwtmAGxph1KEZ+bOBg5yeK6P4qazqHh3xhpeqXGsx23hlbUw3Nk0YJkmYsEYHGRzjnoNvvSR6VMl/8AavtcojZY1MUqgxIQv3o+M8nAIzjPYV0QvFKT2+f9XOanJ2s36HnOveGtaFnqP9hXUX9panIBcXUzeUIrYdFU9ck8k+gwKs6JPb6VdWHhozPqGoRRSPPMyKqwKe59N5fgDt9Km8eN4iP2O00a1l2SuGmuRtIchvuZLAqoAyTg+nSmX/iLWW8V2WjWfh+++wzN+91KYN5BG0MxiJABAz9e1dCcpws7dfw/rY32loSaXd3l3r13JNIwiQrbxSBDgyNJgAD1VVPYcle1aOoaPFeXuj3jzlH0u5kmS3kIZGLxlSdvUEbQyyDOMY44xn3Wtz32rf2doyElfkkvBLgRJyGZT14I2knHJXHBFal7q0GnWV9JErSyW8n2fcxBbGSwBHbBJ654x3qW3e6QSXRljVNLa90W5tNLli02S+QSTXW0kebtBVGxzsBOMDnnPJp/hDR7zRfDlvFq1zDdOGleZ1kLKobAXkjOPunkc8VleIdK1jXbTQlhMh09gklyCRgHqXbJBAQFiMZPOfpDpltqEnjTXrmPXLK80a9h8q0to5BmNsD5SB0CqrEZ68ehot7rV13+7Qht3Oh1K/eBZbWIq1wYDOI+GJO7aCvc4UHj8uayLyyW4/s671PdFd20JaSIDKkA71UnOVbj8BgUXklnYa5p95c3Q8xLEy2tqG2PMUDozov8W0ZY4HYGo9Mto7mebV475ZrIswmSViOoPysTx9D/APXqY6K6NLdiHXZ7XV9NEU+oRQyoIXnizskRZAeJVHQZK464PpnFc/4Ut9RilurHSPEct1HBcCSKwvwVNvjIYoDkc7sfKR9OTWv4s8OWFtc6h4hhsZrjVXtFSSKIkrcJxhwBnsqklSRkZqPRRe6jqcOs6bZxPZvYmL7JPJtdLhMBY5H28AgZDfoK1TSg1Hb5FwV7NnZw2011ZWsd4Y5Vi67xzG5PO32Pce30rjbufxLH44QbojoyR+YcJgCLbzuOc7s/Lx6eleh332pIlgsLUXF8SEihMgRSfdu3fmueOv8AnrMLiwayW2laO/fUT9nFsin/AFgYrtkU44wcc5Jrli3q7JmujdjD8R2en6x4l02LVYblZLGWO/sJEceXL8qko6kE9V4xj0qt471u+0CCWfT2lneadDDM6l1VcElRg8nOB+I9Kmv5IfGfhyD+xL/7IIrpotsqusiCMbWRmU844bI7Ec1GNVt/D9nbwXOo3GpeSUMz8ZjVyqqydxjOQevPvXRHdJrboRayvHr1N/whbtasmm3kkkUOozNcWyzA/wCiSeTG5hyeMBmfGeeMdRVi6vLi40u9u7GMfaTAzROEXEsjKRuU9n+RwfX15rmfB2tXE2v6lJqlnP8A2To8j2dvcyTOxnkE+T14LZALMM4UgZ5q94B0S90u11TTr4hCNcnu7WEzAyC23AK20HKqXBxkDnPTNRKNrt7mbavcpaHq2rXll4T1gIvlXcfk31nLEFLSK+wsCegxggEcVpziyj1LVF0HyW1WN9k87/MckHBU/wAK5GCfWt5LqBRbTq8MkTBbjDfMrR52kqexBZcHvmuft9IWx1/VLhctd3kyERopAVMFgwx1JHPFCknfT+rj6lC1eXULUWviKRomckRiRirFuhGR/n3q7/YVokKQ2twITErxrsx5cT8/K7E5GT36c8msf7akyRnxZpcWl3Mc4FmXfdGxAyMFf4ffpyPeqFxZPqrajqOiX632l6gJLW+RWKtEJF5ODzwdpGRkehHNbKOttvyBzbtYl0HUr/Vp5tN1WEwXMELS21wVZApBOULDhl91J6+9PtvFGqTW9/o2vR3/AIf8Q29sJ4Lq3KyRyxAjLqGG10Gclc9M85FL8L9C1Dwvaatp+r3YnhkZEt0ViyKcMQDngZ/IfjVSf4j3Nhpd3PqOmJcPplwqQkKN3kOSsi9OPl2+x4BrTlUpNQV/6/rQmV42cjf8Gatrd5NcWOvjewO1L+zULHcYGPLmgOCj4JwwAyPbk9E0sflyRBDKgHzx+bwV7g4OT/8AWrE06TTrPUFutK+yWUczJ5pYtEyoy5QYb5VPzYxxgkjFUfFd74p0Oe3GmWNlPavkPNGuX3Z4BTIJU+q56nOKza5paafgFktyO/nvre7li8N+FZbWORQWulVyknsqlsr25x7UVs6LLqt1pZ1HU9Oe3uFA3W4+XBJx94849qK0U2tLGUoK+5TvP7YWa4v5rO1SWVDGUgjLyWUMgCuu0HDMpJBzml1zS57LwXpVu8dte3NtG72zR5VXP8OWPI45x61tRpp+k6pFBobwxX0Essl2rTloQHGCHPJAOOMdyKg8Taley6TqaapdQ3TSkLbQ2LA+WOQVD+uM5NeNOCjLmXU+rw+InPkhbbXze6Xfa7e9rHJ+CdTuLq/MU6iO7BKBhypwP1HWutgY3Er6fbpvkB+dE+6xHTvj+Vcj4Nht2u3ttLso4pdqxgNJuHygk5P58967XRpIVPmyZgRUwrxqMlvc805Wub4l2bcd1/S2NzQ3hkjSD+0LqG8Bw8bEHPrjI/ziqDWGs299PBcRTO53NDe2zBYsejKe/YYrd0C2s7vSUNzHDPcudz7j8+4/qO3NRQRfZdUksl1CUZx5KuQ5/wB0/wCelaWVkeE6tqk1Hp3Xn5dPXocxa2GqareLDCoWNMbpZR9337cZ9Oa2Y7K20i4MOsQRzq2CJ4k5x1OV68e3vVbxJd3el6rG28xnaN09spUMCSMEHIzVqOxvNTkiuoriOSQf8s5QxUke/Wpt2Wp0ynKaUpSSg107+pfMugyxkfbiOPlXzWyPbBq5Y3srWYhOmvPbY2+ZGUCv77SRg+9ULd9LmneDUbaO2uc7drqOT/ssODyPwq3F/aumoxSKO8tcnG7h1U+pHB4ql3OGpFW5Nb9OZ/k1Ygj1U6UPs15p08bZJjAKkFceuagXULS+k8zUJDEx/wBXEASwNXbmyn12NWmEEcEgzlW3j+XWoLHTLbQLnz2Jltyvzlky0Z9R6j2os/kNSo2b/wCXnl/nqVv3f213kkvIrQAFRJETu/HH86n+0wNvj0+Qr82TcPwuP6n2rZTUlKIUtb5lYZDCEgCuO1/VYbK4uZW0u5lnZspF5ZG5vei1tiacpVm1KLVvT/gG/BZ6XHCZGMErkEu8pDM2f5VDYQtbS3P9lWkbwMdyuW249QKgsp9O1PSY576yjtJiCWjbiVD7YrOuNd1KCUW2mQLOFO1GkQgsPoKbshQp1KnMk79+bY6EXmozXf2YW0drIeS8rb8/7oHWq17pGnxwS3GpbZHOSZpByT7AVA4ur6NhqrQwrHhnWPOFJ5HzHocdutYlvBfXWvLPaWcEmmq2AZXYknB5yffFGuzKpU7e9GXLbe3+bJrKDT7S336lpd44c5BaPMYHtz/OmTz2RmEmjo9oMYaTy+NpPKgDqM1f1m4uzK8GoxkRlC0aROFTI6lm744rmo4nmRhBE0yooLbATsBPIx3Peobtoj0KNNVf3lR/jdG1a3GkQTmWZ7u7uByWkTdlvXn+tXbnWrmVle1jECNlRLMQ2PwH4VjWWv2cdnNZIIppgcMoODjrkjqfTtU6wyX3mOLWVPN+ZFjQYx24OBj1I9O1C00RnOlHmcqidl3f6aFKX5zM1wPMdiB5u4BVJ7cduv8A+qqYmhtMSMd2zJ4ByOc89v8APSkuLu3treR7u4W3jiBMks8e1QCeQSMk9vzo1kJGJbdvKV1ABji5GOxB7j8aEmdKUW+WWvkZGu61NcyedFGC+CAB71DHf/uDvIDRn58c4PB5qjcWu5ESwuzGxOSCfvge/p9KWK2WEklWWdxtlbbwTjj60mvM7Yumo2S0On0zVY8SQxOvmKd5GOc+v+fWvomvmXQdE+zXUs07bnbOF6Y7e1fTVPQ+czhJSjbz/Q8f+NkpfWNPttLt9N1LVUSOa40y4Ul5LTzSDIvYFXwQT6NwcYMXhbxLLfP4nXUrLdpmlyI1lMif8fUDLncNxALZ47DnHUGr3xc8J6nrWrJdeHPEM2kanNaR2zo6hoZIklL7uBuDgk46gg44yawvEupweGtOkGn6dNftcSGOGzto8+YxJY5HRVHJJPAGOK6bx5Eo6t/8D+vvPPox9p7r6a/L+rnIfESa707xNDOZY9N04Iy3OrSDJRNxHlp15wuflUlmOOgrS8O2gs/t+p3b6k13eBWZryMxrEnOyJEJ+TC4Lflx0qlqms2/iaRh4ZGn3OuaU4JW9USNat/E8Y6Ehs/Meh59DVfwfcaxdXUkuulHMEe23tD80zx78s8gB6s2MAc4zW1n7NLa33nQrOd2TjwndXWsjUvMitrKJvNsLO3kw0jAfJJKpxxzyO/CjAznX8E6Be20GoSSJFOtw4G55FMSsrFmLkkZLMx9+v41RZxWFvdTX0sxnjfMkoTaNzHKRj6DJbBO3GOuKX4n2Wqal4cs9N0pWXS5Viillil2m2G7c7FOC5bkYBBPPoaOaUnyt6EztFXjqb+oaT9gtry71y7YStGI3nBGzYzYMUQBySwyMnHHTFV9G8NWeg2Uk2iRLPqrwI8dxOwaaKMqSvy9sKcZOTnNYfivwzL4q8H+ENEtnS1S3xLeOM+WsWAhAzxnALf7OM9agTwv4vf4k6lqcWqfY9GlkYpDyFSJBhckgKNpxyDlse9CS5fi/pf5kc0vtI3Z7a6srCLVdXu44bm3nZ5rx1BMUGwblB64ZtowOpIrK1OK38VQGxhsfL0K5hNzBf27bWEmOCccMCRjv36VoeJNas5NO1u4OivqmnW0uyaMLuSUSdXYYJxxwR7HriqHhL7dFZ3V7YW7XdhMsf2e3iI3RxKTlMZ4KnGQfU44OS0ny8z3X9f8HsVGWtg0LQL20ltbnR9Z1KGxs7YWZ01yPMDqP9Yh6A/xdODkYKmn+DP+EosvFUkGv6nLq1ncW3mpdSW5BDeYABu2hSCRyuSVYD8U8R3WsaLNZ32m2WoXv2mVDeQPIWjskA2tIgUZAOecsVyPelEmqWevalrmqNqEEVqSUi06R5YLq2I+9Mh4DqMHK4PHTAyRtyTbs7ryuWkuhr+OfDc3ie8srSSe0ayiZ5rmzdmWZ324jaNlPBDY9+e/IqbSvE1xrmnro/jTw/cQzXEn2SMzReZDKdhPzHJ67SM9z161meJLzV3jvbzTbKTULMwx31hKlurG1ChVMUSr80kjZ3AsAFyeuMVs+KLlrqbSQ9vdWsmpI09jBcho3huY0EvlTOCdnGcDnIDfSskm4pP+uv8AXoKSjzLmJ9Q0azutKSzjKxJJDtcQr5XyYC4LAHjAUHHOAK4nS/Dd7p3iqcXNtF/ZtxCwvElALZZS0UMf8RVSFYnJ+6o7HPTeG9Z1ya6n0/xTHoUF3aEPJaWt75k8e9wF8yIA7AytnO7uuQCeOBR9a8N3ci6hfXWvarqMmbKzgjLtEA5PmMegIwRgccNzxVU4yV43/r+tTSM1NeR6GrSX08MUsWYHULGrHc4beC646LGAMj371naDpzT+NpvFE14wTU7KLSbK3Q7pGk6uSOyjG78/qbey+j0hTqD7r6RQs/lvjy2znAPfGAM/XrUOtzXVp4j8LfYoYZA+pyrclU/1Ksqt6f3Q+fT9DMX0JqRT2Mz4da9Fd+FtBluox5t1NLo6Jg4XYzOM+mfk/H61Y8X+I4tB1KOJIw0k8Kzwyuu45OcbscADPXrzVqDTdJttP06x06SRbqzubl41jxme6RVkcANkcZXj27cmuf1Y2+pePrvQfEtiZ9McQppcsVsYjGzR+YVMmdwA3MMrleorRKMpN20/4JPNrqM8cXVnP4YtT4ghe7t7twwnt5VE1u+DiWIkjjoDkYOe2c1peErfRdL0mO+F9bRwXrrE9w+UWeUqwA2twrld4ZPUGuR8RancaVr0OmapbRx6LcBYLTUEHmoiMBgMD95em4ZGM5HoemD6N4chlupoLK7hIW0lJjaSwtJIyzwyyrtLIA7EBhz8+OeKqUZcqS6l3jBNs19bXXbbwbLLbvZRa3C6qXSMvCf3nAYEZwUwCSOvTjBqCPWLO50yPVrey0++8QRbLe4sY5B5gYgs8KMfvE4Lqh++AVySKxrKxfxL4s0TxRY6pp2NKZ9O1e7tZwouHB+VQh4khcMF6g/N14Fadj9m1zxHr/h7UBb6hEhQfbrMG1urfZIHjguBwXCsB5coBHHJO41KhysiVeM4WS1vv5en6mN4itdZeG5lstMsbq+uHG5ZGZFkjxnPluV2SqcBgWIwcrnNTaJqsfg3SIINTa4jiv1aJIsiRbA45O8NyoduACMgHpmrHxQfUbxrb7BqDNJ5xhvIklETxxkZjdhkfL8rZ9ccA1R1byNN8PLf6vPdXemR2UQzG4jlkeQhFUljtAJPOegGTW8HzRS7/eZyW7Z0d1FrE/huztbG/W212LAAeTb5qjgsGPOOCRz0NFVXnuLbRzqtlZOh8q2SKK4AMyIU/jA644GQADniinT5raJESV3e5ws01xdu8cnkLbxfOyMjK7AdN2Bz+v8AWo1jXfJNJDIryKqxrPKI4+Dj5VzkD+delrpmltbtL9qe2lRixSQgoQeRg9T+dYk+iW18/nFtsucBx/IV5XOloj7inVi91sZ3hi2mt9RRjJaG26SJEpyPxNek6VIbG6eTT4WuLdxlg69h784xXIJAdNUJHgoSCZNmQT7810FprNwsTwG0kCqglbbGChbHC7iQCT0wanVu5yYtqa7l9mXUPE5vfsxeDYENvkKTgYPPTOTn8Kv3C2oV4f7M8tgDtaJizr/tDHX9a563uDKtvPGlxY3jfvBDKFBQcjkZ4Pt6VqPJrSQRhnuVUPvJ2gFh6cg9v50N62ZxypWs4PS3dr/gFq2nDae6pfHzj8ptrkbt47AZ+bn29ayf7U868jS3iaykC7nMDY3AdeDxkYPFOvdRmv8AzLCbc5w4Kw4EgyuDhhyMKe3IrQ8O6XIukRR2upF4hHtCzKJnz6SMep/zk4ppXVkZytR9+dtf66L8zKS6murhoIUku3diw3Jg565/zxXS2giaBV1LS7qzlCj99bBtvHc7DwfqK5+GC+srxnWZraZUZsbN6sAcnA6Y4/8A1VraH4mvL55QumfaBEA0jQZTGemcnHY8VMEVjFKUV7NKy87P/I0LLRNubvSdXlBfOSEVkf8A3gO/Ttms251S4a+EF6u6eFsYhHBI7j86QaiupXmNOils7xid7GYYf6r3qW70G+JErTpclRkrGfKY49z1/MU7N/Cc0UoSviWrva9r/eja/tq2CFphNEBwxkQj9ax77VBcalHJpO25YDBA+vf2qnqE9i1oyC4nSYcGJpGyCOxBNZ9henRPLvLmGYW1y/kxsWAZ268A89vanzN6BTwdOEXNLXZJ9Td+1taSvd6la3CyEcFEDBB9QayvEV1JqdsbnTI5UMYJ80qB2+vPat8X948Bl/s1zHgn/WKCR9K5lrue8aazt1jiWXhQ7AY+gpz2sGFjeftHFJrz0t6GBfzzLY73a5ngTIJOSuc5PPr7nvXQ6PLqOnafb3kEFvLDPGHHz4PIyMgHqKdaX9zZGSxmgsWWFdrFpCN4PYcHmquoXMl40LyxzBEOWiVCiquR9055JH0qFZa9Tum5Vf3bilD8+21rDJLm4uL8T3TRB9pkQSR7kOO2PQ+tWY1uGHnWU5+2SjIjgUAKoOAWJPAzwB1zVfXWtrra2nLsKpgKflP6n6Vh6lBDcWC22q27XFvM6NNEGZRlTlSdpzjOR3B/CmtHqx8rnBOCs+z/ACJG+zW95O5U/wBoMMXAkj+bg4UA9egzg471F9rOmXSzw6nLHIjhzvUtnnoQeD6Y4+lP1zUHn8ySWGSTewLfwM3v/n0rBa9WLiZJtsv3Q6GTJ9DgfTmhSf2To+rqcb1DU1nW7m6lnnit5pQTiRUbJGDjLL7HisYXDzbWDTR9Tg4GD6jnOMdeaq2mqJ5svlTqqLncEUruHpnH8zUN3rdqlpJJFcFFQjzHiJk8sE45wOh9qtRd7IpRUY2a0RuPeWUDfNEyythmbBCuc+mCP89allvlCSSrMzxtG0ZAJzsYYP4+h61y0D3k8xtnEz/JujZ2yJcjO5GBZR29qti31a5jjhbRrzy1O3cG+ZD2ODjK/TpTcGnuSuTld1o/n+VzoLbUITbIYd5i2BACSSNvGMtzketfT9fKNt4b1oWN+jwt9oaNPszxDCh9wzkehGeT7V9XDpUONutzw84nGXIoq1r/AKHmXjt47fxwtwbG6BXS1L3xfEAAmbbGBn7/ACxzjoa8z8QXmo6vPd6eljr9tbSKpg1XS0SVQereYhYfJk5POePz7r4xanHaa/HaxSre6jcaf+50h5xCJQJDl1Y98ZOBgkJwa8u8WeDtP8U39rezapqVuYwsIjtiGjyp4cZx5ZG4AkDHfjPPZRirqU9v6/rsefByVP3N/kSWf9pNpmpaXG0t9q6ARm/u4/s4uUyFJBQbyACArEknOeOKi0SHSdFkvtGsZNO0/wAa3ED+daxmeSV3wXAWWVWG7HOC+CeoFXNRmk8QxXelNF4g0TT7CRVi1GCQxvdbBjaqkZde/XA4JwSBWxb6lodx4ntIZo7OXXYVS1WSFnlm8sDALuSBkDk4X2yK1d7been9Wt5F3u7v+v67lbw2up2mmWp16WOWCe8V45NQITg8LEu7gyvj7oz0JHSp7OLUE1rU7ufxBanSb1c6ezyhDFMG5zuXKADcvfk54rJ8Jwapc6lqZ8SalomoaPFumgMUn2h4JVb5GXIIGOecnk+9dDriadpOl2/9qQz3rQRAOfL3OgbkFl3Dkg7segHrUz0l5sI227EfirFp4Gu4fEeqC28+UW6TvL8js2SFVxkDAUnLYHGOM0v2qG08L6fb3WptNptjDFLNLHN5guWc5iRSDhgcA8dlPtVZJIhrt/cJ4guWvNZslWzTyfMtrMMmEZVz82MAqMDHPGazdPf7VbtoPivxFZXHiDS1N5diGEusUaggl3cBWfayZXHB7ZzkUNPx/rTp3BT1s/kW9b8Q6la6xaTaOyRRTwRyFVh3rcF/vKfbPfHccCrmp6hLbardW0NjKkMMPmLaWyZL7iN20Z5AJbn2wBU/hfUbDVIxZaRvt77TY0ija4iBlVOMYyO44z/k2IdUjuJ4rvSNVtTp9tM63aTgqZirbZMSfw9VK+5zznFJ6aW2HzX1MDVG1K+1ewj0ho5NOGFn8mYxmCQkHMgJyMDscjOafD4l1FfD2oXc2mR213a3BjKXs3kxDPKsXOMZBHHHtSxaVqs+j+JNL1O+0y71PULd2srmztUtbgxt91pVjUdWVcDGeSc4qvap4p/4V5o+iSSwS6kPMgvJZJUlLIzExh/NG0sBgHd0G2qstFpuv8/+ANSfY7fw3qKX9kk0sq/aZEEghgYSPG3XAb7jEqRyCQfXPNVdA0fxJp2gSrdTWmoSid5EMm5vlzweQCrY3A9eveuH0zTPEXhzU7281TVLOHTIrYW0NuCoMW7bmVY2wowRkjd82eD6bfibxjqOm6Xo0mgRnXLy+uWtR5KmODzOCDkFuCDkcjoScYrJ03e0Nbmrfb+vuLGv3OkeF7nRlgvP7PlN0tiE2ieW6iKnKtI/zgREqUO7ALAYx05u/fTNa8MW+jeKJJvD+o6koNtaK5M8Z37YQ6E5YMFXcjbV7/eGa6TX/Dem+LNKjh1yGE3cb48y2kILMBypPUHqAffkcjHG6pcaXfeJ9P0e+03TpI9TiRZb+S5ZJn3dEjKkvtBGMHqTg8VpSV7Xvdav/gETtqltsdl4VtNTt7Hw/p1xfyX62u5rjUGQFVRcjgk4PA2qx7ZPcVqWWp6dPqkCJqULCyVnmggIf947DbuPQhSex69elYOg6tco93aQ6WbbQNPgaGyhCsNzdAN3RiRk5/meaydU8EqnhnxD/wAIsduo620CbVYmO3VW3yRow5++CSfRQKTinL3na/6i6aI0r3Wri8tfG9h4VtPJ1Tw7hIbudCZJ5pC0k5KkYDExMqn3HtW14O8R2ni/wxbahLHbm+a2NxDG3CxOHKOgyeFDjv8A31rT0tBaa5dZ+zm+v44pLy5Eyr9pkjjKmXyjyEJPJ9Olcdq2o6P8PrbSraeO4gF1dTxi4WHYLUyjDhiOCAUjJB5YMWGMcrSfuxWv/A1M7WWrI9D8VXGr6tqGjeKtDisI7WVFS5EHlOByEbaBhl4xxng+1WdHtdT0K8vNG1mRNR0mZXSGe8jWWWFccq275ZYcdc5K4GQBmn6lrtyvji28Ky6bb3UTFTZyXJJMUoXeN3cxHBBIOAcemDwXhDVF1C5uWk1zVo0t9+oXOlX+nx3TOvmYby5w6kncducLgk8da1UG02tFoNyjFpHeWHha2v7u3luLqPVtMFpLbLPZiK3ieB8fujFGPuow3KwJHB54ApfCV/azX8mn2WkXNt/ZRNkXuYlE0CEsQVYsWaHjrgAErxzWJ4ZvLPxHocVtpNrrPhqGGbbHHaMYj5m8vlM5VgSWyDgDPTgGtrWLzQpvENlqFyEs/EOzyIrpBtkcNlQrruw/oM57AdhSfNrGQcuqYvjjT4jZ3Fyt3PFduIoLh7CJftEvUIBnIXOW57Z4qlJcaVpOlnTY0Zri3ha7jt7yQSsXHzneTwXBB9hj2q1qS382lXVrpMv2fVJQq/b79SPMAPCqACF43cgcZqLSLJUitBrCJd6m0DobmKI+WQc7gx4BAU4ycZ545oi7Kz/r/gFWT2RT0O+P2S88Q26SM+oRIsCXGCWkL7nOc8gKrY6/ezRTYPFcialbQ6fZ281mDIsTAKZSQMHKf8s+F4UADaByelFaSi73aM1yvb9S5JqKWm6KORruMNwxHIx3PoMVE92t188UphyD8rIDj6VoaTomsXTr9vtVt4mPRUDFeOCHBwfocY96dc+A9UFyfOlhurVQSu1Ap/Qg/gTXlpW6n17q0VpJlfT9fj067Rlt5pWXq0kXmKe2CP8AOKfHPiaSY3VwiufMYKmV5P5Y9BjisjWtD1y2jKz22FhQkeSxAdO23vu/w4qteJeW0kFzJDew2PlIzN5hc88AGNVLHJHOBx1NPlb2Y26V+b8TtIwksUk+6LGfLhZjtUzEZRCRlgMAn5QTVfT7S4huIhc3spknh3mBGaQbwMOIyQDsGCfmGe3I5OGHv4LqO1luhb3ErAiKdtocdVYMcA8dzg1r2969wt1BbXkLuiM7RozKGC4zhux6YB5IziotZWsTOOrkpafgakSQDVRdSsGZW8zO5skjuQv+Na1tHBbP9rt7xuCSwiHJHXIPIwDxjHbNc/p8lzcwxxMy222NgH8zLNjtuOck56D6VHHKtqyMGV4+GEh/ix6jt7g0tUYzoc94p2Z0kUkWqW10mqz5hliaGRfMCNg9gB1Bx2Oau6U0uiaSkxjhbTEUOQjYZF4APPBPTjOelc7qRj1TV9NutORLW2g2NLFuyDhst2IIZeOcdBWlrqW12ji1WNLOQ/NFExKHHcrjA9j71V0jjlS52oNWT/D7up0Y1DSNViKpNEZB03DZIpx27/lVLTNY1NriS0+zLerGSqzbwhPu3GP0rnbC1svIFqtqsU+7d50bhmbtg7u3TocVsWIfTZQ1xctZzsMss8JZGA7gg0XuzGeFhThKLV30T/NW1t/TNKzS/tJZpp7K3kd5C+9Jfn6DgEqM/nWV4pXT79oTqOl3ZZSQpJ2EfgOO1X4dUvbyTyY2tUAwPORWdefx4qF7ezn1cWtxq0tzf+YVMaYXacZxx0q1e3unPG0KnNWVn5X/AOGH29nc38HkahM1om3altGdrH2LdTx6VieINM0+0u7eK1uGQsQHBbfs9ye1aup+feF7WwuzcbV/eCYKMemD1J4pEuLTRYBHNp05mcEZZQ4fHo3Q/wD1u1Q7Pc2oTnTfMne/2Vp83f8ArzM4ww2d9EsVuwmRSzZJZZBxyCeCcH9DU+pHU9Q1exuYNat7PS4mLzWjwhnlbHZj0HTjtyeaz9Rnu2by41uIpDJuFl5ZOF67hx+NZ086eSkMtoy3QLFpZAQx4Jxj86SlY6vqrq2lJ6/f+f8AwSbxXFO1vJfWkcSLtKRswAEhAznHcdq4jVdSsre0nee5QXePLy8nlsO/vtPt1wK0vEut6i8NpFAxkJfyEUA7YARycDrwD7etY40ya1W5ul02a5mupNzIhBIPXczYO04ORn+XVxSkehTi6MEpv+v1My7uoLGxkt7G4nmnaNZHigOZsN0OOy9Cf1rppfBsnmWy+HdVl1KOW0Mks08mwJLkbV2dNuM5B5ro/DHhGO0eHUNTkN5eFQAzxIrKv+0w5J5x7/Su5tw22PzQUhJyAwA6dOn59a0Ulsjz8VjHGScHt/XzPO9O+Gmnm5nuL++l+0TjBijmJGRjlFHI6eneuntPCujQTtNFaI9wUw7FTub8B/OtIz/YLV5NRvI2Td/riqxAA9FwP8msTxbq+lW6RxXV5rFqQu4JpquGkU9AXAOPoKai5aHFPE1pvf7v6uaOnSW7NJFDpc9j5YyrS2u1c9MAnqfwqxFPN9rn8+3SO3G3ypd4JkJ6gL149ag0Cztld9Rhh1DfNCsRa8dixUD5eGP3vcDP51djvLK9mS3+wXKTqm8vJF0XODg/rxRyrockqkr66j/tC53yAGMDOAdrjj1Ar04civNoo0USrInlORtTdzgH6V6SOlZtHLXeqPJfi9ZQ/wBupe22nLcaudOaGKQuImxuYiNZW4QsSRkc888V5vbz6xL4XuZNUjh0iaEmRI2m83yYkHzFwPp9eM16L8bdSsdI1LTLnU55EhkTygiAsSdx5C9Ceep/wrhY4Ne0bTfN0m60y+1WSVXT+1V8uNI+flRTyp/LqfTB66bfJr+pcfdSkvuMnRdQabww2saHq1nrU8dxi4OrSvbCKPncsZbO1+QSSeh4FWfDkOhzaRrGoafbB7bDRTPaStM0iOCHjRj/AKsNgZZcZxnitDXrm+u9OsW1DTtOub6R2EkAjSSFlOBggja5ySN2M4ArkjZ+HJfFlvoujalf6Xe2CuzWmnBkinLfPgvkkdQvOcAVr8V/010+Rcb21Lnw407w/ZJrGpWFle6dEsHkSm9lDRqpOOpUemf8mu8uNQ0y6kiedQ1zNb7UvYZSiyIQBkEAgEhQDjB4rzn+1dZ1zStStfFEEGkRM0f2ewZT8yjqzkklzjHJ684HNdHotvH4c8P2dsl5btp0SvcahLIwJijyRtVCdwBIwpA6p1GKdVczcm9fv6dwjC1r/wCRD4w1vQvCN5pl1qVpI1wjCO3SAEpCinIbk5bGc5J5POO1UdTtrTwprE1qmmaldWPiM/6Xq/MvkGVwwWNSpHXazgnLZ7hcHbv4tM8VaBaTSI19YzSCWFh8nlbOAU74O7BHccEd60NBh8QzeIby9ubwxaTHJkxsflIB+Vefbj1pRkorXfW4ShfXppYb4L8Mp4Z1a8lubqSWR0SOGNQNsSKc9MnYnGMkjBIApmn+F9N0bQRZaxcxW9s9yZLhpZl2SNI2UG7+FOEGT12knvT/ABLZ6FeaBcadqepy2MGoMwTUoJM4n6qCMYbG09SNwJwR1rmX0xLbwFBpniLUpbvdL5FnqGnp5zTRq5ZDzjgAsuGIxuI5xylefvN7tf18hJWdkjsINAgbX7zWTLuvFtPs0ke/7hBALfgvHoMk1U17WtP0mz2X0cgVmjZbkW7SoN3zH51GFfBwCfT0qPVYdUOqWFxoEkMGnQiOS7uJnVnkVUAUSMegAxnHUk57VX1a40/TdZ0XVdc1fUbbdD5RtUdpbO4X5gWcc7lzyTg9QecAmVG7V9f62NHsWtTvgLBP7Qs1Ggz24la8uJkRbcv86kKQcAAjjnqRkdBP4ZtngVl0DVLW88sAsqgRSAsC0bbQABwTjIOcnBrK1mwv3gV9W1Lz9OZnLWCIrtNgDBRh/qzGx3AjqDjBGaralpDX89zHp9ve6CdPhh829MAdb2JFAXc0Rzn5Tjr3GM0rRatf+v67Fe91Io/E93Hqcn9kaYovoWK6hbbzHdhQfLEkYJK7lzyMAlShzjkaem+FDpE+qxSatemyvZWlsN1mpFhNuySJMltuDt+XHHXsaie5m8RWiwaVJ/aqzR/Y73UYLtYry0PI3iCQBimMdGyRWfYeAdZ0rQ5bPTvEiy3N26s1zOzBUijycRLuLFjkM3bgCtNErXt/X4W9LkX5mbb+HNWvbvUFvdQmnsJLFIltEudrzucDcW5EZ+XfkA4PGDyS7TmvNFubrRfD9jJ9g0zT3aFruUsJrljuGWIG7LnjgZxUF9rR02zS9FheXs2pTLBCqfISqLgPuIODIScAelV/Hun3V5oVmdRuXtYbOIXd1bwOryuV/wCWaHIzsUkjPQt32is1dtKWxpyjvDcWrR+O9O128sna11qyFteIUO22mVAGQg9ASuQe4bHamWV1r+seH7CTQ7iz1WwjupYbqwv4Fxe2YZQCwcZEkeCpH3uh5xza1e60/wAQarp8mmeIDBcT28VythJKRKbbYHG3/a28+vB60/xNr8mi32iQC1imh1CYmW4t1PlnLbPMRwOCVwx9xzVat7a/5XJspWMjxv4j1GGPV4dNjJn0O62XEckeWlspMhXVsZUqSoJXnG3PQ1a8H6lcXOmaXqcejQTG/hCahqNtBELgXGSv7+MKGMbcHeM8n5s1d8YXmm+GSfEOrtcQ3QVbDzLeFX+0krzuQ/IRgHk+gxWffW0eo3tj4j0bXrwaTDAl2dOsozGVAzzGmPmUnhkYc8jPQ01ZwWnz+Wwn2N1oYrp2uhLC1/CpihklAWO3YggEqoGBkYzgYrzXTbOexup9W17wjHYX0M5KXUEzrFvY/NIIpWKqo67wQCcYqbwlc3La/q2oNqctzqRtXNvDdWbWkDnjqThUAReF9WPJxzasI9O1W5Zdd0C0hvkPzvZX8QaUjGUKfMpPPTPORxWkY+zuun9ea0E1sYT6dDo3i20tbnxrqwu7wq8AMDeS4c8LvJKntyFx7iuzhu5Lm+haPTNYuDHPLYqSuIQ23id3JAVCGPYnIxzmrUVjp3h2x2fbpbOGaTzba31UqxtCc/JGv3ufrgDHFL4i1S9sLLTbiGK51uW7l8uJLMthj1xuUHBxnHHGM/Rym6lrf1+QklC9yTTJ9I03xALcBZ9bKESSRIAsOOuW7scYP1xRVvUPD9ndX6743s33EuI/naVsYIGCSceoGOCe9FZtwdm2Tq+h10NzPeXc6WV/fSwu5+eazKpH/srIShI9gDVrTNQilupdPW01FGtlx59xDhJPcE+/Sqtxph1CZ/P1ZhPCdsMlmxjmjU9Q2Sc8dMYq/ieezltGluoNihEuRIpdh/f7jJ+mOa5G4nXq9C0DA8Tv5geMHDhMEAj1X1qCe2DiT7KyLcJko7RkhWI77SDjp0NZTXcPh/T57251BZI4l3SyCJVd+cbm2/ebp0Hbmt2O8hvbOO6t5iYXjyHwcnnt/wDqqHFMq86drbM83OiW3iqNrySaODVzA8bQvO06Ky/xYb5hyeA3Iz1rkbrTX07UJTe/aILppBFaP5pE10y4Ziqqp+QDB+Y46Dk17FoE1tJc3MfmQXOp27COe5az8pmU8rnuwwMZHBK0+4sItZsY5NRsFtros8YwwZghJDAMP4WAB9ccVT0O+lj5RfJLZHlh1Nv3jzP+7kVnKttj8sj0fGevQEelXLG+ihCCWcqJVBO9AwGOh6/U54zR4t8NXUF3HAIna3u50hgW3KwpbRjq8jHJ47AcfjjPNC4tbWGU3TQPJaq4MUgeTYm7bmVVO44LAsF+6D3ORUKHMrI9X2sJLmW1v6/rudDHrSW3mzxzRvayuQEROT1OCO4rY03xK7Rg2d75SyDawKcNz09u/wCZqDTPCmlSaVaanrkkUKqPs6raTbopnkJJCnkuMHj6k9Bwt74d8IaZbg3iXCyQyxRK4uC8yNKCVUbeo4Jxz+NTJRjrcy9tSqvk5b+Vrmxp8cN5FPJJfRmZTuWIqcnHUZ/DpV22uVijEv2p/MRSRGxKtt9Aea5i+02fTruW1F40fmOrQ3KqHYIDkgg4GSMgnHHpW/plpfXGnGSNUdAShJwSmADmo3M6sIJXcvde17GpBYyXVutzA1uHOXwgYOvXrtPbHpUY05LNnubiSb7XINq3duQySA9AdvPQfjWZC7xlZoi0NwrDAikKsBjjPHSrGkpqARhY/dd/Mkjhwrbj1Y54z/8Arqk0clSnON3zK33fjqQa+mgtqmnxw3c1lfuSIgPvS7Bk4yevBPPvVy51TTdZcWuoLi1jG4xR/wCs56fQCrV5FHEXk1OG/R1BHmHYeuMncOtc/exRtfQalbs8cqrsjlWTaxA4G4Dr2AP+TbkZUqan3fZ3/U2JGjggt49AuryG9ibH2mcEkIf4Tu6j8K5x4r5xdy6lerfXCOS8wjOMHgD24GR61oXV615JCbyWZwMBpG28LznGOp7fjXO6xJcnWLcWl0gtgMD7TIuSo6qe7DHQDofapbudWGo8jv1/rrZafccvD4iMzwyrZyQ2hEjTSNjbGEJ+Vj2J4496674d6XFNd6hrmpRXFsZ2KNDNMskMh4YMhAAOcjHX6kVyniG4mFrdNcxTx23zKkkI3TLu4DHswwef6Gu98PaRJqnw/s7RZo1kZRE6vDiMkkDG0fw45GMYP5VS5UtNLm2PqNQub/hrUptVivH1LTZrCSG4MQjm/iUAcggYIOeo4470y91159QifQI/7TVrl7SUQbTHaOqghpWJyEHovB5wc1sXenyTWkGn2d/JZsjxqbmIAnag+Zfm9QuPp9ao6tjS9EvJfDmnW5uPKaSOGBAN8pIPJA9+vYDAxWisfPcynLQZafaIvD8dz4lt7WG6ETG6MQ3REgkZUc/KRg0X8EGr2Kxfarq3tyAySWkmz6dO1O0qW6uNCtTqlmkF08ZFxbEZVCeqEHqPbrWdqtrLpOls+hkOthdKtxDnfmEjI4/EDPpWcp21OijTc5ezbs3sXtK1SCK6fTRcz3M8MWWllTcz/wC0cdxx2FaGr3+oeV/xL7S3uZ1HAeQjIx1yB9KqabDYkvewW6rczjDvjLHtgn8P5VQ1ewdb5NSuLy5FhZjzjbwkgll56j7y+oNXF3ehy1ILm1WqJoE8T30sM15cWttbodzQQQhwwOeGZumPavYh0FeX2N2NQ09Z4PMNvIMqGUr+h5r1EdKibb3OWukrJKx5V8TbP7d4ytI72xt5bP7BmK4aYeYkvmHKhPptIbtg15rDH/aPnWGv6XeaPBZnMU17KJJpmJzzj75I54PHrXoPxl0c3viPRrtbqSExRFSqdSC3UHsefevM5vCoa4ur63k+2X1nu+zSXKgJE/QuFJJYgDI3EKTyQeMdlJx5Fd/194oJuxt6zqEul+Go3tLRjO+Ut/O+/g4G727njoMcnrWHqOpR6bZPeadaWsPiG4tlZ7iODa8sYIBCsOcDGSM5OAOmKoeFdYiuJtWs5L+51bULdHuFtLkEsWUA5Oev/Aee2O9LoXjCz1S0XUtTVLdA+6OGOPzw4HU4xkf3fWtPZST2v/wf0OqMocurNDS9NtNfXTb7WopvtiudywyfwqMq5yCeTjA46+oxVLQ9Q0LxbpOrLHZHR5LuKK2kZi0u3Yx8sYPBQ5bcB1Oc5NOvlHhu/wDEmttcSXdxIqzJbudqQqx3BSBjaM7VAFZvhHW3m0mK51S1tI7q7d5t1rAse8ZI3EDqTgnPXj3p2bi5Lyt5ddhqzkkzro7e80vR7Oz8NPBEqApJczELHAobLyMp7sSTjk9AM1y/ia90zx/aSaHpHiZ3uoyCXELRxznPzZU4O3kc9sdKswRX0s11qGp3Rt7C5jMCWjkPvDDAyv8ADgfmau+E9A0vw9qMi2MUkt0qFvNnwcZONqDoOgz9KjnjD3m/eW3r5mqoSnstP0NLwx4esbHwv/wjSXUWrSeUTKkrYBJOVK56bT0HUc+prZsdGt9G0MWNjFbwWUUTNMkrkqNxzKzMCeMDgYyMccmuR1rxJHaaw1gsf79wtu72v7ucGTp5eASeDkE4U8jIPFLp1hf+GbbWINN1KLVp4phJFYIxZ0iBIZXUkn5gwBHPHU56KSnJXk99fXz8iLJaR6f1Yk0zw/Zz+Hta0/whf38N5NMP3zXiyCOVBnyScnarf3+vyjPArppre11jwvHBYyafrkcUMbQXV1GTETGfLeTdjuUkA2nn6Gs/SND0SDREs5tPj0lNRV45dKNyqlw4wJRzu3dVA7AnpmsfQrZrzwzrGhy6lHqOnQBrK1t9Piazjiki+Z8MTuZmyeG4z65yHKXM229n/Wv/AASUn0Rra3EqXl7qsWoXJtLTy7t9OEbEllGxRGCOjDH+RXN3uor8QtDubbTGn0LUIsGVpNwSWBSSI2IxgZOe3NXPhXqN1Lo99aReH9S0uOONjb3epz+ZBuPRBuVTgnnaCRkZ4rY8Px6vLBcXfirS7W0ktTi2vIljOAwIkKlQ3OAvbkgcGqf7q66q1tV+XUSXOtdjC0VNM8IW8mm67ryTaletHJGbvL7gD0Zuvlkn7pbkjPbntrLMV/cQT3Be8AdvLd/LXK85EY4KAdOc4ArmNEsjfaVJb6zH/wAJAsUrTJqOpQiFEzzu+b720YyD8vHfpVrR/BekxNqlzp97cTf22JN8yy4fbzvCPgKpO4kFhuwcdM5io1K93r/X3GsU4rQ563vPFfh/VJp9T1gapZXl7EJLi3BeO1jBLM5ULhQR8oxwMHJHGe4sLzQvFeiyNYzQS2zh4GmlicNDIy42kHvyMgdua5YaLZeCfDt9Z+Hdau4Z7ll3Pqim6tbdc/MP3a4AfjcdpxtHoTUl94lXw1Y6BD4kgNhPcxyeZpmmxJ5C4dk3oy54fCngnII5xiqlH2msN/u6dv8Agmak46S0NnWtO8M6RJpOp6z9isr+yto4LKeMuCyom0MV67RjPQkepBrjvCmravo/iKx06/jXUNP1G4QwiNF2MWJ2zwsuRjpn9eldR4//AOEbEV7e+JNOjnj01o4ZpJVZ2aXAAVADySAAeQMDJPSp9MvtL1vwBfy+BdqW0cTxRwBWiaGXb90AnGccZHPPU9lF+5qr3012X+Q0+VpXG6nq2ix3th4e1WF7uLUrmWWNJlDxrk4j5ycBnUgY7n2q3EiSO2o+HxHJewIIQjoI0WIqQY1U/KMjHB4z25rkPDmlXGLabxLo8ottNOba4eCSFRE53+U6sdxCuSVOSAeh7Uz4peJdL037Lp2o2eqz2F7bK66hbShWU7sgoSNrlecg4zgdOtHsuaahDX+v8g5uWPNI7fVbSbUPD72d7cpBDKiqqzuByCdp3A+vGBx9a5o2GqeCfC02tTeHLObVlZVaS3nMkv2cD/WFmDYXoAoHTPTHE+hQ2WiaZpfh/wAS6+9/NqOZdMlkhkWORHYbAz84JJHXoWA+s2jeKt/iWTSYEnc2kbhpZUwQ4OX46qmOADwcZwCaSi47K637XQ23N2TsyS6ksNSsbGTUPD1teLd2sV3C0cXmkM6BnVTwwIJxjPrxWHq2oS6lYR2OmT3nhpANpkhthGWTGAv3wyr14UjnrXctdtLHEtuUFt5EzMIXwipsLAAeu4cfU1zaado3j7SopZJL1VR2cAvtdMAZTdj7p4ODyOvvThO3vPZfO3yJcVsV/DXhD/hFRcXFpM11fXSoZL1maNI167UBYtuJxli3PQACiq7favGGmJJaytYHT53tJ7eWR1WIJhVkyMlt33TnPIByOlFbat/vJamDS6LQ9KGi3EuouWBtbcv50k0U+1527AqB04GcnpV+AXb3zpqEccWz7ht5DtkX/aQ8gjjnvVD/AISqwPieXRG8yO6QjDuOHJ/u+vpW1LHEtzHOYlEuNvmjOdvXGe4/xrz5LlVrHc5TlK8txYwmxmiiQMEIyeh9Bn69TWBoF3qup7DewC3vbWUwzRAhYNrdJF67sYwMH1q5Za1Y6teanp2nTzC7tW2PtUq24cEpkc4qHS9QkPiLUNHksr7bFEsn22cApMe4GAMen1zUpNblNaO+5atpZdM1C4TVNbS8juJg9tbSx7TAhAHlse4z0Jq5YyTvdX6tYpa+XgwTtJuS4467RypGSCPyNZvjTSZ9a0YWdvey2TGVHMkWckD+E/57Vf1jT21rR7uxu1ltEmLoslvIFlwOeD0GfShO7E4x5Yyb338jI0KPxPJdGPxRHpH2ARE5td5ZpN5+6TyAFxkHr6ihvB2iz6ib0rGkTOj4UnblCcBRnI+ZicDgnk1qRm+sjbW8VvPeW8NmxbdIDNJIoAVMZ+8Rlieh4rldS8SajaDR9G1Ce5j1HVrGRo7yTaPs0qlgqhVGMgYGfYHFNrm1RVOdRaQdrk1ibrVrltX1PT20z7CZbayglONkLLguynocDOeOOPejwrp2m31pHqEULyi5d54prpCZjtbbuHYd+ew96ueCrL7X4L+z390s7yLIryxMSec8tu/i5OR+dN1XVdB8K6ZDDc36qsKLBHbxOpkfHTIIJGOpwKykpOVuh2wqR5XCF+a/4dfv/wAzB+Jdy1rqWjNCPlZCpjjB2oGYY79sfU5NaXgie+ls5bu0n8khQfLbGHxkcg8Y98ivOtYnfUL661YXzyO/ypLv+aNMjhV7ZyffucCtmzuo7a6tPmuTJLNmRw23ERHVcHBI5/yTRa+qPRnRccOqT1fpc7g6iL/95LiSVgMvnC4/u8Uk+uJaXIjjeSzJZQw+bYpbG0HPc8d6wDqriQecUUdCmMFvrgc8elUtQvYZvEFs0ohhhmcFvK4LDGN23tz3OOnUmiOpzzw6WltPwNm+1ia5jkayuBdNFcNCVkyGVlzuwp9OPzBHFUbtpJYg0sUTyNyqu52n6AHP41j3GrX15pVikbzS3J8w30VqGKMd3VdwyFK7QSe59KyL3WJL68uIrOMqOIVkk+6ZN2Np7+wzgcfWqcHexdBKMU0bWqyLarb3MKNcXNyTGmyTAjI7DH19PxqgmrQWN016m7+0TGp8m43FRnK7SVGRkZxg8Z5FQ+H7PV9TXzLOe8khFwEklUlJYyrYcZ7YOMDuMdK6iw+HWp3V0JNbuonUQeUJLcfvN4b5WUsOuDg9M800lF2Y61anGNptHN3GqnVnstNjW5t76fdNCyyJJHAyDDICozIrcgqTuXg+9ew2lnjSYreKV4mWMpHJ1ePPyhseoz3rn/CPgyLQJb5riODzDIvlyKSxYD+JsgAPkjp6+tdXqNj9u0+a0YTRLKgDGFivyg9A3bj8wae8rnj4uvCVoU3oupDbXS3FvLbQz+e1nMsU7M2479gOGPqRgk+9S2scj+UHAV1AOGPHHByM89j+NTxadHE0s1vCq3MhBkZVG6Z1GAx55+XI7cDqacMEMWy3dSADl+uCMDGKDh51b3TM1zTob+3git9SvbP97/rLeQZUnkMwPU5xx71RttKGmXdrdC8a5kliaOeSUjMi9s4wM9+nak8UDSdU1mx0y9upob6eT7TCkbZZnXgYPTouOagv7e20bUJbmzjkmkvrkXMgkzhCR/D6HDH1/wAC8tjemo8qV2273Vvu1E1i+udJ8OT3ek2cNxNBhjHKxChehcnrwO341Bb6pPcvp19bXEctldQ4/s9B5rF8fN8w4Azzk/lWuLvTdPtTHfmExzKRsl/iQfeA9SMjj/IuaRFpkcTyad5UVu8nMSAdT1yB07flTT02Mqkkm7oq6hdS2NnFLOfLRR+8ABzx2GK9VU5AI6GvKdbvYbXZJJC1xEzhF2jcM5716uOgqJLRHLW6HknxRv5I/H+i2A8kwT2cjSgg71ALfMD0wMHrXC2Pkanqv9r6XqUM8Ekfk3cSZDBlX+Edwfz+vb0L4qXGnSeIodOZohq02nOVwv7wQF9rHPTbz654JxxXmbQWPhTT7i/1a6a7STZFGIkwTgkjPuORn27muymlyLTX8xU29r6HP6dZXGg61GmkaJqC3NxceVHPdyK+LfduOzYBkEnOck4/GuhXxNGbvUfI0u3vL3TiXCyY3SDcPNZHwSMdcd8ZzVLw9r+paj4tjmmgddOVQ6sF2qgzgfU//X9qwtVvbey1/VdJ8PxW1rqJT5NQvfnTzNokMfP3V29GYHJUA8VvJOUrTV3a+/5myty6beh2mjG01t7uT7KFiuNsUsE4DHGG+RuxBJ+uOnNc9ca8bC2mtfEekW9tqlhdJZh4VCwSxStiLy8HjCg8HJAUknJxRqeueIdH8N6Jcz28bavdzpHL5CllKAtg4/2guPzx2rptVsrPxBq+nx3+h3U0looumuHYrbWznHG8kbzx93B/DBrLSLvLVevY2kpO3L/XqYHgjS7vUWuYfEdvculo6yRBhjJJwwJwMqDj6dM07xNoWvXusfaFu47O03l9+4hsHuV6E9xz1FejQT6XHcy25vLYaijbXsi/7zy8A7yuc4IINYPiyDU9RuYP7KuLOKJWxKZVZi656KB1IBPHA6c1iq8vac1rXNYxUo8rd0Yug+IrKbXp9ITU41vI1G4xKSxUcHax6tnqOMbj6Gq+vxaDo1jLHd2zWlvqLNDM9hhp1GQ2ckn5QSCVHX09G3nhy903VpdV0bw600rKoa9jtzI0zH7+cHEZ78Dn1qnreia3LqVvqSa3CukQSI4R5FZbUrgMuCCGOejA9yCF61vCMLpp6fr8vwMZVHeSLOn+H9J1JrbRtJvll1PRd4DEucguC4I44VsYwTjPPWs3U/EfhKXWE0Gaa/tJYpmdpLSNVgmlkO443cgnIAJHbORmumh8OI2nXD+GZzY39427z7mUswwd3ljbuwuSG4zyRnOOEu/D732lWp1rSbS91qAGCzcRjCty4YyLghQckqcjJJwM01ON7ybf537ilzWtGxek0S9tvEt9qup+JPtVlLEIbS2uFyLXJydoyQQAp+bGTu55q1qFmouRaz2my2X93FsbbLKw5JVR6kkkngVyvhq71HUYtX0zWdf059Ru08u1svNjkljdiAGZowVVQcAdexOOlP8Ah9Hd2kl7FrbySR2255J2bcUCk5X5R3bj9KidNxu29Vb+kXTknttqdJPHHdWerabN5EUFxD9nkKvzBngF265YcZHTHvVXwd4UXwlNcrHfXN1bT4RLeRf3cfBycknGcAZ4B461b8O6tpl2l7b2wluIpE8wrJEF2hMkr9evucVR0XTNODvrOgzD7CxaO4FwTmMY3NuPbHBB9utR7yTi9C7wbE8cTaxHLbLbPaRaTcrsmEpDTQupG4MinJXJUZQNjqQBzVfWZ9Q1rVI4YdC0m5tLSQpbXd6rNnGOUGQMAg4yeldDYalNfNZ3GnPbTWF1J5qTsBlWPDLnGe2M/SsHX/EuheFtbjk1Ce9uZTKyojJvCkH5i6YGcZHA69acOZvlSuxKyV2T+JfEOv8AhVoS+g3WtG5fdJepAIrcE9dqqpJ6Zyx7dqXxpJqdl4VibwrZImoy3EU7WwiVDbJhiTt4GS2AT0A9qzbLQ/G3ha51O/tNf1DW9MZDcQ6cObmfceNwP3cc9OuMAc4qhe6v4f8AGfh2LVdW0K7WX7YbO5ha6ZGilOCB0GUIz2GNpFaKMbxa1XX/AIKbRim3e+h2Nk8Y/wCEevDfWtvfPG0iQWk24XoxvMcRPDAktge/FcXJ4/8A7f8ABmr6laaWLmXSpopLiyuow0bwklWBI74xkjkHB6Cugh0FNb12yvb9NAOhaXCDpMFoZYpoMbWAYEbCuQf4s8Lg9cs8TadrOpXuj6l4SvY7KGQ7rtPJEaT/ADFXZk5JJGcg5B+lTHkT1/4byH7zZzXw50KwjvP7Ta+tNS8K30i3lpaXq7ZIJ1cck5+SRMbWIIVwAem3HS+ErTxRb+JNftPFF4LnR7twun3EuG8ws5YCMjnAQHK9AQo9MrqWq6JpfhCYppMdzpsVy6TxWduI40YBQ7bF4AOc44x+lU/BV9LLavBZ2ESacUlmsJHJ/dybSAp5yOcHj68g1c5SmpSa+/8ArcUYJWSJtL8P6ppXxDubmK5guNLS3n322/EkmVO3IPQBgMH/ABqxaXWm+GmeHTdIuLfTrpft093HMJbaB2wpIbvzgYyenFct4TvfEms6ZbWivJp2u6HOsEy3gJjmtnPABOc4wQR0wQcnto+NvG3h/SL2xsba/wBQ064tpmeWOGBkURsD8pRlwwySeAeRkU3CUpcm/p+GwaRV3pc3IbHSbzxD9mlvJhqzqZVjDtEZARksgP3hg5I5I5orkPGFpHqVtZ3fijVl0+9VzBZXYj85bmHGcnaAQ3PDA8gkHtkraNLmSfM/ub/Iy17L70e2zW7XdmbkRJaX6qwWaSNXMDdzz1H8xThEZrW0Y3IumaMAzAbfNPc4HA5q06LLC5YJ5BXa6uRwMdD+dULCP7I0Wl2umulquTBPCwkjweobnI5+teY9UdcJcskzP8O2urQ32rDUYUkty4FvcoQtw6g8o+Owx16n3roGjmMkcsU4Ntgq0eOM/wB4HsenWoDNGZGCyKp6F0kGMj1Hep1SSKYbWJV+u1hz349+Ki5tP3tWPDBZVVMDBxuHIA+lVFTU5NZaSSW1OjNBgIRmYz7uST6YBq9M7QSgvINrH93MsecH0K+tN84yyMm6MwMuG4AaP3A/xp3tozNRdrpEMAZp5UaEx7Wwvzbt49VHYduaoy3sN9qEX2GS2u4oJDHcK4VmiY9CMg45HatIKIuASQvA7gd+P89xWQml22jrqFzodhEt9dkzOkjkCaQA7QP7vJ/XtR0KjZu5swurBlcRAZOccZx0/GvLfiR4dlXU477TtKnvLmcEF0hSQ57AFmGz64JH0rufCer3WrwPcXtkbMoWgdHBzvAyeCM5B9fXvT/Fuipr2iPayRlpjhkBlKA4HcryKWzv2OjDVHQq2eiZ47pt3NpMklq9rDHGSWO2NXfOcH5iD9OMVZa/ttUgltxbLaRR48uBW2iRh6jnj8T7k1hXlk+nBrK8QWzxO20eSYxKAeQm5izc+oA5q7pt8Z3tl+yTpcyfIVYZfYBz174BNOUbq61PfUY35n1NiGIJp1tBE01vBM2CgJbjOB82QQMjnpVSW7MLzJtiuHC/I8Y82RO2UY5HQ89DgViavqzyzRTwXfkTZZLdLglIpx1wCCRgg4z3xiuv8K+DV1i1S6v7mfyElS4tWLAPE2PnhYgA7Qe57Y45pKPKryM6s4QV5GRa6vqU13pqWd1DPKxawaXy0IhmPMaSnhgjE4PIHWtPwpos2r6vcTaja3MWnSwAEE4Hmq43Bh2cMDgjhlI5BzXYaNHZSpPqXhawiu55UkieW4k8t2KnG3BXJUkHk8Y6VdsdcudFktovFtzpgur9wtlZabC8jHnH3m+8c98ACqs2jyquO5bqmjU0CKG3nuLS20xbGWP97I2ODubCnjqzYLfz61qO8SxsJHjjjLAby+0MSOBk9/b6U8lhE/lB1wDuLEEnPTj0rA8WwWy2VjLPareNHcKbdJ5DHAJMEAzFQQF54zxnGaE0jyLOtO71b+ZuF9h3MVdUJH3iMFcZ3D16e1JITJkM3mB8EMwAGQen05yOvIqjoN/cX9mJb/TvsUmSq/vBIGx3B6MAcjI/CtFFaNVdiBH5QLRbAFBJ7Ed+cflQZtKD13Kts6+dsiQqxLFMP/FjgZ9x/wDqq5dRiS2WaMR/Mv3uQxI7/TOeKq397BZRRrersaSaKBEEZJaR2woIxjHXv1rH8W6rc6DoN/dWkIeNUjKNI2T5ofaykf7uPyqXLlV3saUqUsRVjCHxNpfeWL29TTbjT5J4SwM6QtsTPk7iBknspJ4I9R0pdc1G0060tlZfL89vLtt+TvkOcAnk9RjPYn05pbS5iu9MtdRSNFE9ulyBNjDKRkqSTg4zg/SrN7HHe2McNpelFcAxSwgeZCx5DKWBByMjng0lZjn7k0mtV/wTlNINj4ta3Op2riewl83YeB0wR7gjjFdZZaZp2mRXA063hgim5aGNerD1z2/lVe2SSzih+13EN1KMq8ixCPJ9CoPBx71alWN03ROyf7yZ/XNVd7IVS05XWiIntN1sPKjGwDgdmx1x19vSvSF+6K8sbVtPnn+ypPN9tjX54ShEjgfxqAOR64r1McgGoloc1a7s35nkvxhuNF0jxDpmr6laH7d5S2UV3HGzvGsjkYbB2hM55IJGcDrXj134nsLnUfFdhr9or2lmPPjjkBBBV/LCqQefvA59yDnv7P8AFy1u9T17S7GONktFQSvMBnPzEFMdhwMn3ri9S+H2n6tNcNOkjTXTI0s8B8tjtbcMHnuOTx2rqpVYQS5/w9f+HN6FO8fU4zW38QaxoN5baNCIYbyGKW0dMpiI9VDYx04z1607RPhzaalaWY1trq21F7RLeQxSF2DqQTIpI4O0c5+UV6NoL6JCz6Zo8ttdXVquwWcVwG+zYO35lGTkHoG/Ko7XWbnULyBdANuLNZJINQg1C3kiM0QO0vCRwVyCORtPqCCKbxErONPRb3/D8TWMIrWWr26ev4GXrGl6RoM+lSzT+JrbTtMtWu5bwMPs8gjI2rO3JZmONqA8luRg109mv9r6baXewi1uIo7hPMG1grAEMR24I496ZYRWWlWLQm4S9t7Vgj280iTtAjn5Y3A/hHQbucAelK+rLrmi2tz4Zv7UwTzbfOmXKlFbEojHGTx9Pcda55NyWv3+pUXy2cXdP9P8v1MXXf7OtJrrX9J0u1m1fJhkuljO9iPlIb1PY/TrXF67cYl0vW9b8O63dxYZZbizm2tHz8oSJhyM9+D1Ga7QajfX1h5upWEmm3BJZLaedVm8oEbSx6KzemeK89nsft95dazNeazo0UUnmS2pm8+KdsYUxdCp4G4EcZ47V04dJXcun/DW0f5Cqu6UUt/67Hb3Vjp+oWc0L32vW0l7GXIZ0iuMMMmN+uODtIHvWF4i8F22saBp2j6ZrMFhpsEnnlZR5z3LkY+YDClhg4wwHP0qC4lkS2RfEEOlX+hyIJDFdxb5sEYHlqPnyc8dD6nvTbnV20fwpYxeDfD10Jr+Zvs9okL4iGc+ZINxbopwC2DyScKAdEpRtyvr8vxM7J3uv8/wL2pWOl6TpFppTwazbzQBUtJI1BnbBB3MSdpyTnHIHGOlW9X1PSrzw7Jba1qUmjxZ8vy7uUI1xuGGPGDxjJOMZP0FaGmYNtYSahdRW+qmNlnS15iaT+6jdj05HsB2rJ1DwdoeupPq13pl1e6pCnlxxTXLIJdowoIU568cYpKUb+/f1X/BL5Hy+7+P9fqYFnpF54N8WabJpnhxH0lirvrNwGlfyVXdMw2nZCwVTxtycgg8im614+aHQZrjQrBrBBeFLrzlM4Ykbo1LDG1SCwIHOcHnNdDY6XrepaFqNr4hfTtK0cW5hSOIlGhCkEAKhyFAGMMefUVL4R0b/hHNNMiBdVku71JSYFCom0YRcY59yeemT3rWU4PWesl+Pr0M4wfR6EV/rttb2lrDfaguiaxe2v7mCVSvkzNjyw5UfKeRnPTPOOav3Vtq1x4RsIdSsbXWNQZW89JZvItp2ORtbplsAkNwQfzqv4h8N6V4k1SSSwtdKk1JJ4mupLzc7mBifM2r0EnTBP6dasWc+g67Ne6bp0ssyWMTW66ZIRGWcMS/zE4JYjA6dKx92ylFeb8v+B8zRyb92XyMfUrXxBpdx4SsfD+n/Y1fdHcQl/OjiLy5fMh6jGGz7c+h1vG+otp9nb3R182Jmlk+WK1BmnYYOSAMqNmDj06+1a4tLiG/0/TLGa60+GynwsTghcMM7ck8jJ4OT+NXvFGqW9ldagdSsbe8t4GjWOQW6ysWx87bG4K9SO/HPBovdx/rr53KktLHLeKr3R7fxBpWsHxNdaTeajbRSlliMsMqkbQ45BTgc8EAjvXXeJZLMWEFvq7mdNZfBnjKkIygBJgcfM2TkH0Ncot1aeJ9J1o6/wCV4gjtEimiktbYQrFGDtIj2gbcL1HbHcVuWokdDFqtha3Hh6wge80u6t51MyoqAiGZe+Rn5uoK4q5rRJ7r+lbRP7/kQtPmaOpq3gvwbcNdia9tbdfLmngwJlRjncqnjg4HbiuYstdec+GIPDUl3LpH2ow3XnRsJYJH/wCWci87TtJcH7pCtg9q7HQm+0eENJvNQiElxewmGQSnapHzZBHTngc1xeg3q6E7SaRoF1ZteX0VhcQiVp448cow3crjLc5IAHHpUQWkr6v8BvV+RPqc2seG9QFlBdJbWup3V1eXt9IN6WgKokbOT2+UkjuGOOcVLqPi2+8Iaf4XGq2FpeLcKy3NxZsDGWz8pjOAC207tpwTyM10vizQrHXlm07xBZzxQNKhivIRwfQNxjH/ANfkVx9mYtGm8QalYzxa5awyoP7NC+YbR1OFlAPAUd8Zx3q4ONRJtXf5/P5/gZ25Xvodb4tlv/8AhG5ItPM7XVzLi3lTlFUyKQMn7u5c5X1HFcJo+jaf4otbeLVtaluYY7nyHtFn8+BpSSMDODHJgkZXarcY9Dvw30QsdM8W3Go3U1vZLJHdQEY8+aViQmOgX5gAfYVyOg+FdPksNfvtBaS7gubZlSweVUktSGD4kxnouVVgDknB9tKUeWLTdvPz/wCG1Im7s7DxNqWkw2Wm2uo6et1oEEstrPLDlzazxjaigdVbYoUgkdO/GSs7TLKDXNHlv4ru4t9Wmiijmnu9qmdo8DdIBwXCnbvH3gASA27JVxUUrNtW82Z2b1PRb3w7PJ4lN1GZYbZ8ussTAlX75U8FTnnOa1tPtdK8OpDpemwNHFOzSoiljhsDd1Jx646Vp29zHcOYruI29yDg4bEbn1Dds+9Q6lb3pVG0258idX+SWVAwz3Rx1wR+favO5nbc7XJyfLP+vmZEp0VvEDSNDIdTjTGWjb5V6bsDgDnGfepNXvtW06Xzl0V76zCqh+yybpV5++FPJIyOK0Z547qGKTULP7PqUKkRzRjevIwQrcfKR2IqxbSmSAu0ZRedyhuVPG0g9v8AIqLq/cq8uW7X4/kSTWz3Nu5h3SDbteNmwSfX/eFYkUReYCNGkKklgcjB9PY9OOtbwWSGUvLF8rKB5vRnP4dT+FQ3akKlzalRKHG4leRgj73qO3INRON9S6FdwvHvsVoJ/wB2p8v92uQec7M+tUtV1uw0y8tLO9lMct1xADESHboRuHCnOAATzkdM1ozBBe74B5e9Pn28Lnsfp7VhzeIILrxLDpukQLqE0MJaRgm5LeUD5fMbGFB55/IGhRk1ZDTgpc0lo13t/n1N+QbAUkIzkKM9+2PzrFHifTodafTF1C1+2qgcWpkCuwPcZ4b3AOQRyKveHBqX9iJca/8AZU1R3O6GE7kQbjtGc88d6ik06yaV5p9I00zLlxM8UcjyAc5BIyD29aqyT1MU73TKmraJpXi/T/PutPusoSrxMPLlAB+6cnlCegziuMn+H0M2nTXUV3r8skBeWSCSzKSSRuNrQ4yAeuRg8du1elRHzHDDYrscqoxnnnt7cY7EGpZI7ZryJ2hhcqMpLs3Mh644/r6UXNoYqrRXJF6fJ6djznwn8ObFbD7TqdreRZdJore9uUJDKuA7LGPlbHBGTng16JbwCCIRPsjAX5o1A+8fw/zirOWeVXZGO7ktggsc9Aew/lTRIPNRhGxA+YbgQc9MjP5Ypve7MamIqVdJPQhNlbz3IultYopmUxu2PmdewOe3SpSiPOt08UTzQgiJmUnjpgHt+X1p8cax3qM8ztICSwZgB0zjHvn8AKrx3TyeYssU0ZTLN0JPOcg5/Oj1Od3b0ehMGwxbLSvIQrHOOMdsDtnGfpVK3sXEyyyXFzM4LKV3bVCnopUEcDoCev4VcBjef5gFkDfKBHvCr3HGMZxRtSSXZyACdxCscjHTHpx3oFew5FcOqRxII1bO8sSSORzxjPsKY7rIisjSM5IPlpyp5ByT2/8A1U15Vgu44ZFkEU3V1GQnu+Pu5OOfwp80JgGRk/NsAAJIJfqSc9Dj8M9OKRPWw+4eOSYoCziOMNsZQSxDHnPYg4P4/jUCeS5e3lRZYZTmQlC4PfcxPAwc88dOKck8TWhVXXLruLIMFAO+epyOPrnniphCkmnxhysIYB2RVzjvjjr9aNx39mra7/0yl9nt7SFLOKOM2aBsJgFQGyTkHoOTx9Kpadp1npvlWtmpjso1Dra8ny84J2knp1OOnJ6VqT5naN5wIJJSR85G1iP7p7ZznJ/pmuX8ao8uhQTadrV9pt5GTNblI1eWZkP3BCSPMyD90HPHeiKv7pSm3rLrv66mzZRXl5EZNRitYL3e+zyJC6SQ7iVbnOTgA47HNVZUuRJKz3AWMZAQrkqR3/z1o0G8S70qG7xLHOYhIGaFkGQPmARhuQZB4xxn89G5d7iBv3YDEZBkGMEjj5h1HTnjFS3ccG4Ss9jjfFOgxa7psSS3bRX8O7yZQxjYk9jg5HTqK90twwgiDfeCjP1xXneltB4h0drTUbRoLiMbJYSpVlI/jVuDg8HIr0dBhAMngd+tEpO3Kzmq1FN2tZo5XxjDPLcRNDAZY0iLSYJDDrgKAOSTgc4A61yus213Jo2otp0z2t1axPscobg71TccKSu70A71P8VLXTNX8W+FNL1XSr3UYwZ7svDO8cNp5abg8yqcMGK7VDY6NgnkHM8R+JtP0u7is9TkuLddScRtO0QNp86/8tpDwmeQfXPTBNNQukktX/X9fqXSqTWiei9TmtC8X2Eui6VqGq2MtpPrBtYVeFQxmmlDqh3Dk7dhJDHgMAK39KfXxa3NtrEVi1zC+yO7WTzfPQZ/eOqgbO2EBPfJ7nzvQb7VptUbw5ffDx7Hw3AGbZd2khCzKcqVcKVxk8YzwSQea6zV/GU+leOdM0e6tIIrO6t57h7vftEKRxlpCWPUDaTzjt61tKGtopa6/L+rnQ2n73NdL+rj/ERsvDGr3V4fDmsahPrdspupdPtzLC5TjYeflYjL4J6DA61R8E+GrSzsdDTTHj1LTLZLqSxvJX2SwJcbW8rYOHHByTggk8DpXUQeJ7Eanb2dtLMFurcXFtdMhFveR7dxSKQ8M4A+7+hqvoF5fXSX9tqmiTWPklUMsCYt5xncskJ7rjBZT90tgn0hzlZ/1pqvw2+8IR0u36ev9fp5EHiXSLfUNN2quGVhKXi+Y5Xopz/LsfWuF1uy1bTrGVrCxzaxkzTPtad2J5LbRkgKADgDAA9s16KtvNMHhvm3hW/dTqpHmLjhXXswPfnOK4yx8DjR9Sn1PStb1VLzIkkEt2Y4ppMnaJSAcgkjJxn061dGaSs3+FzSpddNfuKGha9pmr6ZHPFfG+gX907mFoir4BwQf0xnIPbmmeObHUvEMUFlok+pRWTKSbskCFNoy0bgHcqgYOSMcHGa1L+0urnQjJa22nWGrQiNmt42SSK3kMg8zJTg5XJDc9Rk96y9X1XWrmz1L/hGXS2gs7hJftbqsh8shidwbgDcq5HOAQT7dEVaXNHTXr0IlUTjZ6/qR6VZ2mrmxxqGoznRII5JSIgiXhLcMhJ4HTnrgZ+mj4kk1G9k0+S3VpInvIQgtG+eJgCS5K9V3ZPPHHtVL+2bK+tLLRboWovL6IPLNpsGyOSTk4U9+h5PWpra0TSdHvNJ0i+a21a+Y+RczE+WH4yn+yCBg+mc81T0ld/L9X/SFG8ou3z/AK/4JVHhq80vQbfR7ee0uftU8l3dXEci4fLfIEHGRgAkgcsT1rUV2tDN4W1TS/N0ZbRjLc7iu9XHJTHJ+YhMDnPpWPqvh+D7Dpuo63qkhu9PiWK78pGVnKvkbc4K5Bx3zgHir1/rOnXt5caja7p9Qt7UzyBVwMDsOOWH+H1pO8vP5de5SjbfQZpCS+FvFWl6fBpt9fx3yiSXUpCckspLcYwAndc5OK0tHt9Rt/F0st1omiw6fdFgLy3DJJIQpHIJJLn165rEEF94zn0y8F61rJp90jo8bMsMsPGcpnAdSPU56Gq6aZqemeHr6FNUS7vrbUGlkO5n8tTjaATkhs5LDjGQBnBpySe712e/3ii72aWn9dDU1rXdV0e5VbqdruB+I4Y4gI4VB+4mQSzKMZzzg11Sz3Fw9leWFjA/nRfvC6sSrDnaxxhTx1I6Hmsq5/tK+htodPk0wanhXvrW4jD4Y98YI6e2RnFL4pu/P8NXFnLd3NntjcSXNgPLQk+2cN2GPSsXZ2VtTRXTZZ1rVrPT4EgNu+n2ssi28nkxiPLEZBGBhgMn6/pUPhzSE0qPVIZrgTRTIUG0hQxOeEJOA3GPTrXD6Tpxh8PLb61cT6tbzOjWjxOSYWX7zKQMg4I+U++evGh8RbGB9AlEWprbXEmrm7tViRs+Qse0rgdSCC2PryK09mr+zT3/AK9ROVlzf195c8V6nq3g/TdW1i0SXdcRxra2jLmO0w3zEjoUAAx6Fjms6H4jpY+BdM1qXw9HA15qAivVgUxoAg3CRM5xu+bAz1Vh6VsaVdG9lVw7TaEkbSDeFDcDaUZTnLHPOB0JrnNB8Q37PqNlrukaTLoFqpDw2sIVYSD9xkPPfgsB2+laQipRalFNrfp5WM6mkk099vzubd+PE9nGqWV3/bTtt/dSOANpyytzghfmycYxjmqP/CcaTaa9Nf3ehJYyWkvkyywqVZj/AB5AABU89c5FaVreWGt6k1/pMjta+QvlzfcIVABtb0YdPfHvWB481O9guol1PR3v/Dt1GAZreAhlOCGO9fmVhnoTghu2KUFzS5ZL9H6DdlHmR093f6VqWhrJpMMd3p+ogmSFPlMmG4A7hlYHA/DnNTX6jw94d1FNAhNndeV9oivJPnd1yAxJfI3gZyvYg8VzNhoP2rRZtKsVeCw4urDUpDnc7YJV8YKkgAEcEYzzVSxvfEuk6RqkeqyQXljGqCQLN9qjc5wWAPKhgMH19jVRpp/C9E9mRNtOzWvc1Ph8bLXFsdW1OM2/iGIy2pxIkQuoOWVpI8dc7uVC8qM8HFFaWjQ6I2jaXrtrMNINnBuV5OFMbnZsYnrhiMZwelFTUg6krwT/AMvIj2ip6Sa+89b1uyuNQ0ue3sLgW90xypA2g4bkexbkE+1M+1QaHos0us3EtnaRmNd94+9gzcBSwGWAPRvTrxzWrORGJQC05j5II3PjGcAdT7Cue0rxPFrOoyWEel6ykSKcz3liY7d8DJBLjr9f0rktf0Nby5bG0wd4RJEeFXjaVKuPXPTHfNcbcXHj6LUbebTbTSRpgkP2gO5jcqAOQW6DvkZ7128axMqhoZMIq7WQYGO2OBx/hTHhkd2VEX5f+Wg4YDtgf1qE+V3KjNNOLX9feLM0lxDEWeNpCA23naTjkA0QEKJvl2uxBYMBuwOMZ7+lWbeAvC3n5UpwTnrjvVZ4yyZ3lWQ5yQCOPWk73uKDi1ydg8uJTwxlBPzqp5A+vt+VYGoXt1YxInh3REvraS7jW5SICNip+8/HUj1/pXRx27FSFXCnqXAHB+vWoNSudI09ImmvVhDsI4wr53v7Ack/SixUZq/Lq3/XYwdR8NXuoa7Yalb61q9klkxUwrIPIuE3fxKSByODkGt8KroJEcoCzKQnzMOenPXHHvjFU7S/0q9nnk02/uLqWJik8bSK20jrkSdOvY1JZ6ho4v7mxtL6K3v0K/abYMuUZhwTjKhsY7mhXYVW1pJWa8rff/mKyRC4lljw8j4DsF5cjgEn1AHT2qVFEbgzEAgcI3zsGz0Ip97Yo9zE00rqVB2eU5Al4+bzF6N68c1EqskbtbATsSBhyec8E8j05/DvQZ83MiUkBCC6BWf+EZAB67uTnHYis3UXayvrW1g02d4bpykl2Js+UccZDZyOnTBFWnnH7wQfKjNtQxx5LD/d6Y+uKq6naWl88KzWsd20Z8yNJkDKrDo3JyOvB5qXqXD3Xr/Xn02L5iSFxtwFPDtgLjng49qiw7oRN8w52Nnd39/XHTtjuRT1JYMksiGQoQ4jDMEA7Hjj6mop5/KdXYL5jAHaTjavZyPSndEpN+pN5LzKoiBIGVLgjnjpx+VRLDLBMrJK8kIIAjkUNz6gn5hUqv5cWYonWItwjj5T7jHTOcjPWmrIm1kijQuM5kkbCx89d3PXpjNBF5P0HTu6vuJjIPWNmZc5GM47fh35+kC3N55YAt4huyyEuOoJ5GRg+lWCTGgUIJgf443DAdj15yPSkuYR5edp+QAEsf4c9s9D19P6UNdhR5VZNGfc38tvbTS21kZJxIrJbswTcpIB+YdOpJGPwq/EyvbQbF2kBh8rcA/3PoMj8qLqGDzTJbJmKTqyyEHPPQH1qBQ+4wFhFjA/eYYgnHAxweQP/rUK5TcGk4qxKBJ5Su+14/vbHYZYkEkK3rjPXrjtxVG70iw1GexbU7Czu5rFjPA8oyYTxyrA89AcdCR61fwv2nJLRwbiNnQfVvUcnjHFJC+Zi0zSsc7IgGwcEjrnj/Ip6rYzd7XMrRrzVbq6uLHVIGaWECRLoNwxOThT1XtWlDJIFV1IMSKPMjKA70PbJ6c9qk2Dc+SiFenOC/PcAc9uarmJXnniiDu0i78ElWwB1GeQe4z6VGw5uM7tKxkfEC2j/sJ2trq5tRIPLEtucsg9Ov3c9RXrduGW3iDnLBQCfU4rzn5JLQ294FmtjhyW5wc5BI9O/fH4GvSU5RcelS0lqiKtSTpxpy6X/GxzfiCZYtWgC7S7RYYHHTJ27vUZB/WvFW+H3iKDU74aX4wit9JuWXK3MH2i5VNzEwHcCHjXdkBupPQYOfWfibDfT6RcxaL5K6tJAUt5JZPLWNidu8t/sBiwHcj3rgdE8WPpMNnpfirT9S0zU5FVUNygl3xr8ommmT5IdxVyQSdoGTkEE70pSSvB/LT9TJcu7NPxHo81/wCHJIptP/t6WKMPHBNIIC8gx8yNyIzgcY44p2nTvr1o6634Tms5kRle21GNX4ZSjbWGchlyDgDOeRVvT9d0zW9KtZrG7E8F75n2Z47sxtcbPv7FyHO0A5wKy9Qvb6xeWx8LQy3l6YmIn1a/3W8QwTyWy7gNtBCgjnBYYo963LJff+P9WNINPVehYW2DWsTWNnLpjxARLZCXZbqo4xtAZeB0wM89R0qxPqUNibe2vbi3t5rvMMMTP998cqpOM5Bz2PTrXJGTVrLxnb3+vwxvBcW1vaSvpYdw9y6DCzxnJABDFJxsO3apLA8WL5P7f8YWsV2LvTbnS381bC4RJbW+h3YWZDjAf64ZDjvyacFfV/1/X4amsJ8yta34/wBf5nRahFfTXNmlg0KafJFJFcSjHmxyZXyio6Z++D74rN0RLpmvtO1W6tp7qCUN8qbGeMjhmXse3FbN3NbWBQ3MhjWWZLdC3GWZvkVj6k8c8ZrP1zTo7mKSaGS4iukUukqu+V4OPu8kZxkLyccVgnZWZ1W5nY4zWvDmr6eLwaa0a2MrriMyEMkSrw5fBZmLfw46DHfNZ07WscNvp91JLBBFb7bqeZgsUTE5UtGTkyPnheTjBJPOOi+GnjC98QC9sdTns7m5tHISaytp442AHJYyKOeRxwetbOt+HtP123WDUbBG2SeeAG+VpNuN+RyePxrrdVwfJV6dTnjT1vHQ8z1Cx1A6jYomgwWkMtuIm1KBw6zQJyG3A5VWQKegPBU9KpajrT3Vhf2ukalBKFgSZD5LJL+7AErHP8QwRxgkGvZ00owwfZEVBZqmxIAu0JjoAPT2qCPwzpMImYwRpJOAsrMg3ScY2kntx0PHFH1qPVbf1rc2hStu9zzTwtHFqjrff2jBf3iQ82rMY3mfBKxEEBTuxjHOT29NDwFqtjcRapOmkPZajGVW4SQlgybm6ZAKkEEFSOOD0NXrLwf4KivJNPtruFL2WRJVhuJyHVlJK7FJzjOcY9K6JPDa2Fre3d1dPJLKGlmkDHO0KQ3AyTx3qp1YNNWetrf0hODUleVrHnniSG98QWyrE6QwW1xv+zghVkiI45GOhHT1J71Hp89npYXV9Rt2/tCUi0lYcrKke0iUjkE4AH4E8c11Eei6QdLe8tr/ADp07h/PhTeZSCeFVBnsc8dcHmtF/Dmm+IbBb2KJr+3VPKijmjaPY6g/PtYA9cHJGDT9tFLltoVy6qV9TzJNCk0HxjPqFrrdn+8aSa2eSYJKRKc7H3clu2SSD14q9pVnqWkWF0JbdXmnm8vyD90oOsmMkA9BxXQXvwmj1y6s59c1C5RoovKlMJUGZeSBk9+cZwePzrudK8O2VjZi3hUS7QEVpBvYADA5PU4HXr3p1cTFxWt3107ChFU27LT+vkeV6vqUNjoSwaPemwuRKJdwiZvNwPmAAydowCT0wDUviNL+yvPDl9PbR6v4ckt1W7KQCR43LcSJ/Fg5HTIGDkZq9aeFdO1nU7q0t57y2m092SUXUZQrngFCRhgfUHoa6nw1Y2cNhFptrBqjW9oSvnzR+UvXoC3JU89ql1IQ9fPzLacnpovL+tjjmka2v7jT7k/YbNvMjs5reIKVbplSR8x5Pbmlhmvrfwxq1xr95Lr8zSJbqyRi2IjAOASoJOCM4wQO2a9R1DSrC9xHeMsjowZY2cZVx0x3B+narEmj2D25iltkNuw+dGIIcj1BH4/yrJV0rK3YiUnPV7nn0UtnbeAnu9Osc+TaPc+U68b1B7DuCMfTmuU0rXNX8cW0MyFbaXSgkUr22UiljcHAZT3B69Qcg8V7FbaNYWrr5MRXYpAwcKFPbHf8auWenWVogitbKCGN+XVIlUOw7kfjRGvGKdlqEldq9zx+Xw74j/4TWxewZ/7Od1aeQvgGMj50IzzkZIIz17V1+jaHaeGZbjVNW1G3tI3Xymkn2RKy54Qg/ePt17V1mi6BYaTqt3eW73kk142ZY5rl5l6k/Ip+5yTwPpVPxVqdnpSabJqWi3mqBLkeRLbwGYQy7SA7dlbBIB65zjpmqdaVS0Vt9xjJqOttTP8AEGi3bhLe0ttasdOZ8rd+H/LkkK7BhZ0cbgNwONmRyM+xWc1j4g1LxdcXV3Z3mhwh2j0y5hmkb7UiqOZ4huQDaSVYhTnA55wVWsUkmjByUneR6XMi3D4eNC7A7ZOQxPrntg0iNJEkK+fI5VQodyct7/zoornS6nRzO/L0MKeS/wBK1Y3cL3+o2sw2vaI0aiE92VmZSM4Hy8jj3q/eQ219aML53FscMCmVdRx1weT270UU07ysayjaPN3JJp4LWe3jkbbC0gSDLPubjPBHt64q/ukl2o26IIc5Rh8/tyOBRRVWsYOV1cJ8yoqrGSwGHZ2yAOQfc9KxdZ0rTtRiSLVbSK6jiYSxPypjYcb17qeBnHWiis5dzWjJ3sjLsfC1umu/2nCjRxkMkkwfmQMwbLAAZOR1NTXWn2a2etW9zYRTW+puzPNCAkm8qPnyedw4I9CKKKi1kdirzqTtN/1c1dJiuk0+whu7sz3UEMYfcTkkD7xPHJBqpr3iS20nTBf3ltcxQBjEzRlX2H1IJz19M0UVrazS7nPRgq07S7kWg67Z65p0V7pFxJLEXYBihTbj681dt9QuIrkhG2RjABbo5xnkD6diKKKiquSTSLjCMm4tFyKe3nmUGZ7SbnESDKN65GMHGfap7CEBLjFx+/3BXdYx83dc8elFFOC5tzixP7vSPkYnifXW0XUdNsHRnGoylRKWyI8cEgdc8/8A161pJ43ZoIPm2pjBzzu6degHXv07dyihm3s4+xhPq1f8RsAtmuUSEZjfJjdcrg9cHvj9aJI35dvtSqvHMigqe4yM5FFFJmUm4ysRqwRHdnVkUbirAtxnBOT/AIU92LKVfKKjEZtzjH1UjB/zxRRTsTLWzGO5a9AhkRi+cKUweO2enbisLW/Fmk6LcRx6hMqSTRl1HlyElfQYBCn9KKK0w9NVZqMiqj5V9xoaX4g0+8iiurdoVgmU7TscSFhwe2OD6/rWoryJkxFHmQFo0kJyOMDn+nFFFFSCg9PM5Jy1ZHjNpOE+b7rbV4yeScZHHU49K72L/VJ8u3gcZziiisJaCbuecfEnxBHaa/Fp9kks+sQWD6ibQIoF1bhirqJCQFZeWGeD071T8M65ca1YNqlvfxf2FdRpJawG3ZZ4xjEgl+Yo/I4AxwKKK3cEqd/Jfi3/AJDj59H+i/zMPVbS50vxNY6vPZaBD4M0eAyfbmikE9qzgrKkKJnqdp+7ghjzu6Y9jpXiG113QL9rh7sSX9w096GTaunlAwt3U4ZwWBZSB8nPBJGCiqi+Wnz+dvw/r9S4+9Jwf9WCW9v9F1PxPoulR3Fs2oWMuoWl6k4nv9Qm8wRtJ5jFEiSJMosZxjGRuNbGkw+K9J0bQ9O1qC41u91G5aO6aa5iIsrcgDZM52mdgvUqOcNgn5clFRVqcq5bX2/Nr+v8tDKOk9P60TF0uPwtNo6eHtO8y50ndJFsdpX2Ku0tHufD/KSpQg8YGDxWhNc39/q2q21miW9lbbBBqDOXM0mPnRk4YY4+buM9exRV14KnVlBa2tv5nXSm3RhU739NCDX9VjvPC+pNKYLmOCCSXy7sytbmRFJPmBfmK8Hpk9K4u2k0jS9T0nSte0Oay/tzS1kUQ30j2+4sS0JRTuGzqkgO4btuSAKKKILlfInpr+CuVKKdpeSN34e+K/D+saclhpV1fnyrl7KI6hlppSo3AbwCMYPBbBwMGmXXxQ8Orq8Olpd3RnuWa3DxxvhnztZecFSD0PIyM56UUV2TwdO7lrtf8zmo4ucnyO29vyNi58KaXrlnHaXEtwNTtlVra+lw9yjqcq4lx94YHJH+NQWuk6zNb3+n+JtRg8x2UW2p6WGtrgADqQAQjBuflODz0oory+eS08z0XrL5f1/TLeiTavbXV3Z3536ZGkaWN6ZBLNcgDD+YCAQ+eSwABzWggjgY7jcTLHhj5cu1sd9xYc9e3vRRWfM5O508iLM82mKrTQ3UkIBGEWLr2P8AnNVje5WOW2kcAyExTEYJC88qPT60UVdOPNFszqx9lKMd0+5j+F7m1tdRvtI0/Sls7WPFxFIG3JcK4zvHzblPBG0gdM5Oa3bS9iu4Z5LbOUmaBxjGHGM49uRRRRJ31M2uV2Irm6kbU7u3vtO8q1iUT294rI8cpA5GwncjDPXHbr68j4vmPhrU9O8SRaxfmGe4+zT6ezs8cm5CQVB4TG3OfUe9FFXTl72nmvwJp01Nxi32/FnTaVqb6hZW1wliUScedGWYHIBww65Ug545B61pmWTIHkpv6hs449O49KKKxlu7Gmi0sVGbVjrbK9vp8WigApdC4kNxK2OyBdq4PByT6g9qoX/iey0TxJY6TOlzPfahBcXFs0SqCViUs0ZbjBIVsHnnqaKK2p2k7NdDmqLlg2u5geKdRk1mDSL2wu7u907VI90GkQxRQvcADcWleTIIXghcjkcZoooreVb2KilFO6v17tdGuxnGiqkpJv4Xbp5eR//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Normal; (B) VAIN II.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Christine Holschneider, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_22_18790=[""].join("\n");
var outline_f18_22_18790=null;
var title_f18_22_18791="Clinical features; diagnosis; therapy; and prevention of Rhodococcus equi infections";
var content_f18_22_18791=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical features; diagnosis; therapy; and prevention of Rhodococcus equi infections",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/22/18791/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/22/18791/contributors\">",
"     Leonard N Slater, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/22/18791/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/22/18791/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/22/18791/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/22/18791/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/22/18791/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 28, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rhodococcus equi once rarely produced human infection. The first case was reported in 1967 [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/1\">",
"     1",
"    </a>",
"    ], and only 12 additional cases were recorded in the next 15 years [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/2\">",
"     2",
"    </a>",
"    ]. While still not commonplace, R. equi has increasingly been appreciated, especially as an opportunistic pathogen. Most human infections have been associated with immune system dysfunction, and a dramatic increase occurred early in the HIV pandemic [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/3-12\">",
"     3-12",
"    </a>",
"    ]. Concurrently, increasing recognition of R. equi as a pathogen has led to improved laboratory identification of infections in both immunocompromised and normal humans.",
"   </p>",
"   <p>",
"    The clinical manifestations, diagnosis, treatment, and prevention of R. equi infections will be reviewed here. The microbiology, pathogenesis, and epidemiology of R. equi infections are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/59/37814?source=see_link\">",
"     \"Microbiology; pathogenesis; and epidemiology of Rhodococcus equi infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES OF HUMAN DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of R. equi infections have occurred in adults, but infection in children as young as nine months old has been reported. Most cases have been observed in men, which is probably partially explained by the predominance of HIV infection in men from North America and Europe, the source of a majority of the R. equi case reports [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/7\">",
"     7",
"    </a>",
"    ]. Nevertheless, cases have now been identified from virtually every continent.",
"   </p>",
"   <p>",
"    The sites of infection and the specimens from which R. equi can be isolated include, in a roughly declining order of frequency [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/3-12\">",
"     3-12",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pulmonary (usually the primary site of infection) - sputum, bronchial washings, lung tissue or abscess contents, pleural fluid (empyema)",
"     </li>",
"     <li>",
"      Blood (predominantly dissemination from lung infection)",
"     </li>",
"     <li>",
"      Central nervous system (predominantly hematogenous spread) - brain abscesses, cerebrospinal fluid",
"     </li>",
"     <li>",
"      Subcutaneous and other soft tissue or organ abscesses (predominantly hematogenous spread)",
"     </li>",
"     <li>",
"      Wound drainage, infected joints, vitreous fluid (usually due to traumatic inoculation)",
"     </li>",
"     <li>",
"      Implanted indwelling devices such as peritoneal dialysis and intravenous catheters",
"     </li>",
"     <li>",
"      Other sites such as pharynx, middle ear, lymph nodes, bone, and stool.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Pulmonary infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary infections are the most common form of human disease caused by R. equi. In one large review of 72 cases, pneumonia occurred in 76 percent of patients, and the lung was the sole site of infection in 82 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/7\">",
"     7",
"    </a>",
"    ]. Pneumonia was accompanied by extrapulmonary infection in 18 percent of cases, while infection at extrapulmonary sites occurred without evidence of pulmonary involvement in 24 percent.",
"   </p>",
"   <p>",
"    Most published cases of pneumonia have occurred in immunocompromised hosts, including transplant recipients [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/5/15449?source=see_link\">",
"     \"Bacterial pulmonary infections in HIV-infected patients\"",
"    </a>",
"    .) In such patients, infection is typically subacute in onset but results in high fever, cough which may or may not be productive, and prominent fatigue [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/3-11\">",
"     3-11",
"    </a>",
"    ]. Chest pain and weight loss are also common [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/15\">",
"     15",
"    </a>",
"    ]. Hemoptysis can occur, sometimes severe enough to require multiple transfusions and even pneumonectomy. In a series of 67 HIV-infected patients with R. equi infection, chest radiography was abnormal in 65 (97 percent); cough, sputum production, and hemoptysis were present in 88, 85, and 31 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A number of local complications can occur in R. equi pulmonary infection. Cavitation arises in more than 50 percent of cases and pleural effusion in approximately 20 percent. Invasion of contiguous chest structures (chest wall, pericardium, mediastinum) and recurrent pneumothorax are unusual complications.",
"   </p>",
"   <p>",
"    When the underlying host immune deficit cannot be ameliorated, pulmonary infection is usually chronic and progressive. However, the course is often punctuated by periods of clinical and radiographic remission in response to aggressive antibacterial therapy (see below).",
"   </p>",
"   <p>",
"    Although pulmonary infection is significantly associated with immunocompromising conditions, pneumonia can occur in immunocompetent hosts. It is difficult to assess how rare this occurrence is since the diagnosis is probably overlooked in normal individuals. Most reported cases have had cavitary lesions on chest roentgenograms; one had multiple lung nodules [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/7,16,17\">",
"     7,16,17",
"    </a>",
"    ]. Extrapulmonary complications have not been reported in these hosts. All have recovered with either prolonged antibiotic therapy or lobectomy without antibiotics.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Extrapulmonary infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common extrapulmonary sites of infection complicating pulmonary infection in immunocompromised hosts have been the brain and skin (subcutaneous abscesses). Brain abscesses, surrounding cerebral edema, and sometimes meningitis may result in a variety of neurologic symptoms such as confusion, agitation, obtundation, coma, seizures, and motor weakness.",
"   </p>",
"   <p>",
"    Extrapulmonary sites have been the first site of diagnosed infection in some cases even when a pulmonary infection is also present. These sites have included rib osteomyelitis and hepatic abscess, resulting from contiguous spread from the lungs; otitis media, probably due to spread within the respiratory tract; and subcutaneous abscess, probably from hematogenous dissemination.",
"   </p>",
"   <p>",
"    However, extrapulmonary infections more commonly become evident weeks to up to two years after the discontinuation of antimicrobial therapy for pulmonary disease. Such sites have included the brain, kidney, bone, and subcutaneous tissue. Recurrence of the initial pulmonary disease may not be associated with late recurrence at another site. However, when extrapulmonary infection occurs during antimicrobial therapy, it is usually associated with concurrent pulmonary relapse [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/3-11\">",
"     3-11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Extrapulmonary infections not associated with pulmonary disease can be categorized by several patterns:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Wound infections &mdash; Septic arthritis, mixed flora cellulitis, and meningitis have occurred after puncture wounds; cases of endophthalmitis have developed following corneal lacerations. There has been no evidence of invasion beyond the primary site of infection; drainage of infected sites, where feasible, may hasten resolution when used in conjunction with antibiotics.",
"     </li>",
"     <li>",
"      Peritoneal catheter-related infections &mdash; Catheters have represented the apparent route of inoculation in a few cases of peritonitis related to peritoneal dialysis [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/18-20\">",
"       18-20",
"      </a>",
"      ]. Antibiotic therapy for more than two weeks may be curative without catheter removal, but removal may be required in some cases.",
"     </li>",
"     <li>",
"      Fever and isolated bacteremia &mdash; These manifestations have been reported in patients with central venous catheters, neutropenia, or recent chemotherapy associated with underlying malignancies [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/7,21,22\">",
"       7,21,22",
"      </a>",
"      ]. Antibiotic therapy for more than two weeks may be curative in some cases without catheter removal, but removal also may be required.",
"     </li>",
"     <li>",
"      Primary inoculation via the gastrointestinal tract with spread to regional lymph nodes &mdash; This type of infection may manifest as cervical or mesenteric lymphadenitis [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/23,24\">",
"       23,24",
"      </a>",
"      ], peritonitis [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/25,26\">",
"       25,26",
"      </a>",
"      ], and pelvic",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      paraspinous masses, which may also involve adjacent bone [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/24,27,28\">",
"       24,27,28",
"      </a>",
"      ]. Relapse after discontinuation of antimicrobial therapy can occur [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/23,25,28\">",
"       23,25,28",
"      </a>",
"      ]. Such infection may also be asymptomatic [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most important factors in the timely diagnosis of R. equi infections are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Appropriate suspicion on the part of clinicians",
"     </li>",
"     <li>",
"      Training and vigilance from microbiology laboratory personnel to recognize and pursue isolates consistent with R. equi and not to discount these organisms as contaminants",
"     </li>",
"     <li>",
"      Prompt communication between clinicians and laboratory personnel to alert one another to their suspicions.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The organism is easy to grow. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/59/37814?source=see_link\">",
"     \"Microbiology; pathogenesis; and epidemiology of Rhodococcus equi infections\"",
"    </a>",
"    .) However, it can easily be dismissed as a contaminant. Thus, isolation of a Gram positive coccobacillus or acid fast organism from an immunocompromised patient with cavitary lung disease should raise suspicion for R. equi infection [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/15\">",
"     15",
"    </a>",
"    ]. If the clinician alerts the microbiology laboratory, the organism is more likely to be identified.",
"   </p>",
"   <p>",
"    In immunocompromised patients without the acquired immunodeficiency syndrome (AIDS), radiographic features of lung abscess caused by Mycobacterium tuberculosis, Nocardia asteroides, and R. equi are similar. All cause consolidation that may evolve to a thick-walled cavity [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/30\">",
"     30",
"    </a>",
"    ]. However, in patients with AIDS, R. equi pulmonary infection still frequently produces a cavitary lesion [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/3-10\">",
"     3-10",
"    </a>",
"    ], while tuberculosis or nontuberculous mycobacteria infections less often cavitate in these hosts [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Blood cultures are positive in more than one-half of immunocompromised patients with R. equi infection compared to only 10 percent of normal hosts [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/7\">",
"     7",
"    </a>",
"    ]. Patients with AIDS have the highest rate of accompanying bacteremia. The magnitude of the bacteremia may correlate with the risk of hematogenous dissemination. Occasionally the isolation of R. equi from blood or tissue is the first clue to the etiology of an infection. If R. equi infection is diagnosed in an apparently normal host, further evaluation of the patient's immune status should be pursued.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple antibiotics are usually the treatment of choice for R. equi infections. The organism is frequently resistant to a number of agents. Unfortunately, methods for the determination of in vitro susceptibilities of this pathogen to antibiotics are not standardized. Several series have tested multiple isolates by disc diffusion",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    minimum inhibitory concentration (MIC) techniques and have indicated that R. equi is usually susceptible in vitro to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"     erythromycin",
"    </a>",
"    and extended spectrum macrolides,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    , fluoroquinolones, aminoglycosides, glycopeptides, and imipenem [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/2-10,32\">",
"     2-10,32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     Clindamycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/54/1897?source=see_link\">",
"     chloramphenicol",
"    </a>",
"    , tetracyclines, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    (TMP-SMX) have activity in up to two-thirds of isolates and may be useful in some regimens. However, these drugs are not reliable for empiric therapy. There may be modest geographic variations in these susceptibility patterns.",
"   </p>",
"   <p>",
"    Most human isolates are resistant in vitro to penicillins and cephalosporins but are susceptible to ampicillin-clavulanate. Beta-lactams probably should be avoided, even if initial susceptibility testing is favorable, since resistance has been shown to develop during therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/24,33,34\">",
"     24,33,34",
"    </a>",
"    ]. The emergence of resistance during treatment has also been demonstrated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/6\">",
"     6",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"     rifampin",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/35\">",
"     35",
"    </a>",
"    ], and TMP-SMX [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/2\">",
"     2",
"    </a>",
"    ]. One report from Taiwan of susceptibility patterns in 13 R. equi isolates adds concern about the emergence of strains resistant to multiple antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The finding that virulent strains are resistant to in vitro intracellular killing has also led to the recommendation that R. equi infections be treated with antibiotics that can penetrate macrophages [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/36\">",
"     36",
"    </a>",
"    ]. Combination antimicrobial therapy should be used in immunocompromised hosts. General guidelines for antimicrobial selection in initiating treatment of R. equi infections include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In vitro susceptibility findings should guide selection (excluding penicillins and cephalosporins); in vitro studies of",
"      <span class=\"nowrap\">",
"       synergy/antagonism",
"      </span>",
"      of combinations can be considered.",
"     </li>",
"     <li>",
"      In immunocompetent persons, single agent therapy may be sufficient, probably best provided with an extended-spectrum macrolide or fluoroquinolone.",
"     </li>",
"     <li>",
"      In immunocompromised persons, two or more agents should be initiated, at least one of which should have excellent penetration into macrophages.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Selection of antimicrobials must be tailored to the patient and clinical situation, using in vitro data regarding susceptibility, synergy and antagonism.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Macrolide:",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/43/33456?source=see_link\">",
"       Azithromycin",
"      </a>",
"      (250 mg PO once daily) or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/57/10138?source=see_link\">",
"       clarithromycin",
"      </a>",
"      (500 mg twice daily) or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"       erythromycin",
"      </a>",
"      stearate (500 mg four times daily). Azithromycin is most convenient due to once daily dosing, and also has the least CYP 450 3A4 interaction.",
"     </li>",
"     <li>",
"      Fluoroquinolone:",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"       levofloxacin",
"      </a>",
"      (500 mg P0 once daily),",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/60/35776?source=see_link\">",
"       ofloxacin",
"      </a>",
"      (500 mg PO twice daily) or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"       ciprofloxacin",
"      </a>",
"      (750 mg PO BID). Levofloxacin has the advantage of once a day dosing.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"       Rifampin",
"      </a>",
"      : (600 mg PO once daily) At least one of the above should be selected for macrophage penetration.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       Vancomycin",
"      </a>",
"      : (1g IV Q 12h), with subsequent dose adjustment based upon serum levels.",
"     </li>",
"     <li>",
"      Imipenem: (500 IV Q 6h). Some clinicians would also add an aminoglycoside to this regimen for extensive pulmonary disease or metastatic disease. The aminoglycoside of first choice would be",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"       gentamicin",
"      </a>",
"      .",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    CNS infection therapy caveats:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       Vancomycin",
"      </a>",
"      penetration is variable; therefore measure levels in CSF after several days of administration.",
"     </li>",
"     <li>",
"      If an HIV-infected patient is on protease inhibitor therapy,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"       rifampin",
"      </a>",
"      becomes contraindicated. Substitution of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/63/32760?source=see_link\">",
"       rifabutin",
"      </a>",
"      in a reduced daily dose of 150 mg may be a consideration with certain protease inhibitors.",
"     </li>",
"     <li>",
"      Central nervous system (CNS) involvement should favor the selection of multiple agents with good CNS penetration.",
"     </li>",
"     <li>",
"      Drug interactions must be anticipated and avoided or circumvented. As an example, co-administration of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"       rifampin",
"      </a>",
"      and HIV protease inhibitors should be avoided. By contrast,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      levels may become elevated when the drug is administrated with macrolides (especially",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"       erythromycin",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/57/10138?source=see_link\">",
"       clarithromycin",
"      </a>",
"      ). Thus, cyclosporine levels need to be monitored and adjusted appropriately.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Initial therapy in immunocompromised persons should last at least two months due to the frequency of relapses following shorter courses. Much longer initial therapy may be mandated by the persistence of radiographic or clinical evidence of infection. If a good clinical response to initial therapy occurs, conversion to combinations of oral medications may be feasible as long as the total duration of treatment is maintained.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     OUTCOME OF TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The immune status of the host may have a substantial impact upon the outcome of the infection. Hosts with normal immune function generally can be cured of R. equi infection, usually with single antibiotic therapy. Many immunocompromised hosts without HIV infection can be cured as well, but chronic or fatal courses have occurred in over one-third of such patients [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Before the era of highly active antiretroviral therapy (HAART), R. equi infection in HIV-infected individuals led to chronic progression",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    death in more than 80 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/7\">",
"     7",
"    </a>",
"    ]. However, recent advances in the potency and durability of HIV therapy may have improved that prognosis. In the series of 67 HIV-infected patients cited above, 23 patients died of R. equi infection; none of these deaths occurred among patients receiving HAART [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/12\">",
"     12",
"    </a>",
"    ]. Any improvement possible in the immunocompetence of the host should be pursued as an important therapeutic adjunct in treating R. equi infections, either through curtailment of immunosuppressive medications or through aggressive antiretroviral therapy.",
"   </p>",
"   <p>",
"    In some circumstances, surgical resection of infected tissue combined with antimicrobial therapy has improved survival in patients with R. equi infection [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18791/abstract/3\">",
"     3",
"    </a>",
"    ]. Resection may be particularly beneficial when lung infection has evolved into an inflammatory pseudotumor or large abscess. Resection alone has been curative in rare cases of lung infection. Drainage procedures for localized abscesses and empyemas have also proven helpful in selected cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Even when patients appear to have achieved a full clinical remission of R. equi infection with initial treatment, long term, and possibly indefinite, secondary prophylaxis should be administered to patients who will be persistently immunosuppressed. This treatment should be with an oral agent which has demonstrated in vitro activity against the specific isolate. If possible, a drug with good CNS penetration should be chosen even when the initial infection did not involve the CNS. This is dependent upon (1) in-vitro susceptibility of the isolate and (2) the circumstance of the patient. For instance, an AIDS patient with a CD4 &lt; 200 would likely be on TMP-SMX already for PCP prevention. If R. equi occurred while on TMP-SMX, it would not be an appropriate therapy, irrespective of susceptibility. Agents used for MAC prophylaxis would likely be good choices for secondary prophylaxis of R. equi.",
"   </p>",
"   <p>",
"    Prospective evaluation of approaches to the prevention of R. equi infection cannot be conducted because the infection occurs relatively infrequently and sporadically. However, immunocompromised persons living or working in environments near grazing animals should be advised about reducing exposure.",
"   </p>",
"   <p>",
"    Anecdotal observations suggest that the widespread application of HAART in persons with HIV infection, which has resulted in better preservation of immunologic function, has caused the incidence of R. equi infection to decline, along with other opportunistic infections. Furthermore, the now commonplace use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/43/33456?source=see_link\">",
"     azithromycin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/57/10138?source=see_link\">",
"     clarithromycin",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/63/32760?source=see_link\">",
"     rifabutin",
"    </a>",
"    prophylaxis against mycobacterium avium complex (MAC) bacteremia in AIDS patients with fewer than 50 to 100 CD4",
"    <span class=\"nowrap\">",
"     cells/microL",
"    </span>",
"    has probably also contributed to the decline in R. equi cases, even among those with the most severe immunologic deficits.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19608682\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Rhodococcus equi infection was reported in 1967 and has been described only in scattered case reports, mainly among immunocompromised patients, such as transplant recipients and HIV-infected hosts. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The majority of R. equi infections have occurred in adults. Cases have been identified from virtually every continent. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical features of human disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Rhodococcus pneumonia is typically subacute in onset but results in high fever, cough, chest pain and weight loss. Hemoptysis occurs in approximately one-third of patients with cavitary lesions on imaging. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pulmonary infections'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most common extrapulmonary sites of infection are the central nervous system and skin. Brain abscesses may result in a variety of neurologic symptoms such as confusion, agitation, obtundation, coma, seizures, and motor weakness. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Extrapulmonary infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Blood cultures are positive in more than one-half of immunocompromised patients with R. equi infection compared with only 10 percent of normal hosts. Thus, isolation of a Gram-positive coccobacillus or acid fast organism from an immunocompromised patient with cavitary lung disease should raise suspicion for R. equi infection. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Selection of antimicrobials must be tailored to the patient and clinical situation, using in vitro data regarding susceptibility, synergy and antagonism. Clinical trial data are not available due to the rarity of this infection. Two drug combination regimens should be used including a macrolide, a fluoroquinolone, or a rifamycin.",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/43/33456?source=see_link\">",
"       Azithromycin",
"      </a>",
"      (250 mg) and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"       levofloxacin",
"      </a>",
"      (500 mg) and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"       rifampin",
"      </a>",
"      (600 mg) offer the advantage of once daily dosing. However,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/63/32760?source=see_link\">",
"       rifabutin",
"      </a>",
"      must be substituted for rifampin in HIV-infected patients taking HIV protease inhibitors because of untoward drug-drug interactions. &nbsp;(See",
"      <a class=\"local\" href=\"#H6\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Beta-lactams should be avoided since drug resistance can develop during therapy. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chronic maintenance therapy with a macrolide plus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/31/10746?source=see_link\">",
"       rifampin",
"      </a>",
"      or a quinolone is effective for secondary prevention in HIV-infected patients. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Prevention'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/1\">",
"      Golub B, Falk G, Spink WW. Lung abscess due to Corynebacterium equi. Report of first human infection. Ann Intern Med 1967; 66:1174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/2\">",
"      Van Etta LL, Filice GA, Ferguson RM, Gerding DN. Corynebacterium equi: a review of 12 cases of human infection. Rev Infect Dis 1983; 5:1012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/3\">",
"      Harvey RL, Sunstrum JC. Rhodococcus equi infection in patients with and without human immunodeficiency virus infection. Rev Infect Dis 1991; 13:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/4\">",
"      Emmons W, Reichwein B, Winslow DL. Rhodococcus equi infection in the patient with AIDS: literature review and report of an unusual case. Rev Infect Dis 1991; 13:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/5\">",
"      Lasky JA, Pulkingham N, Powers MA, Durack DT. Rhodococcus equi causing human pulmonary infection: review of 29 cases. South Med J 1991; 84:1217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/6\">",
"      Drancourt M, Bonnet E, Gallais H, et al. Rhodococcus equi infection in patients with AIDS. J Infect 1992; 24:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/7\">",
"      Verville TD, Huycke MM, Greenfield RA, et al. Rhodococcus equi infections of humans. 12 cases and a review of the literature. Medicine (Baltimore) 1994; 73:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/8\">",
"      Scott MA, Graham BS, Verrall R, et al. Rhodococcus equi--an increasingly recognized opportunistic pathogen. Report of 12 cases and review of 65 cases in the literature. Am J Clin Pathol 1995; 103:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/9\">",
"      Donisi A, Suardi MG, Casari S, et al. Rhodococcus equi infection in HIV-infected patients. AIDS 1996; 10:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/10\">",
"      Arlotti M, Zoboli G, Moscatelli GL, et al. Rhodococcus equi infection in HIV-positive subjects: a retrospective analysis of 24 cases. Scand J Infect Dis 1996; 28:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/11\">",
"      Hsueh PR, Hung CC, Teng LJ, et al. Report of invasive Rhodococcus equi infections in Taiwan, with an emphasis on the emergence of multidrug-resistant strains. Clin Infect Dis 1998; 27:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/12\">",
"      Torres-Tortosa M, Arrizabalaga J, Villanueva JL, et al. Prognosis and clinical evaluation of infection caused by Rhodococcus equi in HIV-infected patients: a multicenter study of 67 cases. Chest 2003; 123:1970.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/13\">",
"      Cronin SM, Abidi MH, Shearer CJ, et al. Rhodococcus equi lung infection in an allogeneic hematopoietic stem cell transplant recipient. Transpl Infect Dis 2008; 10:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/14\">",
"      Arya B, Hussian S, Hariharan S. Rhodococcus equi pneumonia in a renal transplant patient: a case report and review of literature. Clin Transplant 2004; 18:748.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/15\">",
"      Koya S, Patel U, Pinkston GR, Rodr&iacute;guez M. A 40-year-old man with cough and fever. Clin Infect Dis 2007; 44:1460.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/16\">",
"      Egawa T, Hara H, Kawase I, et al. Human pulmonary infection with Corynebacterium equi. Eur Respir J 1990; 3:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/17\">",
"      Linares MJ, L&oacute;pez-Encuentra A, Perea S. Chronic pneumonia caused by Rhodococcus equi in a patient without impaired immunity. Eur Respir J 1997; 10:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/18\">",
"      Brown E, Hendler E. Rhodococcus peritonitis in a patient treated with peritoneal dialysis. Am J Kidney Dis 1989; 14:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/19\">",
"      Tang S, Lo CY, Lo WK, et al. Rhodococcus peritonitis in continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1996; 11:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/20\">",
"      Hoque S, Weir A, Fluck R, Cunningham J. Rhodococcus equi in CAPD-associated peritonitis treated with azithromycin. Nephrol Dial Transplant 1996; 11:2340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/21\">",
"      Hansen W, Graz G, Ploton C, et al. A propos d'un cas chez un immunod&eacute;prim&eacute;. M&eacute;d Mal Infect 1990; 20:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/22\">",
"      McGowan KL, Mangano MF. Infections with Rhodococcus equi in children. Diagn Microbiol Infect Dis 1991; 14:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/23\">",
"      Thomsen F, Henriques R, Magnusson M. Corynebacterium equi Magnusson isolated from a tuberculoid lesion in a child with adenitis colli. Dan Med Bull 1968; 15:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/24\">",
"      Fierer J, Wolf P, Seed L, et al. Non-pulmonary Rhodococcus equi infections in patients with acquired immune deficiency syndrome (AIDS). J Clin Pathol 1987; 40:556.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/25\">",
"      Franklin DB Jr, Yium JJ, Hawkins SS. Corynebacterium equi peritonitis in a patient receiving peritoneal dialysis. South Med J 1989; 82:1046.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/26\">",
"      Peloux Y, Durand JM, Fosse T. P&eacute;ritonite &agrave; Corynebacterium (Rhodococcus) equi chez un cirrhotique. Sem H&ocirc;p Paris 1985; 61:2441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/27\">",
"      Gainsford SA, Frater E. Two cases of infection involving Rhodococcus equi. NZ J Med Lab Technol 1986; 40:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/28\">",
"      Colby TV. Malakoplakia. Two unusual cases which presented diagnostic problems. Am J Surg Pathol 1978; 2:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/29\">",
"      Germain P, Deville J, Remy G, Dropsy G. A propos d'une observation d'infection humaine &agrave; Corynebacterium equi. Med Mal Infect 1975; 5:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/30\">",
"      Takasugi JE, Godwin JD. Lung abscess caused by Rhodococcus equi. J Thorac Imaging 1991; 6:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/31\">",
"      Pitchenik AE, Rubinson HA. The radiographic appearance of tuberculosis in patients with the acquired immune deficiency syndrome (AIDS) and pre-AIDS. Am Rev Respir Dis 1985; 131:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/32\">",
"      McNeil MM, Brown JM. Distribution and antimicrobial susceptibility of Rhodococcus equi from clinical specimens. Eur J Epidemiol 1992; 8:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/33\">",
"      Weingarten JS, Huang DY, Jackman JD Jr. Rhodococcus equi pneumonia. An unusual early manifestation of the acquired immunodeficiency syndrome (AIDS). Chest 1988; 94:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/34\">",
"      Samies JH, Hathaway BN, Echols RM, et al. Lung abscess due to Corynebacterium equi. Report of the first case in a patient with acquired immune deficiency syndrome. Am J Med 1986; 80:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/35\">",
"      Nordmann P, Chavanet P, Caillon J, et al. Recurrent pneumonia due to rifampicin-resistant Rhodococcus equi in a patient infected with HIV. J Infect 1992; 24:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18791/abstract/36\">",
"      Takai S, Michizoe T, Matsumura K, et al. Correlation of in vitro properties of Rhodococcus (Corynebacterium) equi with virulence for mice. Microbiol Immunol 1985; 29:1175.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5510 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-61.234.146.186-E8E148C781-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_22_18791=[""].join("\n");
var outline_f18_22_18791=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19608682\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL FEATURES OF HUMAN DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Pulmonary infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Extrapulmonary infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      OUTCOME OF TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19608682\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/5/15449?source=related_link\">",
"      Bacterial pulmonary infections in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/59/37814?source=related_link\">",
"      Microbiology; pathogenesis; and epidemiology of Rhodococcus equi infections",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_22_18792="Complications of laparoscopic cholecystectomy";
var content_f18_22_18792=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Complications of laparoscopic cholecystectomy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/22/18792/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/22/18792/contributors\">",
"     Nezam H Afdhal, MD, FRCPI",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/22/18792/contributors\">",
"     Charles M Vollmer, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/22/18792/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/22/18792/contributors\">",
"     Stanley W Ashley, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/22/18792/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/22/18792/contributors\">",
"     Kathryn A Collins, MD, PhD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/22/18792/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 8, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the late 1980s after the first successful laparoscopic cholecystectomy in Europe, this revolutionary minimally invasive surgery rapidly became the accepted technique for the treatment of gallbladder disease in the United States. The rapid acceptance of this new technique by the medical profession and the public was related to the obvious advantages of reduced cost, decreased hospital length of stay, and increased patient satisfaction.",
"   </p>",
"   <p>",
"    Few clinical studies were performed to compare this new procedure to standard open cholecystectomy. As laparoscopic cholecystectomy gained wider acceptance, complications which were rarely seen with open cholecystectomy, such as bile duct injury, were reported in as many as 5 percent of patients. At present, approximately 750,000 laparoscopic cholecystectomies are performed annually in the United States (accounting for roughly 90 percent of all cholecystectomies) with an overall serious complication rate that remains higher than that seen in open cholecystectomy, despite increasing experience with the procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The complication rate of open cholecystectomy has increased as well, due to overall declining experience in open surgery as this approach is now reserved for the most complicated and challenging cases (",
"    <a class=\"graphic graphic_figure graphicRef73464 \" href=\"UTD.htm?12/54/13160\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic review will discuss complications that are specifically related to or more commonly encountered with the laparoscopic procedure. The management of acute cholecystitis, indications and surgical techniques for laparoscopic cholecystectomy, common bile duct exploration, and repair of common bile duct injuries are discussed elsewhere in detail. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/9/15511?source=see_link\">",
"     \"Treatment of acute cholecystitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/4/11338?source=see_link\">",
"     \"Laparoscopic cholecystectomy: Techniques\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/55/12152?source=see_link\">",
"     \"Endoscopic management of complications from laparoscopic cholecystectomy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/18/6440?source=see_link\">",
"     \"Common bile duct exploration\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/5/6232?source=see_link\">",
"     \"Repair of common bile duct injuries\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other adverse outcomes, such as retained common bile duct stones (incidence of around 10 percent), postcholecystectomy syndromes, and misdiagnoses (sphincter of Oddi dysfunction) occur with the same frequency with both laparoscopic and open cholecystectomy and will not be discussed here. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40936?source=see_link\">",
"     \"Approach to the patient with suspected choledocholithiasis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/36/12874?source=see_link\">",
"     \"Clinical manifestations and diagnosis of sphincter of Oddi dysfunction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/4/11338?source=see_link&amp;anchor=H689178094#H689178094\">",
"     \"Laparoscopic cholecystectomy: Techniques\", section on 'Postcholecystectomy syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     COMPLICATIONS OF LAPAROSCOPIC APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serious complications that occur with laparoscopic cholecystectomy, including bile duct injury, bile leaks, bleeding and bowel injury result in part from patient selection, surgical inexperience, and the technical constraints that are inherent to the minimally invasive approach [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/2,4-9\">",
"     2,4-9",
"    </a>",
"    ]. A major mode of ductal injury is diathermy burns, which may initially go unnoticed and usually involve the right or common hepatic ducts. These factors, as well as intrinsic sequelae of biliary tract diseases, such as inflammation and scarring, have led to the concept of \"Stop Rules\" for surgeons performing this operation. In essence, if a safe dissection cannot be ensured laparoscopically, early conversion to an open approach should be readily accepted as the proper course [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a study that combined the data from seven large studies with a total of 8856 laparoscopic cholecystectomies, serious complications occurred in 2.6 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/12\">",
"     12",
"    </a>",
"    ]. A combined review of eight large studies of laparoscopic cholecystectomies reported the following types and frequencies of major complications: bleeding (0.11 to 1.97 percent), abscess (0.14 to 0.3 percent), bile leak (0.3 to 0.9 percent), biliary injury (0.26 to 0.6 percent), and bowel injury (0.14 to 0.35 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/13\">",
"     13",
"    </a>",
"    ]. The rate of wound infections and surgical site infections is lower with the laparoscopic approach than with the open approach, but there is no advantage in terms of intra-abdominal abscess formation [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Surgeon experience",
"    </span>",
"    &nbsp;&mdash;&nbsp;The overall incidence of laparoscopic complications is also related to the experience of the surgeon. A report of over 8800 procedures performed by 55 surgeons estimated that 90 percent of bile duct injuries occurred in the first 30 cases for each surgeon, with the incidence falling from 1.7 percent in the first case to 0.17 percent at the 50th case [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/15\">",
"     15",
"    </a>",
"    ]. The incidence of bile duct injury appears to have stabilized at 0.4 to 0.6 percent in other series, which is four times higher than that of open cholecystectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/16-21\">",
"     16-21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Surgeons with more experience have the lowest complication rates [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/19\">",
"     19",
"    </a>",
"    ]. Furthermore, credentialing for laparoscopic surgery is now becoming a reality. Many institutions currently, or soon, will require proof of a fundamental skill-set in basic laparoscopy for credentialing purposes. To this end, the American College of Surgeons and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) have developed a validated assessment tool named Fundamentals in Laparoscopic Surgery (FLS) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. FLS is now required by the American Board of Surgery to qualify for the surgical certification examination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Patient selection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patient selection is also an important determinant of risk. Serious complications are more likely in patients who have acute cholecystitis with active inflammation or chronic cholecystitis with fibrosis of the gallbladder fossa or porta hepatis. We do",
"    <strong>",
"     not",
"    </strong>",
"    currently recommend routine preoperative ERCP or perioperative cholangiography unless there is a high suspicion of common duct stones although the necessity of intraoperative cholangiography continues to be the subject of some controversy. Clinical indicators of risk for choledocholithiasis include initial liver function tests that are elevated, evidence of bile duct dilatation, persistent jaundice, evidence of pancreatitis, or active features of cholangitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/13/24790?source=see_link\">",
"     \"Acute cholangitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     BILIARY INJURY CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A classification of biliary injuries is outlined in the figure (",
"    <a class=\"graphic graphic_figure graphicRef66356 \" href=\"UTD.htm?26/2/26662\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/12\">",
"     12",
"    </a>",
"    ]. The clinical presentation of the various injuries varies from asymptomatic bile leak that resolves spontaneously to complete obstruction of the extrahepatic biliary tree, which will present acutely within days. On the other hand, segmental biliary tree obstruction may not present for several years after the procedure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Type A",
"    </span>",
"    &nbsp;&mdash;&nbsp;These are injuries that involve leakage into the gallbladder bed from either the minor hepatic ducts or the cystic duct, with no loss in continuity of the biliary tree.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Type B and C",
"    </span>",
"    &nbsp;&mdash;&nbsp;These are occlusion (Type B) and transection (Type C) injuries of aberrant right hepatic ducts. &nbsp;These are associated with cystic duct drainage into an aberrant right hepatic duct, an abnormality seen in as many as 2 percent of patients. In this setting, the right hepatic duct can be mistaken for the cystic duct at the point of insertion into either the main hepatic duct or common bile duct.",
"   </p>",
"   <p>",
"    When the injury to the duct is an occlusion (Type B), the patient may remain asymptomatic for years and then present with right upper quadrant pain and fever due to recurrent cholangitis and segmental fibrosis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    atrophy may result. In comparison, a biliary leak occurs when the duct is transected but not occluded (Type C). Concomitant injuries to the right hepatic artery are frequently associated with this particular problem.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Type D",
"    </span>",
"    &nbsp;&mdash;&nbsp;These are injuries with lateral damage to the common bile duct resulting in a biliary leak; they can usually be managed endoscopically but may progress to the more serious Type E injury. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/55/12152?source=see_link\">",
"     \"Endoscopic management of complications from laparoscopic cholecystectomy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Type E",
"    </span>",
"    &nbsp;&mdash;&nbsp;Type E injuries involve the main ducts and are classified according to the level of injury in the biliary tree (Bismuth classification) (",
"    <a class=\"graphic graphic_figure graphicRef66356 \" href=\"UTD.htm?26/2/26662\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      E1 (Bismuth Type I) - Transection &gt;2 cm from the confluence",
"     </li>",
"     <li>",
"      E2 (Bismuth Type II) - Transection &lt;2 cm from the confluence",
"     </li>",
"     <li>",
"      E3 (Bismuth Type III) - Transection in the hilum",
"     </li>",
"     <li>",
"      E4 (Bismuth Type IV) - Separation of major ducts in the hilum",
"     </li>",
"     <li>",
"      E5 (Bismuth Type V) - Type C injury plus injury in the hilum",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Affected patients typically present with jaundice weeks to years after cholecystectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/24\">",
"     24",
"    </a>",
"    ]. Surgical repair via a hepaticojejunostomy is almost always required.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DIAGNOSIS AND MANAGEMENT OF BILIARY INJURIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Biliary injury may be recognized at the time of laparoscopic surgery; if so, conversion to an open procedure and repair of the injury should be attempted only if the surgeon is comfortable with advanced biliary surgery. If not, the surgeon should obtain intraoperative or telephonic consultation with a specialist who is skilled in this problem [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/25,26\">",
"     25,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    External drainage of the gallbladder fossa should be achieved prior to referral to a specialist. Repair of biliary duct injuries should always be approached by an experienced multidisciplinary team consisting of a surgeon, diagnostic radiologist, interventional gastroenterologist, and an interventional radiologist.",
"   </p>",
"   <p>",
"    Recognition of biliary injury may be more likely if routine intraoperative cholangiography is performed [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. However, the value of this approach is controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/27\">",
"     27",
"    </a>",
"    ]. Some studies found no overall benefit of routine intraoperative cholangiography which, it was suggested, should be limited to patients suspected of having a common bile duct stone (which is managed by endoscopic retrograde cholangiopancreatography) or if biliary anatomy is unclear [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/27\">",
"     27",
"    </a>",
"    ]. This is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/18/6440?source=see_link&amp;anchor=H813094#H813094\">",
"     \"Common bile duct exploration\", section on 'Intraoperative cholangiography'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/5/6232?source=see_link\">",
"     \"Repair of common bile duct injuries\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most injuries are not recognized at the time of initial surgery. Early presentation of bile duct injury after laparoscopic cholecystectomy is generally nonspecific with patient complaints of vague abdominal pain, persistent nausea and vomiting, and low grade fever [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Biliary and cystic duct leaks",
"    </span>",
"    &nbsp;&mdash;&nbsp;Biliary and cystic duct leaks represent Type A, C, and D injuries. Small perihepatic fluid collections are seen in approximately one-half of patients who have ultrasound (US) examination within 24 hours of laparoscopic surgery. These are asymptomatic, of no clinical significance, resolve spontaneously, and are due to the normal process of the operation. The number of these fluid collections that actually contain bile is not known.",
"   </p>",
"   <p>",
"    Major biliary leakage is usually seen 2 to 10 days postcholecystectomy. Affected patients typically present with fever, abdominal pain,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bilious ascites. Jaundice is usually mild. Leukocytosis and abnormal liver function tests, particularly elevations in serum alkaline phosphatase and gamma-glutamyl transferase, are common. Bilirubin will be mildly elevated as the body reabsorbs third-spaced bile.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Type A",
"    </span>",
"    &nbsp;&mdash;&nbsp;Injury or leakage of bile without injury to the major common bile or hepatic ducts arises from the cystic duct remnant, or the bile ducts of Luschka [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/29\">",
"     29",
"    </a>",
"    ]. Leakage from the cystic duct remnant can result from laceration of a small cystic duct, dislodgement of one of the clips or ligatures on the cystic duct, ductal necrosis as a result of cholecystitis, or a distal obstruction in the common duct by a stone with resultant blow-out of the cystic duct remnant.",
"   </p>",
"   <p>",
"    The bile ducts of Luschka conceptually include both small ducts that distinctly enter the gallbladder bed, or small tributaries of minor intrahepatic radicals of the right hepatic ductal system. Although true ducts of Luschka cannot be avoided, injury to these tributaries is probably caused by dissection into the liver parenchyma. Regardless of origin, both can continue to leak after removal of the gallbladder. Clinically significant leakage from the ducts is rare.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Types C and D",
"    </span>",
"    &nbsp;&mdash;&nbsp;These injuries involve both a biliary leak and injury to the main or aberrant ducts.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Radiologic workup",
"    </span>",
"    &nbsp;&mdash;&nbsp;Upon presentation, we initially perform transabdominal US to define the extent of the possible bile leak. Bile leaks can present as contained, loculated collections in the gallbladder fossa or around the liver, or as frank, diffuse biliary peritonitis. Ultrasonography can also determine if the intrahepatic ducts are dilated (and at what specific level), suggesting common duct obstruction. If necessary, better definition can be obtained by computed tomography (CT) scan, which is very sensitive in detecting intraperitoneal or pelvic free fluid.",
"   </p>",
"   <p>",
"    Large loculated collections may need to be percutaneously drained by the radiologist under CT or US guidance with a catheter left in place for continuing drainage [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. Bilious fluid is highly suggestive of a bile leak.",
"   </p>",
"   <p>",
"    After the demonstration of fluid in the peritoneum, we obtain a hepatobiliary imino-diacetic acid scan (HIDA) scan to delineate leakage of radiotracer into the peritoneal cavity and confirm that the fluid is bile. Biliary scintigraphy cannot anatomically localize the site of injury but is diagnostic of an ongoing bile leak in virtually all patients [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/32\">",
"     32",
"    </a>",
"    ]. Early films are useful for major leaks but delayed films about three hours after injection of tracer should be obtained if the early scans are negative. If the HIDA scan confirms an active bile leak, determination of the site of the leak is usually made by endoscopic retrograde cholangiopancreatography (ERCP).",
"   </p>",
"   <p>",
"    Magnetic resonance cholangiopancreatography (MRCP) is an alternative way of assessing the bile ducts [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/13\">",
"     13",
"    </a>",
"    ]. MRCP offers a non-invasive method of diagnosing a bile leak, identifying the source of the leak, and identifying tiny stones left in the bile duct, although it does not allow direct intervention as is possible with ERCP. MRCP can be particularly useful for complete imaging of the biliary tree [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/33\">",
"     33",
"    </a>",
"    ]. This is especially important in cases of hilar injury such as a right posterior segmental duct transection or obstruction, where identification via ERCP may not be as thorough. MRCP techniques allow for precision in identification of the injury site because the contrast agents are excreted in the bile [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. This can be useful for distinguishing leaks from the gallbladder fossa dissection bed from those of cystic duct origin. The modality (ERCP versus MRCP) chosen for investigation depends on the suspected injury pattern as well as local expertise in or availability of techniques. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/51/23351?source=see_link\">",
"     \"Magnetic resonance cholangiopancreatography\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Almost all Type A and D injuries can be managed by insertion of a 10 French endoprosthesis across the ampulla at the time of the ERCP to decrease pressure in the proximal biliary system [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/36-38\">",
"     36-38",
"    </a>",
"    ]. As an alternative, a sphincterotomy can be performed to promote free flow of bile across the ampulla without stent insertion. We favor the former approach, and perform sphincterotomy only if there is common bile duct obstruction secondary to choledocholithiasis. Stenting results in a rapid decrease in the drainage of bile through the percutaneous drains which can often be removed in three to five days. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/55/12152?source=see_link\">",
"     \"Endoscopic management of complications from laparoscopic cholecystectomy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are certain cases where, despite these minimally invasive therapeutic maneuvers, the patient continues to have severe abdominal pain from bile peritonitis or evidence of progressive intraabdominal sepsis. In such cases, operative exploration and washout (achieved by either open or laparoscopic means) is important and effective.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Management after diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Subsequent management varies with the type of injury:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In Type A injuries, the stent can be removed endoscopically at two weeks if the patient is asymptomatic and the liver function tests are normal and there is no ongoing leak at the follow-up ERCP.",
"     </li>",
"     <li>",
"      In Type C and D injuries, a repeat HIDA scan is performed two to four weeks after stent insertion. If there is no leak, the stent can be removed endoscopically at repeat ERCP. If there is a minor leak at the time of stent removal, we usually either perform a sphincterotomy to facilitate bile flow into the duodenum or replace the stent for a further four weeks. The success of endoscopic treatment of Type D injuries is dependent on the degree of bile duct injury. Many Type D injuries with lesser degrees of damage can be effectively managed in the short-term by stenting. However, close clinical follow-up with repeated diagnostic ERCP or MRCP may be necessary as these patients are at risk for developing late Type E injuries due to stricture development from either the progressive effects of diathermy injury or the natural healing process. Larger circumferential injuries usually cannot be treated successfully by stenting alone and will require operative intervention. Total endoscopic management of Type C injuries is less successful because by definition, a segment of biliary drainage from the liver is \"disconnected\" from its natural flow into the distal biliary tree.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Occlusive injury to the right hepatic duct (Type B injury)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Occlusive injury to the right hepatic duct is usually an occult injury which results in a segmental cholestasis in the liver and, after many years, atrophy of the right lobe. Some of these patients develop cholangitis secondary to infection or even intrahepatic stone disease. Symptomatic patients present pain and features of cholangitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/13/24790?source=see_link\">",
"     \"Acute cholangitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The diagnosis is usually made by ERCP, which shows an absent segmental hepatic duct on the right side or by MRCP which shows an obstructed segment lacking continuity with the distal biliary tree. CT scan may show focal atrophy or cystic dilation, and a percutaneous cholangiogram may be necessary to show ductal obstruction and overall biliary anatomy. Treatment is surgical, involving preferably a hepaticojejunostomy; segmental resection of the affected lobes may also be necessary if atrophy is significant.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Injuries to common bile or common hepatic ducts (Type E injury)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Injuries to common bile or common hepatic ducts are the most serious and are similar to the injury most commonly seen with open cholecystectomy. The clinical manifestations of these injuries are highly variable, depending upon whether the main duct is completely transected or clipped with no leakage of bile. If a bile leak occurs, it is often recognized at the time of the laparoscopic cholecystectomy and if limited in scope, a surgical repair can be attempted by T-tube drainage of the common bile duct at the site of the injury. Primary repair of the bile duct should be avoided because of its high propensity for breakdown or stricture formation, in the setting of a normal caliber common bile duct. In cases of more significant damage to the duct, a hepaticojejunostomy is preferable. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/5/6232?source=see_link\">",
"     \"Repair of common bile duct injuries\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most patients present with jaundice weeks to years after surgery and US shows dilated intrahepatic ducts. ERCP is usually performed, revealing complete obstruction in the extrahepatic biliary tree with no filling of intrahepatic ducts.",
"   </p>",
"   <p>",
"    The next procedure should be percutaneous transhepatic cholangiography to delineate the intrahepatic ducts and the length of the stricture. Since the biliary system is completely occluded, a drainage procedure of both hepatic lobes should be performed to decompress the liver and reduce the risk of cholangitis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/38\">",
"     38",
"    </a>",
"    ]. This is usually achieved by insertion of large percutaneous stents into both the left and right hepatic ducts. These stents facilitate identification of the ducts during subsequent operation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/39/37491?source=see_link\">",
"     \"Percutaneous transhepatic cholangiography\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In occasional patients, a stricture or occluding clip is susceptible to dilation and stent insertion. With favorable results in limited series, dilation and stent insertion is being adopted more often as a less invasive, first line approach to this problem. In this setting, a combined percutaneous transhepatic cholangiography and ERCP technique can be used to treat the occlusion with good long-term results. However, most strictures that are of high grade and over 1 cm in length are not good candidates for endoscopic therapy. Thus, once the liver has decompressed, a hepaticojejunostomy is usually the treatment of choice using the indwelling stents as a guide to identification of the ducts [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/39,40\">",
"     39,40",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/55/12152?source=see_link\">",
"     \"Endoscopic management of complications from laparoscopic cholecystectomy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/5/6232?source=see_link\">",
"     \"Repair of common bile duct injuries\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is a significant surgical mortality (5 percent) and restenosis rates vary from 5 to 28 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. Factors such as advanced age and comorbid illness are important, but the most important prognostic factor is whether secondary biliary cirrhosis has developed. Patients with this complication may be best treated by hepatic transplantation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/61/25559?source=see_link\">",
"     \"Patient selection for liver transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     BLEEDING COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of uncontrollable bleeding from laparoscopic cholecystectomy is 0.1 to 1.9 percent and can occur from three distinct sites - the liver, arterial sources, or port insertion sites.",
"   </p>",
"   <p>",
"    Significant bleeding from the liver bed is fairly common and is now appreciated to be from the often close proximity of the middle hepatic vein and its radicals to the gallbladder fossa in up to 10 to 15 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/43\">",
"     43",
"    </a>",
"    ]. Bleeding usually occurs during the final aspects of the removal of the gallbladder from the hepatic fossa, and generally requires immediate conversion to open to control profuse hemorrhage through stitch ligation, if initial attempts at laparoscopic hemostatic control fail.",
"   </p>",
"   <p>",
"    Arterial control issues involving the cystic artery can be identified immediately and controlled with clips (only if anatomical landmarks can be safely ensured - or else there is a high association with right hepatic arterial injury). They may also first be evident postoperatively as an acute hemodynamic decline requiring resuscitation, transfusions, and often reoperation. The culprit is usually a dislodged clip in this scenario.",
"   </p>",
"   <p>",
"    Finally, incision or trocar sites can bleed. Patients usually present subacutely during the first postoperative days. We advocate direct visualization of trocar removal at the end of the laparoscopy so that such a problem can be addressed with laparoscopically placed sutures if necessary. When patients present with delayed bleeding, the diagnosis of hematoma can be made with visualization of a heterogeneous fluid collection on US examination. If US examination is not diagnostic, abdominal wall and intraperitoneal hematomas can be visualized on computed tomography as areas of higher attenuation [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/13\">",
"     13",
"    </a>",
"    ]. If the patient is hemodynamically unstable, direct evaluation by re-laparoscopy is advocated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     BOWEL INJURY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inadvertent bowel injury has been described in about one to four cases in 1000 laparoscopic procedures in various reports [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/9,41,44\">",
"     9,41,44",
"    </a>",
"    ]. Management of this complication is dictated by the clinical scenario.",
"   </p>",
"   <p>",
"    If the injury is noted at the time of surgery then conversion to an open procedure for repair is indicated if it cannot be repaired through the laparoscope.",
"   </p>",
"   <p>",
"    Patients may present with trocar site pain, abdominal distention, diarrhea, leukopenia, and cardiovascular collapse from sepsis, typically within 96 hours of the procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/44\">",
"     44",
"    </a>",
"    ]. If the patient is septic or has free air, then an emergent laparotomy is indicated.",
"   </p>",
"   <p>",
"    In cases where the presentation is more indolent and controlled, standard enterocutaneous fistula management with nutritional support and adequate drainage and wound care is appropriate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H945770426\">",
"    <span class=\"h1\">",
"     POSTCHOLECYSTECTOMY SYNDROME",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postcholecystectomy syndrome (PCS) is a complex of heterogeneous symptoms including persistent abdominal pain and dyspepsia that recur and persist after cholecystectomy. This is presented in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/4/11338?source=see_link&amp;anchor=H689178094#H689178094\">",
"     \"Laparoscopic cholecystectomy: Techniques\", section on 'Postcholecystectomy syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     INJURY PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The \"critical view of safety\" is a surgical technique designed to help the surgeon avoid bile duct injury. Using this approach, Calot's triangle is dissected free of all tissue except for the cystic duct and artery, and the base of the liver bed is exposed (",
"    <a class=\"graphic graphic_figure graphicRef66207 \" href=\"UTD.htm?25/3/25649\">",
"     figure 3",
"    </a>",
"    ). When this view is achieved, the two structures emanating from the gallbladder (cystic duct and cystic artery) and the interface with the liver at the base of the gallbladder fossa should be definitively identified [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Difficulty with identification of the critical view should lead the surgeon to consider performing cholangiography or converting the laparoscopic cholecystectomy into an open procedure. This technique was employed in a study of 1046 consecutive patients who underwent laparoscopic cholecystectomy from 2002 to 2007, with no bile duct injury [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18792/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Serious complications of laparoscopic cholecystectomy, including bile duct injury, bile leaks, bleeding and bowel injury result in part from patient selection, surgical inexperience, and the technical constraints of the minimally invasive approach. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Complications of laparoscopic approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Early conversion to an open cholecystectomy should be readily accepted as the proper course if a safe dissection cannot be ensured laparoscopically. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Complications of laparoscopic approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Repair of biliary duct injuries should always be approached by an experienced multidisciplinary team consisting of a surgeon skilled in advanced biliary surgery, diagnostic radiologist, interventional gastroenterologist, and an interventional radiologist. External drainage of the gallbladder fossa should be achieved prior to referral to a specialist. &nbsp;(See",
"      <a class=\"local\" href=\"#H10\">",
"       'Diagnosis and management of biliary injuries'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Biliary leakage should be suspected when patients present after cholecystectomy with fever, abdominal pain,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      bilious ascites. Large loculated collections should be percutaneously drained with radiologic guidance and a catheter left in place for continuing drainage. ERCP may define the leak and allow stent placement. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Diagnosis and management of biliary injuries'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If a patient with a bile leak continues to have severe abdominal pain from bile peritonitis or evidence of progressive intraabdominal sepsis, operative exploration and washout is indicated. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Diagnosis and management of biliary injuries'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Occlusive injury to the right hepatic duct results in a segmental cholestasis and ultimately atrophy of the right lobe. The occlusion is corrected with a hepaticojejunostomy; segmental resection of the affected lobes may also be necessary if atrophy is significant. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Diagnosis and management of biliary injuries'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Limited injuries to common bile or common hepatic ducts that are recognized at the time of surgery can be repaired by T-tube drainage of the common bile duct. Primary repair of the bile duct should be avoided because the high rates of breakdown or stricture formation. In cases of more significant damage to the duct, a hepaticojejunostomy will be required. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Diagnosis and management of biliary injuries'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Delayed presentation of common bile or common hepatic duct injuries requires decompression of the liver with percutaneous stents to reduce the risk of cholangitis and to define the injury. Although some patients can be treated with dilation and stent insertion, most will require a hepaticojejunostomy. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Diagnosis and management of biliary injuries'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bleeding can occur from the liver, arterial sources, or port insertion sites. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Bleeding complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Surgical technique that emphasizes the \"critical view of safety\" will help avoid bile duct injury. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Injury prevention'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/1\">",
"      Vollmer CM Jr, Callery MP. Biliary injury following laparoscopic cholecystectomy: why still a problem? Gastroenterology 2007; 133:1039.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/2\">",
"      Khan MH, Howard TJ, Fogel EL, et al. Frequency of biliary complications after laparoscopic cholecystectomy detected by ERCP: experience at a large tertiary referral center. Gastrointest Endosc 2007; 65:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/3\">",
"      Visser BC, Parks RW, Garden OJ. Open cholecystectomy in the laparoendoscopic era. Am J Surg 2008; 195:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/4\">",
"      Alexander HC. Two unusual hemorrhagic complications during laparoscopic cholecystectomy. Surg Laparosc Endosc 1993; 3:346.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/5\">",
"      Catarci M, Zaraca F, Scaccia M, Carboni M. Lost intraperitoneal stones after laparoscopic cholecystectomy: harmless sequela or reason for reoperation? Surg Laparosc Endosc 1993; 3:318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/6\">",
"      Cervantes J, Rojas GA, Ponte R. Intrahepatic subcapsular biloma. A rare complication of laparoscopic cholecystectomy. Surg Endosc 1994; 8:208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/7\">",
"      Stupak D, Cohen S, Kasmin F, et al. Intra-abdominal actinomycosis 11 years after spilled gallstones at the time of laparoscopic cholecystectomy. Surg Laparosc Endosc Percutan Tech 2007; 17:542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/8\">",
"      Roberts DJ, Chun HM. Dropped gallstone as a nidus of intra-abdominal abscess complicated by empyema. Clin Infect Dis 2005; 41:e64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/9\">",
"      Binenbaum SJ, Goldfarb MA. Inadvertent enterotomy in minimally invasive abdominal surgery. JSLS 2006; 10:336.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/10\">",
"      Strasberg SM. Biliary injury in laparoscopic surgery: part 1. Processes used in determination of standard of care in misidentification injuries. J Am Coll Surg 2005; 201:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/11\">",
"      Strasberg SM. Biliary injury in laparoscopic surgery: part 2. Changing the culture of cholecystectomy. J Am Coll Surg 2005; 201:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/12\">",
"      Strasberg SM, Hertl M, Soper NJ. An analysis of the problem of biliary injury during laparoscopic cholecystectomy. J Am Coll Surg 1995; 180:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/13\">",
"      Thurley PD, Dhingsa R. Laparoscopic cholecystectomy: postoperative imaging. AJR Am J Roentgenol 2008; 191:794.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/14\">",
"      Biscione FM, Couto RC, Pedrosa TM, Neto MC. Comparison of the risk of surgical site infection after laparoscopic cholecystectomy and open cholecystectomy. Infect Control Hosp Epidemiol 2007; 28:1103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/15\">",
"      Moore MJ, Bennett CL. The learning curve for laparoscopic cholecystectomy. The Southern Surgeons Club. Am J Surg 1995; 170:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/16\">",
"      Morgenstern L, McGrath MF, Carroll BJ, et al. Continuing hazards of the learning curve in laparoscopic cholecystectomy. Am Surg 1995; 61:914.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/17\">",
"      Richardson MC, Bell G, Fullarton GM. Incidence and nature of bile duct injuries following laparoscopic cholecystectomy: an audit of 5913 cases. West of Scotland Laparoscopic Cholecystectomy Audit Group. Br J Surg 1996; 83:1356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/18\">",
"      Z'graggen K, Wehrli H, Metzger A, et al. Complications of laparoscopic cholecystectomy in Switzerland. A prospective 3-year study of 10,174 patients. Swiss Association of Laparoscopic and Thoracoscopic Surgery. Surg Endosc 1998; 12:1303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/19\">",
"      Hobbs MS, Mai Q, Knuiman MW, et al. Surgeon experience and trends in intraoperative complications in laparoscopic cholecystectomy. Br J Surg 2006; 93:844.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/20\">",
"      Deziel DJ, Millikan KW, Economou SG, et al. Complications of laparoscopic cholecystectomy: a national survey of 4,292 hospitals and an analysis of 77,604 cases. Am J Surg 1993; 165:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/21\">",
"      Nuzzo G, Giuliante F, Giovannini I, et al. Bile duct injury during laparoscopic cholecystectomy: results of an Italian national survey on 56 591 cholecystectomies. Arch Surg 2005; 140:986.",
"     </a>",
"    </li>",
"    <li>",
"     Fundamentals of laparoscopic surgery. www.flsprogram.org (Accessed on December 08, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/23\">",
"      Swanstrom LL, Fried GM, Hoffman KI, Soper NJ. Beta test results of a new system assessing competence in laparoscopic surgery. J Am Coll Surg 2006; 202:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/24\">",
"      Davidoff AM, Branum GD, Meyers WC. Clinical features and mechanisms of major laparoscopic biliary injury. Semin Ultrasound CT MR 1993; 14:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/25\">",
"      Woods MS, Traverso LW, Kozarek RA, et al. Characteristics of biliary tract complications during laparoscopic cholecystectomy: a multi-institutional study. Am J Surg 1994; 167:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/26\">",
"      Woods MS, Traverso LW, Kozarek RA, et al. Biliary tract complications of laparoscopic cholecystectomy are detected more frequently with routine intraoperative cholangiography. Surg Endosc 1995; 9:1076.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/27\">",
"      Ladocsi LT, Benitez LD, Filippone DR, Nance FC. Intraoperative cholangiography in laparoscopic cholecystectomy: a review of 734 consecutive cases. Am Surg 1997; 63:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/28\">",
"      Lillemoe KD. Current management of bile duct injury. Br J Surg 2008; 95:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/29\">",
"      Woods MS, Shellito JL, Santoscoy GS, et al. Cystic duct leaks in laparoscopic cholecystectomy. Am J Surg 1994; 168:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/30\">",
"      Nu&ntilde;ez D Jr, Becerra JL, Martin LC. Subhepatic collections complicating laparoscopic cholecystectomy: percutaneous management. Abdom Imaging 1994; 19:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/31\">",
"      Boland GW, Mueller PR, Lee MJ. Laparoscopic cholecystectomy with bile duct injury: percutaneous management of biliary stricture and associated complications. AJR Am J Roentgenol 1996; 166:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/32\">",
"      Brugge WR, Alavi A. Cholescintigraphy in the diagnosis of the complications of laparoscopic cholecystectomy. Semin Ultrasound CT MR 1993; 14:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/33\">",
"      Dixon E, Sutherland FR, Vollmer CM Jr, Greig PD. Bile duct injury after laparoscopic cholecystectomy: resection of the entire extrahepatic biliary tree. J Am Coll Surg 2003; 197:862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/34\">",
"      Khalid TR, Casillas VJ, Montalvo BM, et al. Using MR cholangiopancreatography to evaluate iatrogenic bile duct injury. AJR Am J Roentgenol 2001; 177:1347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/35\">",
"      Vitellas KM, El-Dieb A, Vaswani K, et al. Detection of bile duct leaks using MR cholangiography with mangfodipir trisodium (Teslascan). J Comput Assist Tomogr 2001; 25:102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/36\">",
"      Pencev D, Brady PG, Pinkas H, Boulay J. The role of ERCP in patients after laparoscopic cholecystectomy. Am J Gastroenterol 1994; 89:1523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/37\">",
"      Schmitt CM, Baillie J, Cotton PB. ERCP following laparoscopic cholecystectomy: a safe and effective way to manage CBD stones and complications. HPB Surg 1995; 8:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/38\">",
"      Vitale GC, Stephens G, Wieman TJ, Larson GM. Use of endoscopic retrograde cholangiopancreatography in the management of biliary complications after laparoscopic cholecystectomy. Surgery 1993; 114:806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/39\">",
"      vanSonnenberg E, D'Agostino HB, Easter DW, et al. Complications of laparoscopic cholecystectomy: coordinated radiologic and surgical management in 21 patients. Radiology 1993; 188:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/40\">",
"      Csendes A, D&iacute;az JC, Burdiles P, et al. Late results of primary repair and follow-up in 53 patients with injuries to the common bile duct occurring during cholecystectomy (distal perforation, tears, ligation or suture). Hepatogastroenterology 1994; 41:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/41\">",
"      Strasberg SM, Callery MP, Soper NJ. Laparoscopic hepatobiliary surgery. Prog Liver Dis 1995; 13:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/42\">",
"      Lillemoe KD, Pitt HA, Cameron JL. Current management of benign bile duct strictures. Adv Surg 1992; 25:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/43\">",
"      Ball CG, MacLean AR, Kirkpatrick AW, et al. Hepatic vein injury during laparoscopic cholecystectomy: the unappreciated proximity of the middle hepatic vein to the gallbladder bed. J Gastrointest Surg 2006; 10:1151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/44\">",
"      Bishoff JT, Allaf ME, Kirkels W, et al. Laparoscopic bowel injury: incidence and clinical presentation. J Urol 1999; 161:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18792/abstract/45\">",
"      Avgerinos C, Kelgiorgi D, Touloumis Z, et al. One thousand laparoscopic cholecystectomies in a single surgical unit using the \"critical view of safety\" technique. J Gastrointest Surg 2009; 13:498.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3681 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-217.117.136.88-C2C11C53A9-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_22_18792=[""].join("\n");
var outline_f18_22_18792=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      COMPLICATIONS OF LAPAROSCOPIC APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Surgeon experience",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Patient selection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      BILIARY INJURY CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Type A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Type B and C",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Type D",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Type E",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DIAGNOSIS AND MANAGEMENT OF BILIARY INJURIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Biliary and cystic duct leaks",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Type A",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Types C and D",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Radiologic workup",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Management after diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Occlusive injury to the right hepatic duct (Type B injury)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Injuries to common bile or common hepatic ducts (Type E injury)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      BLEEDING COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      BOWEL INJURY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H945770426\">",
"      POSTCHOLECYSTECTOMY SYNDROME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      INJURY PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/3681\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/3681|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?12/54/13160\" title=\"figure 1\">",
"      Open cholecystectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/2/26662\" title=\"figure 2\">",
"      Classification of iatrogenic bile duct injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/3/25649\" title=\"figure 3\">",
"      Critical view of safety in laparoscopic cholecystectomy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/13/24790?source=related_link\">",
"      Acute cholangitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40936?source=related_link\">",
"      Approach to the patient with suspected choledocholithiasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/36/12874?source=related_link\">",
"      Clinical manifestations and diagnosis of sphincter of Oddi dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/18/6440?source=related_link\">",
"      Common bile duct exploration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/55/12152?source=related_link\">",
"      Endoscopic management of complications from laparoscopic cholecystectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/4/11338?source=related_link\">",
"      Laparoscopic cholecystectomy: Techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/51/23351?source=related_link\">",
"      Magnetic resonance cholangiopancreatography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/61/25559?source=related_link\">",
"      Patient selection for liver transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/39/37491?source=related_link\">",
"      Percutaneous transhepatic cholangiography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/5/6232?source=related_link\">",
"      Repair of common bile duct injuries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/9/15511?source=related_link\">",
"      Treatment of acute cholecystitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_22_18793="Pathogenesis and clinical features of bronchopulmonary dysplasia";
var content_f18_22_18793=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathogenesis and clinical features of bronchopulmonary dysplasia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/22/18793/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/22/18793/contributors\">",
"     James M Adams, Jr, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/22/18793/contributors\">",
"     Ann R Stark, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/22/18793/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/22/18793/contributors\">",
"     Gregory Redding, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/22/18793/contributors\">",
"     Joseph A Garcia-Prats, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/22/18793/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/22/18793/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/22/18793/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bronchopulmonary dysplasia (BPD), also known as neonatal chronic lung disease (CLD), is an important cause of respiratory illness in preterm newborns that results in significant morbidity and mortality.",
"   </p>",
"   <p>",
"    The pathogenesis and clinical features of BPD are reviewed here. Management, prognosis, and potential strategies to prevent BPD are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/24/15753?source=see_link\">",
"     \"Management of bronchopulmonary dysplasia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/51/25398?source=see_link\">",
"     \"Outcome of infants with bronchopulmonary dysplasia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/14/27880?source=see_link\">",
"     \"Prevention of bronchopulmonary dysplasia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TERMINOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Different degrees of prematurity are defined by gestational age (GA), which is calculated from the first day of the mother's last period, or birth weight (BW). Data on bronchopulmonary dysplasia (BPD) is often based upon the following classification of preterm infants who are categorized by their birth weight as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Low birth weight (LBW) &ndash; BW less than 2500 g",
"     </li>",
"     <li>",
"      Very low birth weight (VLBW) &ndash; BW less than 1500 g",
"     </li>",
"     <li>",
"      Extremely low birth weight (ELBW) &ndash; BW less than 1000 g",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These terms are used throughout this discussion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The definition of bronchopulmonary dysplasia (BPD) has continued to evolve since 1967 when Northway first described the disorder, which resulted from prolonged mechanical ventilation in premature infants with severe respiratory distress syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/1\">",
"     1",
"    </a>",
"    ]. This is due to changes in neonatal management (ie, surfactant, antenatal glucocorticoid therapy, and less aggressive mechanical ventilation) that have altered the pathology and clinical course of BPD. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Pathology'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Earlier definitions based upon oxygen requirement either at 28 postnatal days [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/2,3\">",
"     2,3",
"    </a>",
"    ] or 36 weeks postmenstrual age (PMA) do not account for extreme prematurity (ie, birth weight &lt;1000 g or gestational age &lt;30 weeks) and the severity of respiratory disease [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. These definitions became less accurate in predicting outcome because of the increasing survival rate of ELBW infants, and the increased prevalence of milder forms of BPD due to improved treatment of RDS. As an example, oxygen supplementation at 28 days of life in ELBW infants may be due to lung immaturity and not BPD. Whereas, an ELBW infant with mild BPD disease who required oxygen within the first 28 days of life, but not at 36 weeks PMA, would not be diagnosed as having BPD using the latter definition. The failure to include gestational age at birth or disease severity led to concerns that these definitions are inadequate, especially when comparing the efficacy of different therapeutic interventions",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    long-term outcome of ELBW infants with BPD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     NICHD criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 2001, a consensus conference of the United States National Institute of Child Health and Human Development (NICHD) modified the pre-existing definitions of oxygen requirement by adding criteria that included gestational age (GA) and severity of disease (",
"    <a class=\"graphic graphic_table graphicRef64789 \" href=\"UTD.htm?31/10/31916\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/6\">",
"     6",
"    </a>",
"    ]. The timing of assessment is based upon GA:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients who are &lt;32 weeks GA are assessed at 36 weeks PMA or when discharged home, whichever comes first.",
"     </li>",
"     <li>",
"      Patients who are &ge;32 weeks GA are assessed between 29 to 55 days of life or when discharged home, whichever comes first.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Infants who require supplemental oxygen for at least 28 postnatal days are classified as having mild, moderate, or severe BPD, depending upon the extent of oxygen supplementation and other respiratory support. To standardize the use of supplemental oxygen, the NICHD criteria also proposed that the need for oxygen be confirmed by using a physiologic test, although a specific test was not defined.",
"   </p>",
"   <p>",
"    A study from the NICHD Neonatal Research Network reported that the NICHD criteria more accurately predicted pulmonary and neurodevelopmental outcomes at 18 to 22 months corrected age in preterm infants &lt;32 weeks GA with BPD than previous definitions [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/7\">",
"     7",
"    </a>",
"    ]. In particular, the definition of supplemental oxygen at 36 weeks PMA would have missed a substantial number of patients with mild BPD who may be at risk for pulmonary and neurodevelopmental complications. NICHD criteria more accurately predicted which preterm survivors would require pulmonary medication and rehospitalization for pulmonary disease. The incidence of neurodevelopmental impairment (ie, lower mental and psychomotor developmental index scores, cerebral palsy, blindness, hearing impairment) increased with the severity of disease based upon the NICHD criteria.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Physiologic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;As mentioned above, the NICHD criteria also proposed that the requirement of supplemental oxygen be confirmed by using a physiologic test, although a specific test was not defined. Adoption of a BPD definition based upon physiologic testing would reduce the effect of clinical practice differences when comparing outcome among centers caring for these patients.",
"   </p>",
"   <p>",
"    One prospective multicenter study compared a physiologic test based upon oxygen administration and saturation to the standard clinical definition of oxygen supplementation at 36 weeks corrected age [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. The physiologic definition lowered the rate of BPD from 35 percent based upon the clinical definition to 25 percent, and reduced the variation in incidence among centers. These results demonstrated that the use of a standardized physiologic definition of BPD is feasible.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rate of bronchopulmonary dysplasia (BPD) varies among institutions, which may reflect neonatal risk factors, care practices (eg, target levels for acceptable oxygen saturation), and differences in the clinical definitions of BPD [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/10-12\">",
"     10-12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Infants with BW &lt;1250 g account for 97 percent of the cases of BPD [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/13\">",
"     13",
"    </a>",
"    ]. The incidence of BPD increases with decreasing birth weight (BW), as illustrated in a report from the NICHD Neonatal Research Network from 1997 to 2002 [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/11\">",
"     11",
"    </a>",
"    ]. In this study of over 18,000 VLBW infants, the overall incidence of BPD (defined as requiring supplemental oxygen at 36 weeks PMA) was 25 percent.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      BW from 1251 to 1500: 6 percent",
"     </li>",
"     <li>",
"      BW from 1001 to 1240: 14 percent",
"     </li>",
"     <li>",
"      BW from 751 to 1000: 33 percent",
"     </li>",
"     <li>",
"      BW from 501 to 750: 46 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is unclear whether or not the incidence of BPD is changing.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study from the NICHD neonatal network of 9575 infants with gestational age between 22 and 28 weeks born from 2003 to 2007, the incidence of BPD did not change over the five years [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/14\">",
"       14",
"      </a>",
"      ]. However, the number of infants with severe BPD (ie, receiving ventilatory support) decreased.",
"     </li>",
"     <li>",
"      In a retrospective multicenter Canadian study, there was a decrease in mortality between infants born between 1996 to 1997 and 2006 to 2007, but a corresponding increase in the incidence of BPD [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In contrast, a study using a United States national database (Nationwide Inpatient Sample) reported a decrease in the rate of BPD of 4.3 percent per year for the study period between 1993 and 2006 [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/16\">",
"       16",
"      </a>",
"      ]. However, increases in the costs and length of hospitalizations for infants with BPD were also seen.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In surfactant-treated ELBW infants, the characteristic pathologic finding of bronchopulmonary dysplasia (BPD) is disruption of lung development, referred to as the \"new\" BPD [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/6,17,18\">",
"     6,17,18",
"    </a>",
"    ]. In these patients, decreased septation and alveolar hypoplasia lead to fewer and larger alveoli with a reduction in the surface area available for gas exchange. There is also dysregulation of pulmonary vasculature development (eg, abnormal distribution of alveolar capillaries, and thickening of the muscle layer of the pulmonary arterioles that results in increase in pulmonary resistance). In comparison to \"old\" BPD, there is a reduction of airway injury and inflammation is less prominent.",
"   </p>",
"   <p>",
"    These findings are in contrast to \"old\" BPD seen in infants prior to the availability of surfactant replacement therapy before the 1980s. The prominent pathologic findings in \"old\" BPD were airway injury, inflammation, and parenchymal fibrosis due to mechanical ventilation and oxygen toxicity (",
"    <a class=\"graphic graphic_figure graphicRef69557 \" href=\"UTD.htm?40/10/41125\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/6,18\">",
"     6,18",
"    </a>",
"    ]. Similar changes may be seen in surfactant-treated infants who develop severe BPD. In these severely affected infants, fibrosis, bronchial smooth muscle hypertrophy, and interstitial edema (\"old\" BP) may be superimposed on the characteristic reduced numbers of alveoli and capillaries (\"new\" BPD). Pulmonary vascular changes, such as abnormal arterial muscularization and obliteration of vessels, may also occur.",
"   </p>",
"   <p>",
"    Lung injury also is associated with increased elastic tissue formation and thickening of the interstitium. These tissue deformations may, in turn, compromise septation and capillary development. In one autopsy study, the amount of elastic tissue, septal thickness, and alveolar and duct diameters increased with the severity of BPD [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     PATHOGENESIS AND RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The etiology of bronchopulmonary dysplasia (BPD) is multifactorial and is due to exposure of antenatal and postnatal factors (eg, mechanical ventilation, oxygen toxicity, and infection), which disrupts pulmonary development, and may cause inflammation and damage to the highly vulnerable premature lung (",
"    <a class=\"graphic graphic_figure graphicRef69557 \" href=\"UTD.htm?40/10/41125\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The following studies illustrate the effect of these factors upon the risk of developing BPD.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a prospective report from the ELGANS (Extremely Low Gestational Age Newborns Study) study, predictive factors for BPD included lower gestational age in this already extreme prematurity cohort, FiO",
"      <sub>",
"       2",
"      </sub>",
"      requirement greater than 0.25 at 14 days of life, and mechanical ventilation at one week of life [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a study of 1244 VLBW infants in North Carolina, significant risk factors for BPD were the need for ventilation at 48 hours of age (odds ratio [OR], 1.64), nosocomial infection (OR 2.0), and increased fluid intake on day two (OR 1.06 per 10 mL increase) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/5\">",
"       5",
"      </a>",
"      ]. Among infants ventilated at 48 hours, patent ductus arteriosus (PDA) was associated with increased risk (OR 1.9).",
"     </li>",
"     <li>",
"      In a study of 119 ELBW with mild initial respiratory distress who required less than three days of supplemental oxygen concentration &gt;25 percent during the first five postnatal days, 44 (37 percent) developed BPD [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/21\">",
"       21",
"      </a>",
"      ]. Risk factors for BPD included low birth weight (OR 2.9 per 100 g decrement), PDA (OR 6.2), and sepsis (OR 4.4).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Individual risk factors are discussed in the following sections.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Prematurity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The lung appears to be most susceptible to damage during the saccular stage of development from 23 to 32 weeks gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/17,22\">",
"     17,22",
"    </a>",
"    ]. At this stage, the premature lung has poorly developed airway supporting structures, surfactant deficiency, decreased compliance, underdeveloped antioxidant mechanisms, and inadequate fluid clearance (",
"    <a class=\"graphic graphic_figure graphicRef69557 \" href=\"UTD.htm?40/10/41125\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/17,23\">",
"     17,23",
"    </a>",
"    ]. The premature lung's structural and functional immaturity increases the risk of injury and disruption of normal pulmonary microvascular and alveolar development from external antenatal and postnatal insults.",
"   </p>",
"   <p>",
"    In addition, fetal growth restriction in premature infants (gestational age below 28 weeks) appears to be an independent risk factor for BPD [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/24\">",
"     24",
"    </a>",
"    ]. Growth restriction may have a significant impact on the vulnerability of lung injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Mechanical ventilation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Injury caused by mechanical ventilation is due to large tidal volumes (volutrauma) that overdistend airways and airspaces rather than increased airway pressures [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. Because of the evidence that aggressive mechanical ventilation played a major role in the pathogenesis of BPD, a more conservative approach towards neonatal ventilation (ie, avoidance of high tidal volume) has evolved. This approach is one of the factors that have resulted in a milder form of BPD (\"new BPD\"). As a result, significant airway injury characteristic of the old BPD is less common, and is only seen in infants with severe BPD. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Pathology'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/39/4729?source=see_link\">",
"     \"Mechanical ventilation in neonates\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/40/17034?source=see_link\">",
"     \"Pulmonary outcomes of bronchopulmonary dysplasia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Acute lung injury results from inflations that are close to the maximum lung volume of small immature lungs, and plays a role in the chronic changes resulting in BPD. The risk of BPD increases with decreasing arterial carbon dioxide tension (PCO",
"    <sub>",
"     2",
"    </sub>",
"    ) as a measure of more aggressive ventilation that includes large tidal volumes [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/2,27,28\">",
"     2,27,28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Positive pressure ventilation typically induces bronchiolar lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/29\">",
"     29",
"    </a>",
"    ]. Disruption of airways may occur early in the course of treatment and may be manifested by increased pulmonary resistance [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/30\">",
"     30",
"    </a>",
"    ]. In one study of ventilated preterm infants in the first five days after birth, mean pulmonary resistance was significantly greater in those who subsequently developed BPD compared with those who did not [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In premature baboons treated with exogenous surfactant, prolonged intubation and low tidal volume ventilation for five days compared with one day intubation and weaning to CPAP resulted in poorer lung mechanics and respiratory function (eg, lower arterial to alveolar oxygen ratio, higher PaCO",
"    <sub>",
"     2",
"    </sub>",
"    , and poorer respiratory drive), increased histopathologic findings of cellular bronchiolitis and peribronchiolar alveolar wall thickening, and increased lavage levels of cytokines [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another animal study has shown that even a small number of large inflations soon after birth can adversely affect surfactant-deficient lungs [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/33\">",
"     33",
"    </a>",
"    ]. In this study of newborn lambs, one lamb of each of five pairs was randomly assigned to receive six large manual inflations (\"bagging\") after preterm delivery, and before starting mechanical ventilation and receiving artificial surfactant. At four hours, the bagged animals compared with controls had lower inspiratory capacity and maximal deflation, were more difficult to ventilate, and had less well expanded alveoli and more widespread lung injury on histologic examination.",
"   </p>",
"   <p>",
"    Differences in the use of mechanical ventilation may explain some of the variation among hospitals in BPD rates. This was illustrated in a case-cohort study of 452 VLBW infants at two centers (two Boston hospitals and Babies' and Children's Hospital in New York) from 1991 to 1993 that found BPD was more prevalent in Boston than in New York (22 versus 4 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/12\">",
"     12",
"    </a>",
"    ]. The initial respiratory management in Boston was more likely to include mechanical ventilation (75 versus 29 percent) and surfactant administration (45 versus 10 percent) during the study period.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Oxygen toxicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;High concentrations of inspired oxygen can damage the lungs, although the exact level or duration of exposure that is unsafe is not known. Cellular damage is caused by the overproduction of cytotoxic reactive oxygen metabolites (ie, superoxide free radical,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/41/41617?source=see_link\">",
"     hydrogen peroxide",
"    </a>",
"    , hydroxyl free radical, and singlet oxygen), which overwhelm the neonates immature antioxidant system.",
"   </p>",
"   <p>",
"    Preterm infants have inadequate antioxidant defenses because of nutrient deficiencies (vitamins A and E, iron, copper, zinc, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/37/13907?source=see_link\">",
"     selenium",
"    </a>",
"    ) or immature antioxidant enzyme systems (superoxide dismutase, catalase, glutathione peroxidase, glutathione-S-transferase) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/34\">",
"     34",
"    </a>",
"    ]. Activity of catalase, glutathione peroxidase, and",
"    <span class=\"nowrap\">",
"     copper/zinc",
"    </span>",
"    <span class=\"nowrap\">",
"     (Cu/Zn)",
"    </span>",
"    superoxide dismutase in cord blood are lower in preterm than in term newborns [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/35\">",
"     35",
"    </a>",
"    ]. There is also evidence of genetic variation in antioxidant defenses. This was illustrated by a study that showed infants with the less efficient isoform of glutathione-S-transferase-P1 were more susceptible to oxygen toxicity predisposing them to BPD [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although antioxidant mechanisms are immature, there is some upregulation of this defense system in preterm infants with BPD. In a study of 44 preterm infants (gestational age from 25 to 30 weeks),",
"    <span class=\"nowrap\">",
"     Cu/Zn",
"    </span>",
"    superoxide dismutase levels, followed sequentially from birth to the first week of life, were greater in infants who developed BPD compared with those without BPD by day six of life [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both postnatal and antenatal infections are associated with BPD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Postnatal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sepsis is associated with an increased risk of BPD. This was illustrated in an observational study from a single Australian tertiary center of 798 preterm infants (mean GA 27.4 weeks) born between 1992 and 2004 that reported neonatal sepsis increased the risk of BPD (OR 2.71 95% CI 1.64-4.51) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/38\">",
"     38",
"    </a>",
"    ]. Infants with candidemia had the highest risk of developing BPD (OR 8.68, 95% CI 1.65-45.63).",
"   </p>",
"   <p>",
"    The rate of BPD increases when sepsis is present in conjunction with a symptomatic patent ductus arteriosus (PDA). In a series of 119 ELBW infants who had mild or no initial respiratory distress syndrome, the risk of developing BPD was significantly higher with both sepsis and PDA (OR 48.3) compared with PDA alone (odds ratio 6.2) or sepsis alone (OR 4.4) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Chorioamnionitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antenatal infection has been suggested as a risk factor in development of BPD [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/39-41\">",
"     39-41",
"    </a>",
"    ]. The hypothesis was based on the finding of increased concentration of proinflammatory cytokines (interleukin [IL]-6, IL-1 beta, and IL-8) in the amniotic fluid of infants who subsequently develop BPD compared with those who did not [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/42\">",
"     42",
"    </a>",
"    ]. In particular, infection with Ureaplasma urealyticum appeared to cause a sustained dysregulated inflammatory response that impairs lung development, resulting in BPD [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. In addition, impaired response to surfactant has been reported in premature infants born to mothers with severe chorioamnionitis. This poor response appeared to be associated with an increased risk of BPD compared to infants who receive surfactant, but whose mothers who do not have chorioamnionitis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/45\">",
"     45",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Inflammation'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    However, a systematic review of the literature though 2009 reported that the magnitude of the association of chorioamnionitis and BPD is less definitive than previously thought [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/46\">",
"     46",
"    </a>",
"    ]. After adjusting for confounding variables (eg, gestational age and birth weight), exposure to chorioamnionitis increased the risk of BPD (OR 1.58, 95% CI 1.11-2.24). However, there was substantial heterogeneity among the 59 included studies likely due to differences in study design, the gestational age of patients, therapeutic interventions (eg, antenatal corticosteroid administration), and the definitions of BPD and chorioamnionitis. The authors also reported evidence of publication bias that suggested potential overestimation of the association between chorioamnionitis and BPD. A repeat analysis that adjusted for publication bias demonstrated no association between chorioamnionitis and BPD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Inflammation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Proinflammatory and chemotactic factors are present in greater concentration in infants who subsequently develop BPD compared with those without BPD [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/42,47-51\">",
"     42,47-51",
"    </a>",
"    ]. The presence of these mediators is associated with complement activation, increased vascular permeability, protein leakage, and mobilization of neutrophils into the interstitial and alveolar compartments. Release of reactive oxygen radicals, elastase, and collagenase by activated neutrophils results in lung damage [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/52\">",
"     52",
"    </a>",
"    ]. Interaction between macrophages and other cell types (eg, endothelial and epithelial cells) perpetuates the production of proinflammatory mediators, and sustains the cycle of lung injury. Persistence of factors (eg, macrophage inflammatory protein-1 and IL-8) and decreases of counterregulatory cytokines (eg, IL-10, IL-17) may lead to unregulated and persistent inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The development of BPD may begin before birth in some newborns through intrauterine exposure to proinflammatory cytokines, possibly due to chorioamnionitis. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Chorioamnionitis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Genetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Genetic predisposition may influence the development of BPD. This was illustrated in a study of monozygotic and dizygotic premature twins with GA &le;30 weeks that demonstrated the correlation of developing BPD, defined by the NICHD criteria, was greater in monozygotic compared with dizygotic pairs [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/53\">",
"     53",
"    </a>",
"    ]. However, further studies are required to determine whether or not there is a genetic predisposition, and if so, what are the underlying genetic factors.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Late surfactant deficiency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Delayed recovery or late deficiency of postnatal surfactant may play a role in the pathogenesis of BPD. In a study of 68 ventilator-dependent premature infants (gestational ages between 23 and 30 weeks), 75 percent of tracheal aspirates exhibited abnormally low surface tension [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/54\">",
"     54",
"    </a>",
"    ]. In these samples, surfactant proteins A, B, and C were reduced by 50, 80, and 72 percent, respectively. In addition, there appear to be a temporal association between samples with low surface tension and episodes of infection and respiratory deterioration. These results suggest that premature infants who require continued respiratory support have transient surfactant dysfunction or deficiency, which may affect their clinical status.",
"   </p>",
"   <p>",
"    In a pilot trial of 136 premature infants (birth weights between 600 and 900 g) who required mechanical ventilation between day three and ten of life, patients were randomly assigned to receive low dose synthetic surfactant, high dose synthetic surfactant, or placebo every 48 hours up to five doses while they remained ventilated [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/55\">",
"     55",
"    </a>",
"    ]. Although there was a trend to lower oxygen requirements in the surfactant groups compared with the control group, and a lower incidence of either death or BPD in the high dose surfactant group compared with either low dose surfactant or placebo groups, these differences did not reach statistical significance. A larger trial is currently underway that is examining the effect of late or periodic surfactant replacement, and possible synergistic effects, if combined with inhaled nitric oxide therapy upon the risk of developing BPD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Other potential factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other potential pathogenetic contributors include endostatin and bombesin-like peptides.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Impaired angiogenesis",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is increasing evidence that suggests the growth of lung blood vessels actively promotes alveolar growth. Disruption of angiogenesis has been proposed as a mechanism that impairs alveolarization, thereby contributing to the new form of BPD [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/56\">",
"     56",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Pathology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Support for the potential role of impaired angiogenesis in the pathogenesis of BPD includes the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study, elevated cord plasma endostatin levels, an antiangiogenic growth factor, were associated with an increased risk of BPD in very low birth weight infants (birth weight less than 1500 g) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/57\">",
"       57",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a prospective study of 107 preterm infants born between 23 and 32 weeks gestation, the risk of BPD was increased in infants born to mothers with preeclampsia compared to those born to mothers without preeclampsia (44 versus 22 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/58\">",
"       58",
"      </a>",
"      ]. These findings suggest factors that trigger maternal endothelial dysfunction (impaired angiogenesis), resulting in preeclampsia, are transferred to infants, which may contribute to the pathogenesis of BPD. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/61/34777?source=see_link&amp;anchor=H10#H10\">",
"       \"Pathogenesis of preeclampsia\", section on 'Systemic endothelial dysfunction'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Bombesin-like peptides",
"    </span>",
"    &nbsp;&mdash;&nbsp;Injury may be mediated in part by bombesin-like peptides (BLP), which are derived from pulmonary neuroendocrine cells and play an important role in normal lung growth and maturation. In one study, the number of BLP-positive cells was greater in infants who died with BPD than in controls [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/59\">",
"     59",
"    </a>",
"    ]. In a baboon model, urine BLP levels were increased soon after birth in animals who developed BPD, and administration of anti-BLP antibody attenuated the disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/60\">",
"     60",
"    </a>",
"    ]. In infants &le;28 weeks gestational age, elevated urine BLP levels in the first four days after birth were associated with an increased risk of BPD [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;As discussed above, bronchopulmonary dysplasia (BPD) is associated with multiple risk factors, including prematurity, mechanical ventilation, oxygen toxicity, sepsis, and patent ductus arteriosus. It occurs infrequently in infants with GA &ge; 30 weeks or BW more than 1250 g [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/6,13\">",
"     6,13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The evolution to BPD typically is recognized at approximately two weeks of age based upon the need for supplemental oxygen. This was illustrated in a the previously mentioned ELGANS study that enrolled 1340 preterm infants less than 28 weeks gestation in a multicenter prospective study between 2002 and 2004 [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/20\">",
"     20",
"    </a>",
"    ]. During the first two weeks of postnatal life, three clinical pulmonary courses emerged with differing rates of BPD.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      About 40 percent had persistent lung dysfunction defined as a consistent requirement of FiO",
"      <sub>",
"       2",
"      </sub>",
"      above 0.25. About two-thirds of these patients developed BPD.",
"     </li>",
"     <li>",
"      About 40 percent had deterioration of lung dysfunction defined as an increase of FiO",
"      <sub>",
"       2",
"      </sub>",
"      above 0.25 at 14 days of age. About one-half of these patients developed BPD.",
"     </li>",
"     <li>",
"      About 20 percent had no or minimal lung dysfunction defined as no consistent need of FiO",
"      <sub>",
"       2",
"      </sub>",
"      above 0.25. Only 17 percent of this group developed BPD.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physical examination is variable. Infants usually are tachypneic. Depending upon the extent of pulmonary edema",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    atelectasis, they may have mild to severe retractions, and scattered rales may be audible. Intermittent expiratory wheezing may be present in infants with airway narrowing from scar formation, constriction, mucus retention, collapse,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    edema.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Chest radiograph",
"    </span>",
"    &nbsp;&mdash;&nbsp;As BPD evolves, the chest radiograph becomes diffusely hazy, reflecting atelectasis, inflammation,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pulmonary edema. Lung volumes are normal or low. There may be areas of atelectasis that alternate with areas of gas trapping, related to airway obstruction from secretions or other debris.",
"   </p>",
"   <p>",
"    The chest radiograph in infants who develop severe BPD shows hyperinflation. Streaky densities or cystic areas may be prominent, corresponding to fibrotic changes. During acute exacerbations, pulmonary edema may be apparent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Cardiopulmonary function",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with severe BPD, abnormalities of pulmonary function include decreased tidal volume, increased airway resistance, and decreased dynamic lung compliance. Uneven airway obstruction leads to gas trapping and hyperinflation with abnormal distribution of ventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/62\">",
"     62",
"    </a>",
"    ]. Bronchomalacia can result in airway collapse during expiration. Severely affected infants have hypoxemia and hypercapnia.",
"   </p>",
"   <p>",
"    In these patients, pulmonary vascular resistance is increased because of reduced cross sectional area of pulmonary vessels. In addition, alveolar hypoxia in underventilated areas of the lung induces local vasoconstriction. The high microvascular pressure promotes increased fluid filtration into the perivascular interstitium. Elevated right atrial pressure inhibits pulmonary lymphatic drainage, further promoting pulmonary edema.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     CLINICAL COURSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most infants improve gradually during the next two to four months. As pulmonary function improves, they can be weaned to continuous positive airway pressure, then supplemental oxygen alone, until they can maintain adequate oxygenation when breathing room air.",
"   </p>",
"   <p>",
"    Some infants develop severe BPD that leads to prolonged ventilator dependence. The clinical course during the first few weeks after birth includes marked instability with bronchopulmonary dysplasia (BPD) changes in oxygenation and intermittent episodes of acute deterioration requiring increased ventilator support. The marked instability typically subsides after four to six weeks.",
"   </p>",
"   <p>",
"    Pulmonary hypertension is an important complication of BPD, particularly those with severe disease [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/63\">",
"     63",
"    </a>",
"    ]. In a prospective study of 145 ELBW infants, 77 percent of patients had BPD defined as an oxygen requirement at 36 weeks postmenstrual age (PMA) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/64\">",
"     64",
"    </a>",
"    ]. Echocardiography at four weeks of age for all patients and subsequent imaging in symptomatic patients also demonstrated pulmonary hypertension in 18 percent of the cohort. Almost all of the infants with pulmonary hypertension (96 percent) had BPD. Three of the 26 patients with pulmonary hypertension died before hospital discharge. These results suggest that pulmonary hypertension is a relatively common feature in ELBW infants with BPD, and is associated with increased mortality risk. Of note, the prevalence rate of BPD in this small ELBW cohort was higher than that reported for similar size patients in the NICHD Neonatal Research Network from 1997 to 2002 [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H24\">",
"     'Cardiopulmonary function'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In our practices, echographic evaluation to detect pulmonary hypertension is performed at 36 to 37 weeks PMA for infants with moderate to severe BPD as defined by one the following criteria:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Requiring mechanical ventilation or continuous positive airway pressure",
"     </li>",
"     <li>",
"      Requiring oxygen supplementation with a FiO",
"      <sub>",
"       2",
"      </sub>",
"      &ge;0.30",
"     </li>",
"     <li>",
"      Persistent PCO",
"      <sub>",
"       2",
"      </sub>",
"      values &ge;60 mmHg",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Elevated pulmonary vascular resistance may impair pulmonary lymphatic drainage and exacerbate interstitial edema. In some cases, anastomoses develop between pulmonary and systemic vessels that may worsen the pulmonary hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18793/abstract/63\">",
"     63",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/40/17034?source=see_link&amp;anchor=H12#H12\">",
"     \"Pulmonary outcomes of bronchopulmonary dysplasia\", section on 'Pulmonary artery hypertension'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?31/24/32129?source=see_link\">",
"       \"Patient information: Bronchopulmonary dysplasia (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bronchopulmonary dysplasia (BPD) remains a major complication of prematurity, resulting in significant mortality and morbidity. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/51/25398?source=see_link\">",
"     \"Outcome of infants with bronchopulmonary dysplasia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The current definition of BPD is based upon the need for oxygen supplementation, gestational age of the infant, and the severity of disease (",
"      <a class=\"graphic graphic_table graphicRef64789 \" href=\"UTD.htm?31/10/31916\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Definition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Infants with birth weights (BW) &lt;1250 g account for 97 percent of the cases of BPD. The incidence of BPD in very low BW infants (BW below 1500 g) is about 25 percent, although rates of BPD vary among institutions. The risk of developing BPD increases with decreasing birth weight (BW). (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Changes in neonatal management (ie, use of surfactant, antenatal glucocorticoid therapy, and less aggressive mechanical ventilation) have resulted in a milder form of BPD, referred to as \"new\" BPD. The \"new\" BPD is characterized by disruption of lung development that results in large alveoli and dysregulation of vasculature development. In contrast, the \"old\" BPD was characterized by airway injury, inflammation, and parenchymal fibrosis, which were primarily due to injury from mechanical ventilation and oxygen. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Pathology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The etiology of BPD is multifactorial and is due to exposure of antenatal and postnatal factors that cause arrest of pulmonary development, and potentially, inflammation and damage to the highly vulnerable premature lung (",
"      <a class=\"graphic graphic_figure graphicRef69557 \" href=\"UTD.htm?40/10/41125\">",
"       figure 1",
"      </a>",
"      ). These factors include mechanical ventilation, oxygen toxicity, infection, inflammation, and possibly genetic predisposition and late surfactant deficiency. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Pathogenesis and risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Infants who require oxygen supplementation above a FiO",
"      <sub>",
"       2",
"      </sub>",
"      of 25 percent at two weeks of age are at risk for developing BPD. Although the physical findings of BPD vary, most affected infants are tachypneic. Other findings include retractions, rales, and wheezes. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The chest radiograph in infants with BPD may be diffusely hazy, reflecting atelectasis, inflammation, and pulmonary",
"      <span class=\"nowrap\">",
"       congestions/edema.",
"      </span>",
"      (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Chest radiograph'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with severe BPD are hypoxemic and hypercapnic because of significant cardiopulmonary abnormalities. These include decreased tidal volume, increased airway resistance, decreased dynamic lung compliance, uneven airway obstruction, resulting in trapping and hyperinflation with abnormal distribution of ventilation, and increased vascular resistance. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Cardiopulmonary function'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most infants with BPD improve gradually during the next two to four months. Those with severe disease may have a prolonged course of mechanical ventilation, and may develop pulmonary hypertension and cor pulmonale. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Clinical course'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/1\">",
"      Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967; 276:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/2\">",
"      Kraybill EN, Runyan DK, Bose CL, Khan JH. Risk factors for chronic lung disease in infants with birth weights of 751 to 1000 grams. J Pediatr 1989; 115:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/3\">",
"      Sinkin RA, Cox C, Phelps DL. Predicting risk for bronchopulmonary dysplasia: selection criteria for clinical trials. Pediatrics 1990; 86:728.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/4\">",
"      Shennan AT, Dunn MS, Ohlsson A, et al. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988; 82:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/5\">",
"      Marshall DD, Kotelchuck M, Young TE, et al. Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. North Carolina Neonatologists Association. Pediatrics 1999; 104:1345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/6\">",
"      Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163:1723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/7\">",
"      Ehrenkranz RA, Walsh MC, Vohr BR, et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005; 116:1353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/8\">",
"      Walsh MC, Wilson-Costello D, Zadell A, et al. Safety, reliability, and validity of a physiologic definition of bronchopulmonary dysplasia. J Perinatol 2003; 23:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/9\">",
"      Walsh MC, Yao Q, Gettner P, et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics 2004; 114:1305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/10\">",
"      Ellsbury DL, Acarregui MJ, McGuinness GA, et al. Controversy surrounding the use of home oxygen for premature infants with bronchopulmonary dysplasia. J Perinatol 2004; 24:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/11\">",
"      Fanaroff AA, Stoll BJ, Wright LL, et al. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol 2007; 196:147.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/12\">",
"      Van Marter LJ, Allred EN, Pagano M, et al. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics 2000; 105:1194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/13\">",
"      Walsh MC, Szefler S, Davis J, et al. Summary proceedings from the bronchopulmonary dysplasia group. Pediatrics 2006; 117:S52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/14\">",
"      Stoll BJ, Hansen NI, Bell EF, et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010; 126:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/15\">",
"      Shah PS, Sankaran K, Aziz K, et al. Outcomes of preterm infants &lt;29 weeks gestation over 10-year period in Canada: a cause for concern? J Perinatol 2012; 32:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/16\">",
"      Stroustrup A, Trasande L. Epidemiological characteristics and resource use in neonates with bronchopulmonary dysplasia: 1993-2006. Pediatrics 2010; 126:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/17\">",
"      Baraldi E, Filippone M. Chronic lung disease after premature birth. N Engl J Med 2007; 357:1946.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/18\">",
"      Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 1998; 29:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/19\">",
"      Thibeault DW, Mabry SM, Ekekezie II, Truog WE. Lung elastic tissue maturation and perturbations during the evolution of chronic lung disease. Pediatrics 2000; 106:1452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/20\">",
"      Laughon M, Allred EN, Bose C, et al. Patterns of respiratory disease during the first 2 postnatal weeks in extremely premature infants. Pediatrics 2009; 123:1124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/21\">",
"      Rojas MA, Gonzalez A, Bancalari E, et al. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 1995; 126:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/22\">",
"      Langston C, Kida K, Reed M, Thurlbeck WM. Human lung growth in late gestation and in the neonate. Am Rev Respir Dis 1984; 129:607.",
"     </a>",
"    </li>",
"    <li>",
"     Randell SH, Young SI. nique features of the immature lung that make it vulnerable to injury. In: Chronic Lung Disease in Early Infancy, Bland RD, Coalson JJ (Eds), Marcel Dekk, New York 2000. p.377.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/24\">",
"      Bose C, Van Marter LJ, Laughon M, et al. Fetal growth restriction and chronic lung disease among infants born before the 28th week of gestation. Pediatrics 2009; 124:e450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/25\">",
"      Hernandez LA, Peevy KJ, Moise AA, Parker JC. Chest wall restriction limits high airway pressure-induced lung injury in young rabbits. J Appl Physiol 1989; 66:2364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/26\">",
"      Carlton DP, Cummings JJ, Scheerer RG, et al. Lung overexpansion increases pulmonary microvascular protein permeability in young lambs. J Appl Physiol 1990; 69:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/27\">",
"      Garland JS, Buck RK, Allred EN, Leviton A. Hypocarbia before surfactant therapy appears to increase bronchopulmonary dysplasia risk in infants with respiratory distress syndrome. Arch Pediatr Adolesc Med 1995; 149:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/28\">",
"      Dreyfuss D, Saumon G. Role of tidal volume, FRC, and end-inspiratory volume in the development of pulmonary edema following mechanical ventilation. Am Rev Respir Dis 1993; 148:1194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/29\">",
"      Nilsson R, Grossmann G, Robertson B. Lung surfactant and the pathogenesis of neonatal bronchiolar lesions induced by artificial ventilation. Pediatr Res 1978; 12:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/30\">",
"      Robertson B. The evolution of neonatal respiratory distress syndrome into chronic lung disease. Eur Respir J Suppl 1989; 3:33s.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/31\">",
"      Goldman SL, Gerhardt T, Sonni R, et al. Early prediction of chronic lung disease by pulmonary function testing. J Pediatr 1983; 102:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/32\">",
"      Thomson MA, Yoder BA, Winter VT, et al. Delayed extubation to nasal continuous positive airway pressure in the immature baboon model of bronchopulmonary dysplasia: lung clinical and pathological findings. Pediatrics 2006; 118:2038.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/33\">",
"      Bj&ouml;rklund LJ, Ingimarsson J, Curstedt T, et al. Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs. Pediatr Res 1997; 42:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/34\">",
"      Frank L, Sosenko IR. Development of lung antioxidant enzyme system in late gestation: possible implications for the prematurely born infant. J Pediatr 1987; 110:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/35\">",
"      Georgeson GD, Szony BJ, Streitman K, et al. Antioxidant enzyme activities are decreased in preterm infants and in neonates born via caesarean section. Eur J Obstet Gynecol Reprod Biol 2002; 103:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/36\">",
"      Manar MH, Brown MR, Gauthier TW, Brown LA. Association of glutathione-S-transferase-P1 (GST-P1) polymorphisms with bronchopulmonary dysplasia. J Perinatol 2004; 24:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/37\">",
"      Fu RH, Yang PH, Chiang MC, et al. Erythrocyte Cu/Zn superoxide dismutase activity in preterm infants with and without bronchopulmonary dysplasia. Biol Neonate 2005; 88:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/38\">",
"      Lahra MM, Beeby PJ, Jeffery HE. Intrauterine inflammation, neonatal sepsis, and chronic lung disease: a 13-year hospital cohort study. Pediatrics 2009; 123:1314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/39\">",
"      Watterberg KL, Demers LM, Scott SM, Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996; 97:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/40\">",
"      Moss TJ, Nitsos I, Kramer BW, et al. Intra-amniotic endotoxin induces lung maturation by direct effects on the developing respiratory tract in preterm sheep. Am J Obstet Gynecol 2002; 187:1059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/41\">",
"      Soraisham AS, Singhal N, McMillan DD, et al. A multicenter study on the clinical outcome of chorioamnionitis in preterm infants. Am J Obstet Gynecol 2009; 200:372.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/42\">",
"      Yoon BH, Romero R, Jun JK, et al. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1997; 177:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/43\">",
"      Hannaford K, Todd DA, Jeffery H, et al. Role of ureaplasma urealyticum in lung disease of prematurity. Arch Dis Child Fetal Neonatal Ed 1999; 81:F162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/44\">",
"      Viscardi RM, Hasday JD. Role of Ureaplasma species in neonatal chronic lung disease: epidemiologic and experimental evidence. Pediatr Res 2009; 65:84R.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/45\">",
"      Been JV, Rours IG, Kornelisse RF, et al. Chorioamnionitis alters the response to surfactant in preterm infants. J Pediatr 2010; 156:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/46\">",
"      Hartling L, Liang Y, Lacaze-Masmonteil T. Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2012; 97:F8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/47\">",
"      Ozdemir A, Brown MA, Morgan WJ. Markers and mediators of inflammation in neonatal lung disease. Pediatr Pulmonol 1997; 23:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/48\">",
"      Groneck P, Speer CP. Inflammatory mediators and bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed 1995; 73:F1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/49\">",
"      Groneck P, G&ouml;tze-Speer B, Oppermann M, et al. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates. Pediatrics 1994; 93:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/50\">",
"      Ambalavanan N, Carlo WA, D'Angio CT, et al. Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants. Pediatrics 2009; 123:1132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/51\">",
"      Wright CJ, Kirpalani H. Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies? Pediatrics 2011; 128:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/52\">",
"      Davies PL, Spiller OB, Beeton ML, et al. Relationship of proteinases and proteinase inhibitors with microbial presence in chronic lung disease of prematurity. Thorax 2010; 65:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/53\">",
"      Lavoie PM, Pham C, Jang KL. Heritability of bronchopulmonary dysplasia, defined according to the consensus statement of the national institutes of health. Pediatrics 2008; 122:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/54\">",
"      Merrill JD, Ballard RA, Cnaan A, et al. Dysfunction of pulmonary surfactant in chronically ventilated premature infants. Pediatr Res 2004; 56:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/55\">",
"      Laughon M, Bose C, Moya F, et al. A pilot randomized, controlled trial of later treatment with a peptide-containing, synthetic surfactant for the prevention of bronchopulmonary dysplasia. Pediatrics 2009; 123:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/56\">",
"      Th&eacute;baud B, Abman SH. Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. Am J Respir Crit Care Med 2007; 175:978.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/57\">",
"      Jan&eacute;r J, Andersson S, Kajantie E, Lassus P. Endostatin concentration in cord plasma predicts the development of bronchopulmonary dysplasia in very low birth weight infants. Pediatrics 2009; 123:1142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/58\">",
"      Hansen AR, Barn&eacute;s CM, Folkman J, McElrath TF. Maternal preeclampsia predicts the development of bronchopulmonary dysplasia. J Pediatr 2010; 156:532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/59\">",
"      Johnson DE, Lock JE, Elde RP, Thompson TR. Pulmonary neuroendocrine cells in hyaline membrane disease and bronchopulmonary dysplasia. Pediatr Res 1982; 16:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/60\">",
"      Sunday ME, Yoder BA, Cuttitta F, et al. Bombesin-like peptide mediates lung injury in a baboon model of bronchopulmonary dysplasia. J Clin Invest 1998; 102:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/61\">",
"      Cullen A, Van Marter LJ, Allred EN, et al. Urine bombesin-like peptide elevation precedes clinical evidence of bronchopulmonary dysplasia. Am J Respir Crit Care Med 2002; 165:1093.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/62\">",
"      Watts JL, Ariagno RL, Brady JP. Chronic pulmonary disease in neonates after artificial ventilation: distribution of ventilation and pulmonary interstitial emphysema. Pediatrics 1977; 60:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/63\">",
"      Goodman G, Perkin RM, Anas NG, et al. Pulmonary hypertension in infants with bronchopulmonary dysplasia. J Pediatr 1988; 112:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18793/abstract/64\">",
"      Bhat R, Salas AA, Foster C, et al. Prospective analysis of pulmonary hypertension in extremely low birth weight infants. Pediatrics 2012; 129:e682.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4987 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.66.252.144-A6750C7309-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_22_18793=[""].join("\n");
var outline_f18_22_18793=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TERMINOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      NICHD criteria",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Physiologic testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      PATHOGENESIS AND RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Prematurity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Mechanical ventilation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Oxygen toxicity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Postnatal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Chorioamnionitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Inflammation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Genetics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Late surfactant deficiency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Other potential factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Impaired angiogenesis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Bombesin-like peptides",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Chest radiograph",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Cardiopulmonary function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      CLINICAL COURSE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/4987\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/4987|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/10/41125\" title=\"figure 1\">",
"      Pathogenesis of bronchopulmonary dysplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/4987|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?31/10/31916\" title=\"table 1\">",
"      Definition of BPD",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/24/15753?source=related_link\">",
"      Management of bronchopulmonary dysplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/39/4729?source=related_link\">",
"      Mechanical ventilation in neonates",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/51/25398?source=related_link\">",
"      Outcome of infants with bronchopulmonary dysplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/61/34777?source=related_link\">",
"      Pathogenesis of preeclampsia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/24/32129?source=related_link\">",
"      Patient information: Bronchopulmonary dysplasia (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/14/27880?source=related_link\">",
"      Prevention of bronchopulmonary dysplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/40/17034?source=related_link\">",
"      Pulmonary outcomes of bronchopulmonary dysplasia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_22_18794="Classification and diagnosis of Sjgren's syndrome";
var content_f18_22_18794=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Classification and diagnosis of Sj&ouml;gren's syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/22/18794/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/22/18794/contributors\">",
"     Robert Fox, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/22/18794/contributors\">",
"     Paul Creamer, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/22/18794/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/22/18794/contributors\">",
"     Peter H Schur, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/22/18794/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/22/18794/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/22/18794/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 19, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sj&ouml;gren&rsquo;s syndrome (SS) is a chronic inflammatory disorder characterized by diminished lacrimal and salivary gland function. SS occurs in a primary form not associated with other diseases and in a secondary form that complicates other rheumatic conditions. The most common disease associated with secondary SS is rheumatoid arthritis.",
"   </p>",
"   <p>",
"    In primary or secondary SS, decreased exocrine gland function leads to the &ldquo;sicca complex,&rdquo; a combination of dry eyes (keratoconjunctivitis sicca) and dry mouth (xerostomia) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. In addition, a variety of other disease manifestations can occur in SS. The clinical manifestations of SS are divided into the exocrine gland features and the extraglandular disease features [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An effective classification system for SS must accommodate the range of clinical manifestations of this disorder. The ends of the clinical spectrum of SS are diverse:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      At the severe end are patients with florid salivary gland enlargement, adenopathy, antibodies to the",
"      <span class=\"nowrap\">",
"       Ro/SSA",
"      </span>",
"      and",
"      <span class=\"nowrap\">",
"       La/SSB",
"      </span>",
"      antigens, cryoglobulinemia, hypocomplementemia, a propensity to develop non-Hodgkin lymphoma, and other extraglandular disease manifestations.",
"     </li>",
"     <li>",
"      At the mild end are patients with moderate symptoms of dry eyes, dry mouth, a low titer of antinuclear antibody, and vague symptoms of fatigue, myalgias, and cognitive dysfunction. In many patients with mild disease, distinguishing SS patients from individuals with fibromyalgia or depression who have ocular",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      oral dryness caused or exacerbated by medications with anticholinergic side effects is a major challenge.",
"     </li>",
"     <li>",
"      Another group of patients with extraglandular manifestations may be found to have antinuclear antibody and",
"      <span class=\"nowrap\">",
"       Ro/SSA",
"      </span>",
"      antibody during evaluation, even though they lack dominant manifestations of dry eyes or dry mouth. These laboratory findings may be found during evaluation of neuropathies, nephropathies, hematologic abnormalities, or lymphoproliferative involvement of other organs with a pattern suggestive of SS or of systemic lupus erythematosus in the extraglandular organs.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This topic will review the classification, diagnosis, and epidemiology of SS. The clinical manifestations, pathogenesis, treatment, and prognosis of this disorder are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/1/11287?source=see_link\">",
"     \"Clinical manifestations of Sj&ouml;gren's syndrome: Exocrine gland disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/42/27306?source=see_link\">",
"     \"Clinical manifestations of Sj&ouml;gren's syndrome: Extraglandular disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/36/25162?source=see_link\">",
"     \"Pathogenesis of Sj&ouml;gren's syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/12/26826?source=see_link\">",
"     \"Treatment of dry eyes in Sj&ouml;gren's syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/57/36762?source=see_link\">",
"     \"Treatment of dry mouth and other non-ocular sicca symptoms in Sj&ouml;gren's syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/14/2282?source=see_link\">",
"     \"Treatment of systemic and extraglandular manifestations of Sj&ouml;gren&rsquo;s syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     NOMENCLATURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;A thorough understanding of the classification and diagnosis of SS necessitates familiarity with medical terminology related to the disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Mikulicz syndrome and IgG4-related disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 1892, Mikulicz reported a farmer with bilateral parotid and lacrimal gland enlargement and a round cell infiltrate of the salivary glands [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/4\">",
"     4",
"    </a>",
"    ]. A 2005 review of this paper concluded that the index patient was not only the first case of SS described in the medical literature but was also the first case of non-Hodgkin lymphoma associated with SS [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/42/27306?source=see_link&amp;anchor=H31#H31\">",
"     \"Clinical manifestations of Sj&ouml;gren's syndrome: Extraglandular disease\", section on 'Lymphoma'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Additionally, some patients identified as having Mikulicz syndrome have an uncommon but increasingly recognized condition termed IgG4-related disease. It is characterized by raised serum levels of IgG4 and by infiltration of IgG4-positive plasma cells in the tissue with fibrosis or sclerosis. Despite marked lacrimal and salivary gland enlargement (IgG4-related dacryoadenitis and sialadenitis), these patients experience relatively mild xerophthalmia and xerostomia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/55/13178?source=see_link\">",
"     \"Overview of IgG4-related disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/55/13178?source=see_link&amp;anchor=H16601951#H16601951\">",
"     \"Overview of IgG4-related disease\", section on 'Salivary and lacrimal gland involvement'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other examples of IgG4-related disease that may affect salivary glands include sclerosing sialadenitis (K&uuml;ttner&rsquo;s tumor), type 1 autoimmune pancreatitis, IgG4-related cholangitis, and isolated noninfectious aortitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/55/13178?source=see_link\">",
"     \"Overview of IgG4-related disease\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H30\">",
"     'Differential diagnosis'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/14/40168?source=see_link\">",
"     \"Autoimmune pancreatitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/44/9927?source=see_link&amp;anchor=H6966761#H6966761\">",
"     \"Salivary gland tumors: Epidemiology, diagnosis, evaluation, and staging\", section on 'Differential diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The terms Mikulicz syndrome and SS have been used synonymously for many years in the past, particularly in the pathology literature. Because of confusion about the precise meaning of the term Mikulicz disease (ie, SS in general, SS associated with non-Hodgkin lymphoma or with cervical adenopathy due to extraglandular tuberculosis, or IgG4-related dacryoadenitis and sialadenitis), Mikulicz syndrome as a term for a clinical entity should no longer be used. Some pathologists describe biopsies with characteristic features of benign lymphoepithelial lesions as Mickulicz lesions, including IgG4-related disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Keratoconjunctivitis sicca",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 1933, the Swedish ophthalmologist Henrik Sj&ouml;gren described clinical and histologic findings in 19 women with dry mouth and dry eyes [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/6\">",
"     6",
"    </a>",
"    ]. Thirteen of the patients had probable rheumatoid arthritis.",
"   </p>",
"   <p>",
"    Sj&ouml;gren introduced the term &ldquo;keratoconjunctivitis sicca&rdquo; (KCS) to describe the ocular component of this syndrome, using KCS to distinguish the disorder from the xerophthalmia associated with hypovitaminosis A. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/1/11287?source=see_link&amp;anchor=H3#H3\">",
"     \"Clinical manifestations of Sj&ouml;gren's syndrome: Exocrine gland disease\", section on 'Keratoconjunctivitis sicca'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Dysfunctional tear syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The success of topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    in ocular disease has led ophthalmologists to refer to the subtype of dry eye in SS as &ldquo;dysfunctional tear syndrome&rdquo; [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/7\">",
"     7",
"    </a>",
"    ]. KCS and dysfunctional tear syndrome are used interchangeably in the literature.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H720851742\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence and prevalence of SS depend upon the specific classification criteria used. Little is known about the prevalence of SS in the general population, but some data indicate that there is a substantial number of undiagnosed cases of SS in the community. The following observations indicate the range of findings, but none used the American-European Consensus Group classification criteria.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H720851749\">",
"    <span class=\"h2\">",
"     Sj&ouml;gren's syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;An annual incidence of SS of approximately 4 per 100,000 people was found in a population-based study from Olmsted County, Minnesota that used the 1993 European criteria [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/8\">",
"     8",
"    </a>",
"    ]. Of the incident cases, 70 percent were diagnosed as primary SS, and the remainder was associated with underlying illnesses. In contrast, a higher prevalence of 3 to 4 percent was noted in a study of randomly selected of adults in the United Kingdom using the same criteria [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In different reports limited to older adults, 0.1 to 4.8 percent fulfilled criteria for SS [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. The use of different criteria across these studies probably contributed to the variation in the reported prevalence rates.",
"   </p>",
"   <p>",
"    Not surprisingly, the proportion of patients who satisfied the American-European classification criteria for SS was higher among patients attending a rheumatology clinic than a medical clinic at the same institution (19 versus 4 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/12\">",
"     12",
"    </a>",
"    ]. However, the prevalence with primary SS was similar in the two settings (2.8 and 2.5 percent, respectively). The presence of SS had not been recognized in 60 percent of those who met criteria for the disease.",
"   </p>",
"   <p>",
"    SS is present in only a minority of patients with dry eyes. As an example, SS was identified, based upon the American&ndash;European Consensus Group criteria, in 11.6 percent of 327 patients in a prospective cohort with clinically significant aqueous-deficient dry eye who were drawn from a variety of eye care practices, including 6.4 and 5.2 percent with primary and secondary SS, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H202391358\">",
"     'American-European Consensus Group criteria for SS'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H720851756\">",
"     'Dry eye in older adults'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H720851756\">",
"    <span class=\"h2\">",
"     Dry eye in older adults",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sicca symptoms are much more common than SS, with a higher prevalence in older adults. It has been estimated that approximately 35 percent of older subjects have the sensation of dry eyes and dry mouth [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/10,14-16\">",
"     10,14-16",
"    </a>",
"    ]. This is partly due to age-related atrophy of secreting tissue and to other causes (especially medications). However, only about 10 percent of these subjects have objective evidence of reduced tear or saliva production, placing the community prevalence of keratoconjunctivitis sicca (KCS) in older adults in the range of 4 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/15,16\">",
"     15,16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a study of 62 nursing home residents, 23 percent had an abnormal Schirmer test, and 20 percent had positive Rose Bengal staining [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/11\">",
"     11",
"    </a>",
"    ]. However, none of the subjects complained of sicca symptoms, and most abnormalities in salivary gland biopsies were due to age-related fibrosis and atrophy. Only 13 percent showed lymphocytic infiltrates",
"   </p>",
"   <p>",
"    It is unclear whether the mild sicca symptoms seen in older adults and the more fulminant disease associated with glandular destruction, autoantibodies, and systemic symptoms represent different ends of a SS spectrum or two separate diseases. The term &ldquo;xerosis of the elderly&rdquo; was established for subjects who have significant symptoms of dryness in the absence of autoantibodies and who have a salivary gland biopsy showing only nonspecific changes or a low",
"    <span class=\"nowrap\">",
"     (&lt;1/mm",
"     <sup>",
"      2",
"     </sup>",
"     )",
"    </span>",
"    focus score [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Salivary gland biopsy'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H720851763\">",
"    <span class=\"h2\">",
"     Geographic distribution",
"    </span>",
"    &nbsp;&mdash;&nbsp;SS has a worldwide distribution, and the characteristics of SS in one report were similar in subjects in China, Japan, and California [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/17\">",
"     17",
"    </a>",
"    ]. A similar frequency of autoantibodies was found in each country, and the autoantibodies were directed against the same epitopes, despite the fact that each ethnic group had a different class II human leukocyte antigen (HLA) as a risk factor. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/36/25162?source=see_link\">",
"     \"Pathogenesis of Sj&ouml;gren's syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     MEDICAL HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Specific questions may be required to elicit from the patient the complaints typical of SS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Ocular symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;KCS is characterized primarily by a deficiency in tear production. The symptoms of dry eyes may be sought with questions such as:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      &ldquo;Do you often feel a gritty or sandy sensation in your eyes?&rdquo; [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/10\">",
"       10",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      &ldquo;Have you had symptoms of dry eyes on a daily basis for more than three months?&rdquo; [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/18\">",
"       18",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Use of a tear substitute more than three times daily, even in the absence of complaints of ocular dryness, is sufficient to fulfill criteria for dry eyes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Oral symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complaints of mouth dryness may be elicited by questions such as:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      &ldquo;Do you have to wake up at night to drink water because your mouth is so dry?&rdquo;",
"     </li>",
"     <li>",
"      &ldquo;Do you frequently drink liquids to help in swallowing dry foods?&rdquo; [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/18\">",
"       18",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC TESTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation of SS may consist of the following types of tests:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Tests to confirm KCS",
"     </li>",
"     <li>",
"      Tests to quantify xerostomia",
"     </li>",
"     <li>",
"      Salivary gland biopsy",
"     </li>",
"     <li>",
"      Serologic testing for antibodies to",
"      <span class=\"nowrap\">",
"       Ro/SSA",
"      </span>",
"      and",
"      <span class=\"nowrap\">",
"       La/SSB",
"      </span>",
"     </li>",
"     <li>",
"      Magnetic resonance imaging (MRI)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Tests for KCS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are three commonly used tests for KCS: the Schirmer test, the Rose Bengal test, and tear break-up time. Ophthalmologists usually perform all of these tests.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Schirmer test",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tear production may be measured using the Schirmer test. A small piece of sterile filter paper, supplied in a standard kit, is placed in the lateral third of the lower eyelid. The extent of wetting in a given time is measured [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/19\">",
"     19",
"    </a>",
"    ]. The Schirmer II test is performed by gently inserting a cotton swab into the nose and by stimulating the nasolacrimal reflex, which is measured by the sterile filter paper [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/20\">",
"     20",
"    </a>",
"    ]; this test supplements the Schirmer I by measuring lacrimal gland function stimulated by another cranial nerve reflex.",
"   </p>",
"   <p>",
"    Wetting of less than 5 mm in five minutes is considered abnormal. Use of topical anesthesia and blotting of the tear reservoir prior to the test may improve accuracy as a measure of basal tear production. The findings are typically similar in both eyes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Rose Bengal test",
"    </span>",
"    &nbsp;&mdash;&nbsp;End-organ damage to conjunctival and corneal epithelial cells may be assessed by the Rose Bengal test, which stains areas of devitalized tissue (",
"    <a class=\"graphic graphic_picture graphicRef59477 \" href=\"UTD.htm?17/17/17695\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    To perform the Rose Bengal test, 10 microliters of 1 percent Rose Bengal are instilled into the inferior fornix of the anesthetized eye. The patient is asked to blink twice to spread the stain over the conjunctiva and cornea. Staining can then be scored by the ophthalmologist using a slit lamp [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Tear break-up time",
"    </span>",
"    &nbsp;&mdash;&nbsp;The tear break-up time (or tear clearance) provides a global assessment of the function of the lacrimal functional unit and tear exchange on the ocular surface [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/21-23\">",
"     21-23",
"    </a>",
"    ]. The test is performed by measuring break-up time and tear osmolality after instillation of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/27/29108?source=see_link\">",
"     fluorescein",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    Although the tear break-up time is an indirect measure of KCS-associated inflammation on the ocular surface, its correlation with the severity of ocular symptoms and corneal epithelial disease is better than that of the Schirmer test. Delayed tear clearance may prove to be the best measure for identifying patients with tear film disorders who will respond to antiinflammatory therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Quantifying xerostomia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Four tests may be employed to quantify xerostomia, which are primarily performed in research settings:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Salivary gland scintigraphy (technetium excretion radionucleotide scanning)",
"     </li>",
"     <li>",
"      Parotid sialography",
"     </li>",
"     <li>",
"      Unstimulated production of saliva, also known as whole sialometry",
"     </li>",
"     <li>",
"      The Saxon test",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Salivary gland scintigraphy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Quantitative salivary gland scintigraphy gives a dynamic picture of the function of all major salivary glands [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/24\">",
"     24",
"    </a>",
"    ]. The finding of very low uptake of the radionuclide is relatively insensitive but highly specific for SS. Approximately one-third of patients with SS have positive tests [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Parotid gland sialography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Parotid gland sialography is performed by retrograde cannulation of the major salivary gland ducts, followed by instillation of an oil-based contrast material. Although this method gives excellent visualization of the ducts, it is limited by the risk of rupturing the duct and should not be performed during an episode of acute parotitis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/26,27\">",
"     26,27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A comparison of scintigraphy and parotid gland sialography suggests that scintigraphy correlates better with parotid function [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/24\">",
"     24",
"    </a>",
"    ]. Interpretation of sialography requires both training and experience [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/26\">",
"     26",
"    </a>",
"    ]. In the United States, radiologists or otolaryngologists do not commonly perform retrograde sialography, and, thus, there is considerable difficulty in comparing studies from Europe (where MRI imaging is less available and where sialograms are frequently done) and the US (where the converse is true).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Whole sialometry",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sialometry is the measurement of the rate of saliva production. The unstimulated whole salivary flow rate is a relatively simple test that assesses saliva production from more than just a single parotid gland and avoids the need for special equipment or imaging agents.",
"   </p>",
"   <p>",
"    The patient is asked to expectorate once and then to collect all saliva into a graduated container. After 15 minutes the volume of saliva is measured. A collection of &le;1.5 mL during this time is considered to be a positive test.",
"   </p>",
"   <p>",
"    Detailed changes in salivary protein and their post-translational processing have been reported using molecular tools of proteomics [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. Additional studies of the modulation of small molecules in saliva (defensins, histatins) and of the effect of androgens have been noted [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/30-34\">",
"     30-34",
"    </a>",
"    ]. These studies find that almost 30 percent of salivary proteins and mucins are altered in SS patients, indicating that the volume of saliva is not the only alteration in patients with sicca symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Saxon test",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Saxon test is a modification of whole sialometry. In the Saxon test, the patient chews a gauze sponge for two minutes without swallowing. The difference in the weight of the sponge before and after chewing represents the amount of saliva produced [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/35\">",
"     35",
"    </a>",
"    ]. This test predominantly measures submandibular saliva production.",
"   </p>",
"   <p>",
"    Data from normal subjects suggest that an accumulation of less than 2.75 grams of saliva on the sponge over a two-minute period constitutes a positive test [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/35\">",
"     35",
"    </a>",
"    ]. Disadvantages of the Saxon test include inadvertent swallowing of some saliva, the variability of saliva secretion with the time of day and with meals, and failure of the test to measure unstimulated salivary flow.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Salivary gland biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;A labial salivary gland biopsy is an important diagnostic tool in patients with suspected SS. Indications for salivary gland biopsy include [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/36\">",
"     36",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Confirmation of a suspected diagnosis of SS",
"     </li>",
"     <li>",
"      Exclusion of other conditions that can cause xerostomia and bilateral gland enlargement (see",
"      <a class=\"local\" href=\"#H30\">",
"       'Differential diagnosis'",
"      </a>",
"      below)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The biopsy should be taken from a nontraumatized part of the lower lip that is macroscopically normal. In order to be considered acceptable for evaluation, the biopsy should contain at least four lobules of salivary gland tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/37\">",
"     37",
"    </a>",
"    ]. The key histologic feature is a focal collection or collections of lymphocytes, often beginning centrally within the lobule (",
"    <a class=\"graphic graphic_picture graphicRef79996 \" href=\"UTD.htm?17/10/17577\">",
"     picture 2",
"    </a>",
"    ). The most widely accepted grading system records the number of foci of lymphoid tissue, defined as collections of 50 or more lymphocytes per 4 mm",
"    <sup>",
"     2",
"    </sup>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/38,39\">",
"     38,39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most criteria require more than one focus of lymphocytes per 4 mm",
"    <sup>",
"     2",
"    </sup>",
"    for a definitive diagnosis of SS. Immunocytology shows most of the lymphocytes are CD4+ T cells. Experience in the reading of salivary gland biopsies is critical for proper interpretation [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/40\">",
"     40",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/36/25162?source=see_link\">",
"     \"Pathogenesis of Sj&ouml;gren's syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is some disagreement about the sensitivity and specificity of labial salivary gland biopsy for SS [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/41\">",
"     41",
"    </a>",
"    ]. Sampling error may occur even in patients with classic disease. On the other hand, SS-like findings have been reported in other connective tissue disorders and in normal older adult subjects [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One approach to improving the accuracy of labial salivary gland biopsy is to calculate a cumulative focus score by examining several sections separated by at least 200 microns [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/42\">",
"     42",
"    </a>",
"    ]. In one study, the multisection approach improved the specificity of salivary gland biopsy from 85 to 94 percent compared with focus scores calculated on the basis of only one section. The sensitivity of the test was not altered by multisection analysis (94 percent with both methods).",
"   </p>",
"   <p>",
"    Certain pathologic features such as parenchymal atrophy, fibrosis, and scattered lymphoid cells are almost universal in older adults [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/11,14\">",
"     11,14",
"    </a>",
"    ]. Thus, these features are excluded from diagnostic criteria for SS. As long as focal collections of lymphocytes, rather than diffuse scatterings, are considered, most experts believe salivary gland biopsy to be the most specific method of confirming the diagnosis of SS [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Factors that predict a positive lip biopsy were evaluated in 289 patients with dry mouth symptoms in a study from the National Institutes of Health [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/44\">",
"     44",
"    </a>",
"    ]. An elevated serum immunoglobulin G (IgG) concentration (&gt;1482",
"    <span class=\"nowrap\">",
"     mg/dL)",
"    </span>",
"    had a high specificity (97 percent) but poor sensitivity (40 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18785486\">",
"    <span class=\"h2\">",
"     Laboratory variation in measurement of ANA",
"    </span>",
"    &nbsp;&mdash;&nbsp;One potential pitfall in diagnosis is the intra-laboratory variation in the measurement of antinuclear antibodies (ANA). These tests classically used immunofluorescence assays (IFA) on mouse kidney cells and subsequently have been performed using the human Hep-2 cell line. Some laboratories use enzyme linked immunosorbent assays (ELISA) to detect reactivity with extracted cells. Multicenter studies to standardize the methods of detection have shown significant variability in results with different techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/45-47\">",
"     45-47",
"    </a>",
"    ], particularly when the antibody titers are low.",
"   </p>",
"   <p>",
"    As an example, using the same sample of patient sera in the same commercial clinical laboratory, a negative result may be found using an ELISA method while the test is strongly positive using an immune fluorescence method. A description of the diagnostic difficulties posed by different laboratory methods is illustrated by a case in which the correct diagnosis was clear only after the ELISA assay for ANA was repeated using a different IFA method [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/48\">",
"     48",
"    </a>",
"    ]. Thus, clinicians should determine if changes in testing methods are responsible for apparent changes in autoantibody test results in an individual patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Antibodies to Ro/SSA and La/SSB",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with primary SS often possess antibodies to the",
"    <span class=\"nowrap\">",
"     Ro/SSA",
"    </span>",
"    or",
"    <span class=\"nowrap\">",
"     La/SSB",
"    </span>",
"    antigens. Many patients possess both types of antibodies. The frequency of",
"    <span class=\"nowrap\">",
"     anti-Ro/SSA",
"    </span>",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    <span class=\"nowrap\">",
"     anti-La/SSB",
"    </span>",
"    antibodies has varied in different studies, but 50 percent positivity of one or both of these autoantibodies is compatible with most reports of primary SS patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/23/8568?source=see_link&amp;anchor=H11717369#H11717369\">",
"     \"The anti-Ro/SSA and anti-La/SSB antigen-antibody systems\", section on 'Sj&ouml;gren&rsquo;s syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cloning of the",
"    <span class=\"nowrap\">",
"     Ro/SSA",
"    </span>",
"    antigens revealed that",
"    <span class=\"nowrap\">",
"     Ro/SSA",
"    </span>",
"    actually consists of a 60 kD antigen and a 52 kD antigen [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/49\">",
"     49",
"    </a>",
"    ]. SS patients may express activity against both the 60 kD and the 52 kD proteins or against either protein alone [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/50,51\">",
"     50,51",
"    </a>",
"    ].",
"    <span class=\"nowrap\">",
"     Anti-Ro/SSA",
"    </span>",
"    antibodies directed against one of these antigens as opposed to the other do not predict specific clinical features or prognosis in SS.",
"   </p>",
"   <p>",
"    In considering the diagnosis of SS, it is important to recognize that systemic lupus erythematosus (SLE) is comprised of multiple clinical subsets of disease and that each SLE subset has its own characteristic pattern of autoantibodies and human leukocyte antigen (HLA)-DR associated genes [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/52\">",
"     52",
"    </a>",
"    ]. One of the subsets of SLE is characterized by antibodies to",
"    <span class=\"nowrap\">",
"     Ro/SSA,",
"    </span>",
"    and the labeling of the antibody as &ldquo;Sj&ouml;gren&rsquo;s syndrome associated&rdquo; (SSA) in the laboratory report may lead to confusion by suggesting that this antibody is specific for SS, which it is not, as it is also found in patients with SLE [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Magnetic resonance imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Magnetic resonance (MR) imaging provides a noninvasive technique for performing sialography on salivary glands [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/54-57\">",
"     54-57",
"    </a>",
"    ]. MR imaging is superior to ultrasonography and to computed tomography for evaluating the salivary glands, particularly when fat suppression studies are used. The MR results correlate well with the results of salivary gland biopsy [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Gadolinium-enhanced MR studies with heavily T2-weighted sequences and with digital subtraction methods for the suppression of fat signal can be used to distinguish ductal pathology. Stensen&rsquo;s duct can be visualized reliably with this technique [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/54,55\">",
"     54,55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Intra- and extraglandular duct dilatations and duct strictures are delineated well by MRI in patients with chronic sialadenitis. Sialolithiasis with a calculus obstructing the duct can also be demonstrated.",
"   </p>",
"   <p>",
"    Because MR imaging is noninvasive, the only contraindications are those applicable to the performance of MR studies in general. In particular, gadolinium administration in the setting of significantly reduced renal function has been associated with the development of a severe disease called nephrogenic systemic fibrosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/22/31082?source=see_link\">",
"     \"Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy in advanced renal failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     CLASSIFICATION CRITERIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Classification criteria have evolved over time for use in scientific communication and clinical research. A variety of classification schemes for SS have been proposed and discussed in the literature since the 1980s [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/18,59-66\">",
"     18,59-66",
"    </a>",
"    ]. The most widely accepted set of criteria are known as the American-European Consensus Group classification criteria [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. A provisional set of criteria, which has not been fully validated, was proposed in 2012 as the American College of Rheumatology Classification Criteria for Sj&ouml;gren&rsquo;s syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/67\">",
"     67",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H202391358\">",
"     'American-European Consensus Group criteria for SS'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H26379282\">",
"     'ACR classification criteria for SS'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H202391358\">",
"    <span class=\"h2\">",
"     American-European Consensus Group criteria for SS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American-European Consensus Group (AECG) classification criteria for SS were proposed in 2002 [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. These criteria were not developed for use in routine clinical practice, and not every patient who receives a clinical diagnosis of SS fulfills the proposed criteria. In addition, disorders that can be confused with SS must be excluded before a patient can be classified as having the disease. (See",
"    <a class=\"local\" href=\"#H28\">",
"     'Diagnosis'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H25\">",
"     'Exclusion criteria'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The AECG criteria combine subjective symptoms of dry eye and dry mouth with objective signs of KCS and xerostomia. The requirement in the consensus criteria for either a characteristic minor salivary gland biopsy or a characteristic autoantibody (such as",
"    <span class=\"nowrap\">",
"     anti-Ro/SSA",
"    </span>",
"    or",
"    <span class=\"nowrap\">",
"     anti-La/SSB",
"    </span>",
"    autoantibodies) helps distinguish the dryness of SS from other disorders.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;The AECG criteria consist of six items, each of which is defined by one to three criteria (",
"    <a class=\"graphic graphic_table graphicRef64166 \" href=\"UTD.htm?32/33/33308\">",
"     table 1",
"    </a>",
"    ). An item is considered present if any of its elements is present. The six items are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Ocular symptoms of inadequate tear production",
"     </li>",
"     <li>",
"      Ocular signs of corneal damage due to inadequate tearing",
"     </li>",
"     <li>",
"      Oral symptoms of decreased saliva production",
"     </li>",
"     <li>",
"      Salivary gland histopathology demonstrating foci of lymphocytes",
"     </li>",
"     <li>",
"      Tests indicating impaired salivary gland function",
"     </li>",
"     <li>",
"      Presence of autoantibodies",
"      <span class=\"nowrap\">",
"       (anti-Ro/SSA",
"      </span>",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      <span class=\"nowrap\">",
"       anti-La/SSB)",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the AECG classification criteria, the gold standard for SS upon which the criteria were based was the clinical observations of expert clinicians.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h4\">",
"     Exclusion criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who would otherwise fulfill the classification criteria are excluded if any of the following disorders is present:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Prior head",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      neck irradiation",
"     </li>",
"     <li>",
"      Infection with hepatitis C virus",
"     </li>",
"     <li>",
"      Acquired immunodeficiency syndrome (AIDS)",
"     </li>",
"     <li>",
"      Lymphoma",
"     </li>",
"     <li>",
"      Sarcoidosis",
"     </li>",
"     <li>",
"      Graft-versus-host disease",
"     </li>",
"     <li>",
"      Recent use of medications with anticholinergic properties",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Primary SS",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with no associated connective tissue disease and no exclusionary diagnoses cited above, a classification of primary SS might be made according to the consensus rules in one of the three following ways (",
"    <a class=\"graphic graphic_figure graphicRef65807 \" href=\"UTD.htm?37/53/38751\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/68\">",
"     68",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The patient has either a positive salivary gland biopsy or",
"      <span class=\"nowrap\">",
"       anti-Ro/SSA",
"      </span>",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      <span class=\"nowrap\">",
"       anti-La/SSB",
"      </span>",
"      autoantibodies and satisfies a total of four of the six items. This rule is associated with a sensitivity of 97 percent and a specificity of 90 percent.",
"     </li>",
"     <li>",
"      The patient satisfies three of the four objective items (ocular signs, biopsy, salivary gland involvement, or autoantibodies). This rule has a sensitivity of 84 percent and a specificity of 95 percent.",
"     </li>",
"     <li>",
"      A classification tree with a sensitivity of 96 percent and a specificity of 94 percent can be used to determine whether or not patients are classified as having primary SS (",
"      <a class=\"graphic graphic_figure graphicRef65807 \" href=\"UTD.htm?37/53/38751\">",
"       figure 1",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Secondary SS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A classification of secondary SS is made according to the consensus rules if a connective tissue disease is present and if both of the following criteria are met:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      At least one item indicative of ocular or oral dryness is present.",
"     </li>",
"     <li>",
"      Any two of the following three objective items are present:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Ocular signs",
"     </li>",
"     <li>",
"      Positive salivary gland biopsy",
"     </li>",
"     <li>",
"      Abnormal tests of salivary gland function",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The associated connective tissue diseases include systemic lupus erythematosus, systemic sclerosis (scleroderma), rheumatoid arthritis, mixed connective tissue disease, inflammatory muscle disease, autoimmune liver disease, and autoimmune thyroid disease [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26379282\">",
"    <span class=\"h2\">",
"     ACR classification criteria for SS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Classification criteria have been developed through a consensus approach by the Sj&ouml;gren&rsquo;s International Collaborative Clinical Alliance (SICCA) investigators, using data from their collective cohort of patients with SS; these were adopted as a provisional criteria set by the American College of Rheumatology (ACR) in 2012 [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/67\">",
"     67",
"    </a>",
"    ]. These provisional ACR classification criteria for SS were developed, in part, in an effort to improve the specificity of criteria used for entry into clinical trials of biologic agents and other therapies. These criteria do not distinguish between primary and secondary forms of SS. They have not been adopted by the European League Against Rheumatism.",
"   </p>",
"   <p>",
"    The proposed case definition for SS requires at least two of the following three findings:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Positive serum anti-SSA",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      anti-SSB antibody testing",
"      <strong>",
"       OR",
"      </strong>",
"      a positive rheumatoid factor and an antinuclear antibody titer &ge;1:320",
"     </li>",
"     <li>",
"      Ocular staining score &ge;3 (assuming the individual is not concurrently using daily eye drops)",
"     </li>",
"     <li>",
"      Presence of focal lymphocytic sialadenitis with a focus score &ge;1",
"      <span class=\"nowrap\">",
"       focus/4",
"      </span>",
"      mm",
"      <sup>",
"       2",
"      </sup>",
"      in labial salivary gland biopsy samples",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The ACR criteria differ from the well-established AECG criteria in not including criteria based upon symptoms of glandular manifestations (ie, ocular and oral dryness).",
"   </p>",
"   <p>",
"    Several critiques have been raised regarding the",
"    <span class=\"nowrap\">",
"     ACR/SICCA",
"    </span>",
"    criteria, including the potential for confusion on the part of regulatory agencies and rheumatologists familiar with the well-established AECG criteria; the difficulty of comparing and extending results from research on treatment and prognosis done from 2002 onward that used the AECG criteria to define the SS population under study; and the absence of clinical symptoms as criteria, given their clinical relevance to patients with SS.",
"   </p>",
"   <p>",
"    Further efforts to reach consensus among investigators of SS with respect to the differences between the criteria sets are expected and will be of value in helping to interpret studies of SS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no single diagnostic test for SS. The clinical diagnosis of SS is made in the presence of compatible clinical and laboratory features and after the exclusion of other causes of ocular",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    oral dryness. (See",
"    <a class=\"local\" href=\"#H30\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    As mentioned above, the American-European Consensus Group classification criteria for SS were not developed for use in routine clinical practice, and not every patient who receives a clinical diagnosis of SS fulfills the proposed criteria [",
"    <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. Patients who have symptoms and findings that satisfy four or more of the American-European Consensus Group criteria probably have SS. (See",
"    <a class=\"local\" href=\"#H24\">",
"     'Criteria'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Recommendations",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to a thorough medical history and physical examination, the following tests are recommended for use in clinical practice when SS is suspected:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Schirmer test (see",
"      <a class=\"local\" href=\"#H12\">",
"       'Schirmer test'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Rose Bengal test (see",
"      <a class=\"local\" href=\"#H13\">",
"       'Rose Bengal test'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Basic laboratory testing, which should include:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Complete blood count with differential",
"     </li>",
"     <li>",
"      Serum electrolytes and liver function tests",
"     </li>",
"     <li>",
"      Erythrocyte sedimentation rate",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      C-reactive protein",
"     </li>",
"     <li>",
"      Urinalysis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Specialized laboratory testing should include assays for:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Antinuclear antibodies",
"     </li>",
"     <li>",
"      Rheumatoid factor",
"     </li>",
"     <li>",
"      Antibodies to the",
"      <span class=\"nowrap\">",
"       Ro/SSA,",
"      </span>",
"      <span class=\"nowrap\">",
"       La/SSB,",
"      </span>",
"      Sm, and RNP antigens",
"     </li>",
"     <li>",
"      Anticardiolipin antibody and lupus anticoagulant",
"     </li>",
"     <li>",
"      Antibody to anticentromere B or topoisomerase, in patients with nucleolar pattern of ANA and with symptoms of overlap with systemic sclerosis",
"     </li>",
"     <li>",
"      Antineutrophil cytoplasmic antibody (ANCA), in patients with evidence of vasculitis",
"     </li>",
"     <li>",
"      Antibodies to double-stranded DNA, in patients with proteinuria",
"     </li>",
"     <li>",
"      Serum C3 and C4",
"     </li>",
"     <li>",
"      Serum cryoglobulins",
"     </li>",
"     <li>",
"      Serum and urine protein electrophoresis with immune electrophoresis",
"     </li>",
"     <li>",
"      Quantitative immunoglobulin levels (IgG, IgM, IgA)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Additional tests include those aimed at conditions that may complicate SS itself or that may mimic some of the disease manifestations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Testing for hepatitis C virus, HIV, and HTLV-1, which are indicated in the setting of risk factors for these infections",
"     </li>",
"     <li>",
"      Testing for leprosy (skin biopsy) or extraglandular manifestations of tuberculosis. We have found quantitative tuberculin blood testing to be useful in patients who are anergic on routine skin tests or who have had prior Bacillus Calmette-Guerin (BCG)",
"     </li>",
"     <li>",
"      MR with fat suppression, particularly if there is unilateral salivary gland enlargement. Gadolinium contrast should be avoided in patients with moderate to severe kidney disease. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Magnetic resonance imaging'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A plain radiograph of the chest and high resolution chest computerized tomography (CT) scan, if there is evidence of interstitial pneumonitis, hilar adenopathy, or pulmonary emboli",
"     </li>",
"     <li>",
"      Minor salivary gland biopsy (see",
"      <a class=\"local\" href=\"#H20\">",
"       'Salivary gland biopsy'",
"      </a>",
"      above)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is important to remember that not all immune disorders fit into a simple diagnostic &ldquo;box&rdquo; and that overlap syndromes may occur in patients with features of SS and SLE or of SS and scleroderma, and these should be considered in the course of evaluation. However, it is important to distinguish primary SS from SLE because of the different array of clinical problems that these conditions respectively pose. Further, a &ldquo;false positive&rdquo; ANA and even",
"    <span class=\"nowrap\">",
"     Ro/SSA",
"    </span>",
"    may accompany infectious diseases (ranging from hepatitis C to leprosy) and paraneoplastic processes.",
"   </p>",
"   <p>",
"    The differential diagnosis of SS involves consideration of diseases that cause similar symptoms",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    salivary or lacrimal gland swelling (",
"    <a class=\"graphic graphic_table graphicRef77821 \" href=\"UTD.htm?37/39/38524\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Causes of ocular dryness and pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms of ocular dryness may be caused by many diseases and disorders. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypovitaminosis A [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/65\">",
"       65",
"      </a>",
"      ], since mucin production is decreased by vitamin A deficiency [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/7,70\">",
"       7,70",
"      </a>",
"      ] (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/14/21736?source=see_link\">",
"       \"Overview of vitamin A\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Decreased tear production by major and minor lacrimal glands unrelated to an autoimmune process, which may lead to increased tear viscosity and to symptoms of dryness [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/71\">",
"       71",
"      </a>",
"      ]. This may result from secondary inflammation of the ocular surface as a form of desiccative stress of the conjunctiva [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/72\">",
"       72",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Chronic blepharitis or conjunctivitis, often in association with rosacea, which may cause a foreign body sensation and burning. Meibomian gland dysfunction leads to decreased lipid production, to increased evaporative rate, and to instability of the tear film [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/65,73\">",
"       65,73",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/46/36584?source=see_link\">",
"       \"Rosacea: Pathogenesis, clinical features, and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Impaired blinking due to trauma or neurologic disorders (eg, Parkinson disease, Bell&rsquo;s palsy). The blink reflex determines the efficiency of delivery of available tears to the conjunctiva and normally decreases with aging [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/74,75\">",
"       74,75",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Dry eye symptoms, which are common among office workers who work for hours at computer monitors [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/76,77\">",
"       76,77",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Infiltration of the lacrimal glands (eg, amyloidosis, sarcoidosis, lymphoma, IgG4-related systemic disease) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/55/13178?source=see_link&amp;anchor=H16601951#H16601951\">",
"       \"Overview of IgG4-related disease\", section on 'Salivary and lacrimal gland involvement'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Low estrogen levels, as occur in postmenopausal women [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/78,79\">",
"       78,79",
"      </a>",
"      ] (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/23/32122?source=see_link&amp;anchor=H43#H43\">",
"       \"Postmenopausal hormone therapy: Benefits and risks\", section on 'Dry eye syndrome'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Medications with anticholinergic side effects",
"     </li>",
"     <li>",
"      Herpetic ocular lesions (simplex or zoster), especially if symptoms are sudden in onset and are unilateral",
"     </li>",
"     <li>",
"      Corneal abrasions",
"     </li>",
"     <li>",
"      Prior keratoplasty by either photorefractive keratectomy (PRK) or laser-assisted in situ keratomileusis (LASIK) methods",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Causes of oral dryness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Causes of symptomatic oral dryness include (",
"    <a class=\"graphic graphic_table graphicRef77821 \" href=\"UTD.htm?37/39/38524\">",
"     table 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Medications with anticholinergic effects (eg, tricyclic and other antidepressants; antihistamines; certain antiarrhythmic and blood pressure medications; and certain antiepileptic drugs)",
"     </li>",
"     <li>",
"      Sialadenitis due to chronic obstruction (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/2/22568?source=see_link&amp;anchor=H13#H13\">",
"       \"Salivary gland stones\", section on 'Chronic obstruction'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Chronic viral infections, particularly hepatitis C virus and HIV (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/2/22568?source=see_link&amp;anchor=H24#H24\">",
"       \"Salivary gland stones\", section on 'Human immunodeficiency virus'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/8/15498?source=see_link&amp;anchor=H10#H10\">",
"       \"Extrahepatic manifestations of hepatitis C virus infection\", section on 'Sialadenitis'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Irradiation, as with therapy for head and neck cancer (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/1/22554?source=see_link&amp;anchor=H7#H7\">",
"       \"Management and prevention of complications of head and neck cancer during initial treatment\", section on 'Salivary gland damage and xerostomia'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      IgG4-related disease (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/55/13178?source=see_link&amp;anchor=H16601951#H16601951\">",
"       \"Overview of IgG4-related disease\", section on 'Salivary and lacrimal gland involvement'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Causes of salivary gland swelling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unilateral and bilateral salivary gland swelling generally have different causes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h3\">",
"     Unilateral swelling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unilateral swelling of a parotid or minor salivary gland suggests one of the following disorders that may complicate SS or that may be unrelated:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute or chronic bacterial infection, which typically occurs in association with obstruction of the ductal system or with low salivary flow rates. Acute bacterial sialadenitis is typically painful and is associated with fever and tenderness over the affected gland. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/2/22568?source=see_link&amp;anchor=H22#H22\">",
"       \"Salivary gland stones\", section on 'Acute bacterial sialadenitis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Neoplasms of the salivary glands, which may include adenomas, carcinomas, lymphomas, and tumors of mixed cell types (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/44/9927?source=see_link\">",
"       \"Salivary gland tumors: Epidemiology, diagnosis, evaluation, and staging\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      IgG4-related disease, which may present with unilateral or bilateral glandular swelling (see",
"      <a class=\"local\" href=\"#H3\">",
"       'Mikulicz syndrome and IgG4-related disease'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/55/13178?source=see_link\">",
"       \"Overview of IgG4-related disease\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Actinomycosis [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/80\">",
"       80",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h3\">",
"     Bilateral salivary gland swelling",
"    </span>",
"    &nbsp;&mdash;&nbsp;The causes of bilateral swelling include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute viral infection (eg, mumps, coxsackie, echovirus, and Epstein-Barr viral infection) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/2/22568?source=see_link&amp;anchor=H21#H21\">",
"       \"Salivary gland stones\", section on 'Viral sialadenitis'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Chronic viral infections (eg, hepatitis C virus and HIV) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/8/15498?source=see_link&amp;anchor=H10#H10\">",
"       \"Extrahepatic manifestations of hepatitis C virus infection\", section on 'Sialadenitis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/2/22568?source=see_link&amp;anchor=H24#H24\">",
"       \"Salivary gland stones\", section on 'Human immunodeficiency virus'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Granulomatous diseases, such as sarcoidosis and tuberculosis [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/81,82\">",
"       81,82",
"      </a>",
"      ] (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21914?source=see_link&amp;anchor=H24#H24\">",
"       \"Clinical manifestations and diagnosis of sarcoidosis\", section on 'Exocrine glands'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Malnutrition and alcoholism [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/83\">",
"       83",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Eating disorders, such as bulimia [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/84,85\">",
"       84,85",
"      </a>",
"      ] (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/2/23593?source=see_link\">",
"       \"Eating disorders: Epidemiology, pathogenesis, clinical features, and course of illness\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Acromegaly [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/86,87\">",
"       86,87",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Diabetes mellitus [",
"      <a class=\"abstract\" href=\"UTD.htm?18/22/18794/abstract/83\">",
"       83",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      IgG4-related disease (see",
"      <a class=\"local\" href=\"#H3\">",
"       'Mikulicz syndrome and IgG4-related disease'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/55/13178?source=see_link\">",
"       \"Overview of IgG4-related disease\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here is the patient education article that is relevant to this topic. We encourage you to print or e-mail this topic to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?0/34/547?source=see_link\">",
"       \"Patient information: Sj&ouml;gren&rsquo;s syndrome (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?43/11/44212?source=see_link\">",
"       \"Patient information: Sj&ouml;gren&rsquo;s syndrome (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ends of the clinical spectrum of SS are extremely diverse:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      At the severe end are patients with florid salivary gland enlargement, adenopathy, antibodies to the",
"      <span class=\"nowrap\">",
"       Ro/SSA",
"      </span>",
"      and",
"      <span class=\"nowrap\">",
"       La/SSB",
"      </span>",
"      antigens, cryoglobulinemia, hypocomplementemia, a propensity to develop non-Hodgkin lymphoma, and other extraglandular disease manifestations.",
"     </li>",
"     <li>",
"      At the mild end are patients with moderate symptoms of dry eyes, dry mouth, a low titer positive antinuclear antibody, and vague symptoms of fatigue, myalgias, and cognitive dysfunction. In many patients with mild disease, distinguishing SS patients from individuals with fibromyalgia or depression who have ocular",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      oral dryness caused or exacerbated by medications with anticholinergic side effects is a major challenge.",
"     </li>",
"     <li>",
"      The prevalence estimates of SS range as high as nearly 5 percent, depending upon the disease definitions or classification criteria employed. In some studies, a high percentage of patients with SS are asymptomatic or undiagnosed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The evaluation of SS may consist of the following types of tests:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tests to confirm keratoconjunctivitis sicca (see",
"      <a class=\"local\" href=\"#H11\">",
"       'Tests for KCS'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Tests to quantify xerostomia (see",
"      <a class=\"local\" href=\"#H15\">",
"       'Quantifying xerostomia'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Salivary gland biopsy (see",
"      <a class=\"local\" href=\"#H20\">",
"       'Salivary gland biopsy'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Serologic testing for antibodies to",
"      <span class=\"nowrap\">",
"       Ro/SSA",
"      </span>",
"      and",
"      <span class=\"nowrap\">",
"       La/SSB",
"      </span>",
"      (see",
"      <a class=\"local\" href=\"#H21\">",
"       'Antibodies to Ro/SSA and La/SSB'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Magnetic resonance imaging (see",
"      <a class=\"local\" href=\"#H22\">",
"       'Magnetic resonance imaging'",
"      </a>",
"      above)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Consensus criteria for the purpose of the classification of SS and the division of SS patients into primary and secondary SS categories have been published. These are known as the American-European Consensus Group classification criteria. Additional criteria for SS have been proposed by the American College of Rheumatology and the Sj&ouml;gren&rsquo;s International Collaborative Clinical Alliance. (See",
"    <a class=\"local\" href=\"#H23\">",
"     'Classification criteria'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    For the clinical evaluation of patients with possible SS, the following work-up is reasonable:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Schirmer test (see",
"      <a class=\"local\" href=\"#H12\">",
"       'Schirmer test'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Rose Bengal test (see",
"      <a class=\"local\" href=\"#H13\">",
"       'Rose Bengal test'",
"      </a>",
"      above)",
"     </li>",
"     <li>",
"      Basic laboratory testing, including:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Complete blood count with differential",
"     </li>",
"     <li>",
"      Serum electrolytes and liver function",
"     </li>",
"     <li>",
"      Erythrocyte sedimentation rate",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      C-reactive protein",
"     </li>",
"     <li>",
"      Urinalysis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Specialized laboratory testing, which should include assays for the following to assess for both SS and underlying connective tissue disorders that may be associated with SS:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Antinuclear antibodies",
"     </li>",
"     <li>",
"      Rheumatoid factor",
"     </li>",
"     <li>",
"      Antibodies to the",
"      <span class=\"nowrap\">",
"       Ro/SSA,",
"      </span>",
"      <span class=\"nowrap\">",
"       La/SSB,",
"      </span>",
"      Sm, and RNP antigens",
"     </li>",
"     <li>",
"      Antibodies to cardiolipin and lupus anticoagulant",
"     </li>",
"     <li>",
"      Serum C3 and C4",
"     </li>",
"     <li>",
"      Serum and urine protein electrophoresis with immune electrophoresis",
"     </li>",
"     <li>",
"      Quantitative immunoglobulin levels (IgG, IgM, IgA)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Testing for hepatitis C virus and the human immunodeficiency virus, which are indicated in the setting of risk factors for these infections",
"     </li>",
"     <li>",
"      MR with fat suppression, particularly if there is unilateral salivary gland enlargement",
"     </li>",
"     <li>",
"      A plain radiograph of the chest",
"     </li>",
"     <li>",
"      Minor salivary gland biopsy (see",
"      <a class=\"local\" href=\"#H20\">",
"       'Salivary gland biopsy'",
"      </a>",
"      above)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Tests designed to quantify the degree of xerostomia are generally reserved for research settings.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/1\">",
"      Ramos-Casals M, Tzioufas AG, Font J. Primary Sj&ouml;gren's syndrome: new clinical and therapeutic concepts. Ann Rheum Dis 2005; 64:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/2\">",
"      Pertovaara M, Korpela M, Uusitalo H, et al. Clinical follow up study of 87 patients with sicca symptoms (dryness of eyes or mouth, or both). Ann Rheum Dis 1999; 58:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/3\">",
"      Asmussen K, Andersen V, Bendixen G, et al. A new model for classification of disease manifestations in primary Sj&ouml;gren's syndrome: evaluation in a retrospective long-term study. J Intern Med 1996; 239:475.",
"     </a>",
"    </li>",
"    <li>",
"     Mikulicz JH. Uber eine eigenartige symmetrische Erkrankung der Tranen- und Mundspeicheldrusen. In: Beitr. Chir. Fortschr, Billroth GT (Ed), Stuttgart, 1892. p.610.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/5\">",
"      Ihrler S, Harrison JD. Mikulicz's disease and Mikulicz's syndrome: analysis of the original case report of 1892 in the light of current knowledge identifies a MALT lymphoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 100:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/6\">",
"      Sj&ouml;gren H. Zur Kenntnis der Keratoconjunctivitis sicca. Acta Ophthalomol 1933; 11(suppl II):1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/7\">",
"      Behrens A, Doyle JJ, Stern L, et al. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea 2006; 25:900.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/8\">",
"      Pillemer SR, Matteson EL, Jacobsson LT, et al. Incidence of physician-diagnosed primary Sj&ouml;gren syndrome in residents of Olmsted County, Minnesota. Mayo Clin Proc 2001; 76:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/9\">",
"      Thomas E, Hay EM, Hajeer A, Silman AJ. Sj&ouml;gren's syndrome: a community-based study of prevalence and impact. Br J Rheumatol 1998; 37:1069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/10\">",
"      Jacobsson LT, Axell TE, Hansen BU, et al. Dry eyes or mouth--an epidemiological study in Swedish adults, with special reference to primary Sj&ouml;gren's syndrome. J Autoimmun 1989; 2:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/11\">",
"      Drosos AA, Andonopoulos AP, Costopoulos JS, et al. Prevalence of primary Sj&ouml;gren's syndrome in an elderly population. Br J Rheumatol 1988; 27:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/12\">",
"      S&aacute;nchez-Guerrero J, P&eacute;rez-Dosal MR, C&aacute;rdenas-Vel&aacute;zquez F, et al. Prevalence of Sj&ouml;gren's syndrome in ambulatory patients according to the American-European Consensus Group criteria. Rheumatology (Oxford) 2005; 44:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/13\">",
"      Liew MS, Zhang M, Kim E, Akpek EK. Prevalence and predictors of Sjogren's syndrome in a prospective cohort of patients with aqueous-deficient dry eye. Br J Ophthalmol 2012; 96:1498.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/14\">",
"      Strickland RW, Tesar JT, Berne BH, et al. The frequency of sicca syndrome in an elderly female population. J Rheumatol 1987; 14:766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/15\">",
"      Schein OD, Hochberg MC, Mu&ntilde;oz B, et al. Dry eye and dry mouth in the elderly: a population-based assessment. Arch Intern Med 1999; 159:1359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/16\">",
"      Hochberg MC, Tielsch J, Munoz B, et al. Prevalence of symptoms of dry mouth and their relationship to saliva production in community dwelling elderly: the SEE project. Salisbury Eye Evaluation. J Rheumatol 1998; 25:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/17\">",
"      Kang HI, Fei HM, Saito I, et al. Comparison of HLA class II genes in Caucasoid, Chinese, and Japanese patients with primary Sj&ouml;gren's syndrome. J Immunol 1993; 150:3615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/18\">",
"      Vitali C, Bombardieri S, Moutsopoulos HM, et al. Preliminary criteria for the classification of Sj&ouml;gren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993; 36:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/19\">",
"      Afonso AA, Monroy D, Stern ME, et al. Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms. Ophthalmology 1999; 106:803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/20\">",
"      Tsubota K. Tear dynamics and dry eye. Prog Retin Eye Res 1998; 17:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/21\">",
"      van Bijsterveld OP. Diagnostic tests in the Sicca syndrome. Arch Ophthalmol 1969; 82:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/22\">",
"      Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sj&ouml;gren syndrome. Arch Intern Med 2004; 164:1275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/23\">",
"      de Paiva CS, Pflugfelder SC. Tear clearance implications for ocular surface health. Exp Eye Res 2004; 78:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/24\">",
"      Aung W, Yamada I, Umehara I, et al. Sj&ouml;gren's syndrome: comparison of assessments with quantitative salivary gland scintigraphy and contrast sialography. J Nucl Med 2000; 41:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/25\">",
"      Hermann GA, Vivino FB, Goin JE. Scintigraphic features of chronic sialadenitis and Sj&ouml;gren's syndrome: a comparison. Nucl Med Commun 1999; 20:1123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/26\">",
"      Kalk WW, Vissink A, Spijkervet FK, et al. Morbidity from parotid sialography. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 92:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/27\">",
"      Daniels TE, Benn DK. Is sialography effective in diagnosing the salivary component of Sj&ouml;gren's syndrome? Adv Dent Res 1996; 10:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/28\">",
"      Hu S, Wang J, Meijer J, et al. Salivary proteomic and genomic biomarkers for primary Sj&ouml;gren's syndrome. Arthritis Rheum 2007; 56:3588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/29\">",
"      Giusti L, Baldini C, Bazzichi L, et al. Proteome analysis of whole saliva: a new tool for rheumatic diseases--the example of Sj&ouml;gren's syndrome. Proteomics 2007; 7:1634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/30\">",
"      Barone F, Bombardieri M, Rosado MM, et al. CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren's syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization. J Immunol 2008; 180:5130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/31\">",
"      Haldorsen K, Moen K, Jacobsen H, et al. Exocrine function in primary Sj&ouml;gren syndrome: natural course and prognostic factors. Ann Rheum Dis 2008; 67:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/32\">",
"      Porola P, Virkki L, Przybyla BD, et al. Androgen deficiency and defective intracrine processing of dehydroepiandrosterone in salivary glands in Sj&ouml;gren's syndrome. J Rheumatol 2008; 35:2229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/33\">",
"      Laine M, Porola P, Udby L, et al. Low salivary dehydroepiandrosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sj&ouml;gren's syndrome. Arthritis Rheum 2007; 56:2575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/34\">",
"      Peluso G, De Santis M, Inzitari R, et al. Proteomic study of salivary peptides and proteins in patients with Sj&ouml;gren's syndrome before and after pilocarpine treatment. Arthritis Rheum 2007; 56:2216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/35\">",
"      Kohler PF, Winter ME. A quantitative test for xerostomia. The Saxon test, an oral equivalent of the Schirmer test. Arthritis Rheum 1985; 28:1128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/36\">",
"      Lee M, Rutka JA, Slomovic AR, et al. Establishing guidelines for the role of minor salivary gland biopsy in clinical practice for Sj&ouml;gren's syndrome. J Rheumatol 1998; 25:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/37\">",
"      Daniels TE, Fox PC. Salivary and oral components of Sj&ouml;gren's syndrome. Rheum Dis Clin North Am 1992; 18:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/38\">",
"      Greenspan JS, Daniels TE, Talal N, Sylvester RA. The histopathology of Sj&ouml;gren's syndrome in labial salivary gland biopsies. Oral Surg Oral Med Oral Pathol 1974; 37:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/39\">",
"      Daniels TE, Whitcher JP. Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sj&ouml;gren's syndrome. Arthritis Rheum 1994; 37:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/40\">",
"      Vivino FB, Gala I, Hermann GA. Change in final diagnosis on second evaluation of labial minor salivary gland biopsies. J Rheumatol 2002; 29:938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/41\">",
"      Radfar L, Kleiner DE, Fox PC, Pillemer SR. Prevalence and clinical significance of lymphocytic foci in minor salivary glands of healthy volunteers. Arthritis Rheum 2002; 47:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/42\">",
"      Morbini P, Manzo A, Caporali R, et al. Multilevel examination of minor salivary gland biopsy for Sjogren's syndrome significantly improves diagnostic performance of AECG classification criteria. Arthritis Res Ther 2005; 7:R343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/43\">",
"      Daniels TE. Labial salivary gland biopsy in Sj&ouml;gren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 1984; 27:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/44\">",
"      Brennan MT, Sankar V, Leakan RA, et al. Risk factors for positive minor salivary gland biopsy findings in Sj&ouml;gren's syndrome and dry mouth patients. Arthritis Rheum 2002; 47:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/45\">",
"      Tan EM. Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. Adv Immunol 1982; 33:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/46\">",
"      Tan EM, Feltkamp TE, Smolen JS, et al. Range of antinuclear antibodies in \"healthy\" individuals. Arthritis Rheum 1997; 40:1601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/47\">",
"      Tan EM, Smolen JS, McDougal JS, et al. A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity. Arthritis Rheum 1999; 42:455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/48\">",
"      Stone JH, Caruso PA, Deshpande V. Case records of the Massachusetts General Hospital. Case 24-2009. A 26-year-old woman with painful swelling of the neck. N Engl J Med 2009; 361:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/49\">",
"      Chan EK, Tan EM, Ward DC, Matera AG. Human 60-kDa SS-A/Ro ribonucleoprotein autoantigen gene (SSA2) localized to 1q31 by fluorescence in situ hybridization. Genomics 1994; 23:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/50\">",
"      Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989; 44:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/51\">",
"      Ben-Chetrit E, Chan EK, Sullivan KF, Tan EM. A 52-kD protein is a novel component of the SS-A/Ro antigenic particle. J Exp Med 1988; 167:1560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/52\">",
"      Arnett FC. Histocompatibility typing in the rheumatic diseases. Diagnostic and prognostic implications. Rheum Dis Clin North Am 1994; 20:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/53\">",
"      Harley JB, Sestak AL, Willis LG, et al. A model for disease heterogeneity in systemic lupus erythematosus. Relationships between histocompatibility antigens, autoantibodies, and lymphopenia or renal disease. Arthritis Rheum 1989; 32:826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/54\">",
"      Jungeh&uuml;lsing M, Fischbach R, Schr&ouml;der U, et al. Magnetic resonance sialography. Otolaryngol Head Neck Surg 1999; 121:488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/55\">",
"      Tonami H, Ogawa Y, Matoba M, et al. MR sialography in patients with Sj&ouml;gren syndrome. AJNR Am J Neuroradiol 1998; 19:1199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/56\">",
"      Heverhagen JT, Kalinowski M, Rehberg E, et al. Prospective comparison of magnetic resonance sialography and digital subtraction sialography. J Magn Reson Imaging 2000; 11:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/57\">",
"      Eracleous E, Kallis S, Tziakouri C, et al. Sonography, CT, CT sialography, MRI and MRI sialography in investigation of the facial nerve and the differentiation between deep and superficial parotid lesions. Neuroradiology 1997; 39:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/58\">",
"      Niemel&auml; RK, Takalo R, P&auml;&auml;kk&ouml; E, et al. Ultrasonography of salivary glands in primary Sjogren's syndrome. A comparison with magnetic resonance imaging and magnetic resonance sialography of parotid glands. Rheumatology (Oxford) 2004; 43:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/59\">",
"      Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sj&ouml;gren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61:554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/60\">",
"      Vitali C. Classification criteria for Sj&ouml;gren's syndrome. Ann Rheum Dis 2003; 62:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/61\">",
"      Fox RI. Sj&ouml;gren's syndrome. Controversies and progress. Clin Lab Med 1997; 17:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/62\">",
"      Vitali C, Moutsopoulos HM, Bombardieri S. The European Community Study Group on diagnostic criteria for Sj&ouml;gren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sj&ouml;gren's syndrome. Ann Rheum Dis 1994; 53:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/63\">",
"      Vitali C, Bombardieri S. The European classification criteria for Sj&ouml;gren's syndrome (SS): proposal for modification of the rules for classification suggested by the analysis of the receiver operating characteristic (ROCS) curve of the criteria performance. J Rheum 1997; 24:S18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/64\">",
"      Pillemer SR, Smith J, Fox PC, Bowman SJ. Outcome measures for Sj&ouml;gren's syndrome, April 10-11, 2003, Bethesda, Maryland, USA. J Rheumatol 2005; 32:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/65\">",
"      Bowman SJ. Collaborative research into outcome measures in Sj&ouml;gren's syndrome. Update on disease assessment. Scand J Rheumatol Suppl 2002; 116:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/66\">",
"      Bowman SJ, Booth DA, Platts RG, et al. Validation of the Sicca Symptoms Inventory for clinical studies of Sj&ouml;gren's syndrome. J Rheumatol 2003; 30:1259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/67\">",
"      Shiboski SC, Shiboski CH, Criswell L, et al. American College of Rheumatology classification criteria for Sj&ouml;gren's syndrome: a data-driven, expert consensus approach in the Sj&ouml;gren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken) 2012; 64:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/68\">",
"      Cacoub P, Renou C, Rosenthal E, et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine (Baltimore) 2000; 79:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/69\">",
"      Theander E, Jacobsson LT. Relationship of Sj&ouml;gren's syndrome to other connective tissue and autoimmune disorders. Rheum Dis Clin North Am 2008; 34:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/70\">",
"      Corrales RM, Stern ME, De Paiva CS, et al. Desiccating stress stimulates expression of matrix metalloproteinases by the corneal epithelium. Invest Ophthalmol Vis Sci 2006; 47:3293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/71\">",
"      Tiffany JM. The viscosity of human tears. Int Ophthalmol 1991; 15:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/72\">",
"      Niederkorn JY, Stern ME, Pflugfelder SC, et al. Desiccating stress induces T cell-mediated Sj&ouml;gren's Syndrome-like lacrimal keratoconjunctivitis. J Immunol 2006; 176:3950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/73\">",
"      Begley CG, Himebaugh N, Renner D, et al. Tear breakup dynamics: a technique for quantifying tear film instability. Optom Vis Sci 2006; 83:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/74\">",
"      Nakamori K, Odawara M, Nakajima T, et al. Blinking is controlled primarily by ocular surface conditions. Am J Ophthalmol 1997; 124:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/75\">",
"      Peshori KR, Schicatano EJ, Gopalaswamy R, et al. Aging of the trigeminal blink system. Exp Brain Res 2001; 136:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/76\">",
"      Wolkoff P, N&oslash;jgaard JK, Franck C, Skov P. The modern office environment desiccates the eyes? Indoor Air 2006; 16:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/77\">",
"      Sheedy JE, Gowrisankaran S, Hayes JR. Blink rate decreases with eyelid squint. Optom Vis Sci 2005; 82:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/78\">",
"      Erdem U, Ozdegirmenci O, Sobaci E, et al. Dry eye in post-menopausal women using hormone replacement therapy. Maturitas 2007; 56:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/79\">",
"      Uncu G, Avci R, Uncu Y, et al. The effects of different hormone replacement therapy regimens on tear function, intraocular pressure and lens opacity. Gynecol Endocrinol 2006; 22:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/80\">",
"      Hensher R, Bowerman J. Actinomycosis of the parotid gland. Br J Oral Maxillofac Surg 1985; 23:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/81\">",
"      Janmeja AK, Das SK, Kochhar S, Handa U. Tuberculosis of the parotid gland. Indian J Chest Dis Allied Sci 2003; 45:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/82\">",
"      Ramos-Casals M, Brito-Zer&oacute;n P, Garc&iacute;a-Carrasco M, Font J. Sarcoidosis or Sj&ouml;gren syndrome? Clues to defining mimicry or coexistence in 59 cases. Medicine (Baltimore) 2004; 83:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/83\">",
"      Kim D, Uy C, Mandel L. Sialosis of unknown origin. N Y State Dent J 1998; 64:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/84\">",
"      Buchanan JA, Fortune F. Bilateral parotid enlargement as a presenting feature of bulimia nervosa in a post-adolescent male. Postgrad Med J 1994; 70:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/85\">",
"      Vavrina J, M&uuml;ller W, Gebbers JO. Enlargement of salivary glands in bulimia. J Laryngol Otol 1994; 108:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/86\">",
"      Manetti L, Bogazzi F, Brogioni S, et al. Submandibular salivary gland volume is increased in patients with acromegaly. Clin Endocrinol (Oxf) 2002; 57:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/22/18794/abstract/87\">",
"      Thomson JA, McCrossan J, Mason DK. Salivary gland enlargement in acromegaly. Clin Endocrinol (Oxf) 1974; 3:1.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5603 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-183.166.191.243-37B631BF3D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_22_18794=[""].join("\n");
var outline_f18_22_18794=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H41\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      NOMENCLATURE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Mikulicz syndrome and IgG4-related disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Keratoconjunctivitis sicca",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Dysfunctional tear syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H720851742\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H720851749\">",
"      Sj&ouml;gren's syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H720851756\">",
"      Dry eye in older adults",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H720851763\">",
"      Geographic distribution",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      MEDICAL HISTORY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Ocular symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Oral symptoms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DIAGNOSTIC TESTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Tests for KCS",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Schirmer test",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Rose Bengal test",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Tear break-up time",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Quantifying xerostomia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Salivary gland scintigraphy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Parotid gland sialography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Whole sialometry",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Saxon test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Salivary gland biopsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18785486\">",
"      Laboratory variation in measurement of ANA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Antibodies to Ro/SSA and La/SSB",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      CLASSIFICATION CRITERIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H202391358\">",
"      American-European Consensus Group criteria for SS",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Criteria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Exclusion criteria",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Primary SS",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Secondary SS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26379282\">",
"      ACR classification criteria for SS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Recommendations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Causes of ocular dryness and pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Causes of oral dryness",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Causes of salivary gland swelling",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      - Unilateral swelling",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      - Bilateral salivary gland swelling",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H41\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"RHEUM/5603\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/5603|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?37/53/38751\" title=\"figure 1\">",
"      Classification tree Sjogren",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/5603|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/17/17695\" title=\"picture 1\">",
"      Rose Bengal stain in Sjogrens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/10/17577\" title=\"picture 2\">",
"      Lip gland biopsy in Sjogrens",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/5603|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?32/33/33308\" title=\"table 1\">",
"      Revised internat criteria SS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/39/38524\" title=\"table 2\">",
"      Differential dx Sjogrens synd",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/14/40168?source=related_link\">",
"      Autoimmune pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21914?source=related_link\">",
"      Clinical manifestations and diagnosis of sarcoidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/1/11287?source=related_link\">",
"      Clinical manifestations of Sj&ouml;gren's syndrome: Exocrine gland disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/42/27306?source=related_link\">",
"      Clinical manifestations of Sj&ouml;gren's syndrome: Extraglandular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/2/23593?source=related_link\">",
"      Eating disorders: Epidemiology, pathogenesis, clinical features, and course of illness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/8/15498?source=related_link\">",
"      Extrahepatic manifestations of hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/1/22554?source=related_link\">",
"      Management and prevention of complications of head and neck cancer during initial treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/22/31082?source=related_link\">",
"      Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy in advanced renal failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/55/13178?source=related_link\">",
"      Overview of IgG4-related disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/14/21736?source=related_link\">",
"      Overview of vitamin A",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/36/25162?source=related_link\">",
"      Pathogenesis of Sj&ouml;gren's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?43/11/44212?source=related_link\">",
"      Patient information: Sj&ouml;gren&rsquo;s syndrome (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?0/34/547?source=related_link\">",
"      Patient information: Sj&ouml;gren&rsquo;s syndrome (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/23/32122?source=related_link\">",
"      Postmenopausal hormone therapy: Benefits and risks",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/46/36584?source=related_link\">",
"      Rosacea: Pathogenesis, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/2/22568?source=related_link\">",
"      Salivary gland stones",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/44/9927?source=related_link\">",
"      Salivary gland tumors: Epidemiology, diagnosis, evaluation, and staging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/23/8568?source=related_link\">",
"      The anti-Ro/SSA and anti-La/SSB antigen-antibody systems",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/12/26826?source=related_link\">",
"      Treatment of dry eyes in Sj&ouml;gren's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/57/36762?source=related_link\">",
"      Treatment of dry mouth and other non-ocular sicca symptoms in Sj&ouml;gren's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/14/2282?source=related_link\">",
"      Treatment of systemic and extraglandular manifestations of Sj&ouml;gren&rsquo;s syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_22_18795="Utility of cardiac MRI";
var content_f18_22_18795=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F79652&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F79652&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Advantages and disadvantages of cardiac MRI",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Advantages",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Three-dimensional",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        High spatial and temporal resolution",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intrinsic high contrast; no need for iodinated contrast",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No ionizing radiation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No interference from lung or bone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Multiple imaging techniques in a single system",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Disadvantages",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Contraindicated with certain medical implants such as aneurysm clips, TENS units, and certain pacemakers",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acquisition time can be lengthy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Electrocardiogram can be distorted by the magnetic field interfering with monitoring of acutely ill patients",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Requires ECG and respiratory gating",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Claustrophobia",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_22_18795=[""].join("\n");
var outline_f18_22_18795=null;
var title_f18_22_18796="Etiology long term problems";
var content_f18_22_18796=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F63506&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F63506&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Environmental and occupational causes of health problems: latent or long-term effects",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Latent or long-term effects",
"       </td>",
"       <td class=\"subtitle1\">",
"        Agent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Potential exposures",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"3\" rowspan=\"1\">",
"        Chronic dyspnea",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Pulmonary fibrosis",
"       </td>",
"       <td class=\"sublist_other\">",
"        Asbestos, silica, beryllium, coal, aluminum, nylon flock",
"       </td>",
"       <td class=\"sublist_other\">",
"        Mining, insulation, pipefitting, sandblasting,",
"quarrying, metal alloy work, aircraft or electrical parts nylon",
"flocking industry",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Chronic bronchitis, emphysema",
"       </td>",
"       <td class=\"sublist_other\">",
"        Cotton dust, cadmium coal dust, organic solvents,",
"cigarettes",
"       </td>",
"       <td class=\"sublist_other\">",
"        Textile industry, battery production, soldering,",
"mining, solvent use",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lung cancer",
"       </td>",
"       <td>",
"        Asbestos, arsenic, uranium, coke oven emission",
"       </td>",
"       <td>",
"        Insulation, pipefitting, smelting, coke ovens, shipyard",
"work, nickel refining, uranium mining",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bladder cancer",
"       </td>",
"       <td>",
"        &beta;-Naphthylamine, benzidine dyes",
"       </td>",
"       <td>",
"        Dye industry, leather, rubber working, chemists",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Peripheral neuropathy",
"       </td>",
"       <td>",
"        Lead, arsenic, n-hexane, methyl butylketone, acrylamide",
"       </td>",
"       <td>",
"        Battery production, plumbing, smelting, painting,",
"shoemaking, solvent use, insecticides",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Behavioral changes",
"       </td>",
"       <td>",
"        Lead, carbon disulfide, manganese",
"       </td>",
"       <td>",
"        Battery makers, smelting, viscose rayon industry,",
"degreasing, manufacture/repair of scientific instruments, dental",
"amalgam work, mining, ceramics",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Extrapyramidal syndrome",
"       </td>",
"       <td>",
"        Carbon disulfide, manganese",
"       </td>",
"       <td>",
"        Viscose rayon industry, steel production, battery",
"production, foundry, mining",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Aplastic anemia, leukemia",
"       </td>",
"       <td>",
"        Benzene, ionizing radiation",
"       </td>",
"       <td>",
"        Chemists, furniture refinishing, cleaning, degreasing,",
"radiation work",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Goldman RH, Peters JM. JAMA 1981; 246:2831.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_22_18796=[""].join("\n");
var outline_f18_22_18796=null;
var title_f18_22_18797="Linear scleroderma";
var content_f18_22_18797=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F78212&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F78212&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Linear scleroderma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 209px; height: 178px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The longitudinal bands of linear scleroderma resulting in atrophy of soft tissue and muscle.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_22_18797=[""].join("\n");
var outline_f18_22_18797=null;
var title_f18_22_18798="Contents: Patient Information";
var content_f18_22_18798=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      Patient Information",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     <strong>",
"      Patient Information",
"     </strong>",
"    </a>",
"    <ul>",
"     <li>",
"      <a href=\"UTD.htm?43/17/44314\">",
"       The Basics",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"UTD.htm?37/29/38362\">",
"       Beyond the Basics",
"      </a>",
"     </li>",
"    </ul>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Patient Information",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <p>",
"      UpToDate provides hundreds of patient information topics, allowing patients and ",
"healthcare providers to share in the decision making process. To view a list of ",
"available topics, click on the appropriate health category below or visit",
"      <a href=\"/home/uptodate-benefits-patients\">",
"       www.uptodate.com/patients",
"      </a>",
"     </p>",
"     <p>",
"      You can also find patient information topics through the normal ",
"search mechanism (e.g., search \"patient info asthma\"). All patient information topics can ",
"be printed or emailed.",
"      <br/>",
"      <br/>",
"      <a href=\"/home/patient-information\">",
"       Learn more about our patient information.",
"      </a>",
"      <br/>",
"      <br/>",
"      <a href=\"/home/md-referral-program\">",
"       Learn about our free patient education tools for your practice.",
"      </a>",
"     </p>",
"     <br/>",
"     <p>",
"      To view a list of all available topics, click on the appropriate health category below.",
"     </p>",
"     <br/>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds valign=\"top\" width=\"33%\">",
"        <a class=\"tocItem\" href=\"UTD.htm?4/15/4351\">",
"         Allergies and asthma",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?34/20/35150\">",
"         Arthritis",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?35/54/36718\">",
"         Autoimmune disease",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?9/13/9439\">",
"         Blood disorders",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?9/42/9889\">",
"         Bones, joints, and muscles",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?2/46/2784\">",
"         Brain and nerves",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?21/9/21650\">",
"         Cancer",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?3/55/3957\">",
"         Children's health",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?10/1/10271\">",
"         Diabetes",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?17/63/18430\">",
"         Diet and weight",
"        </a>",
"        <br/>",
"       </tds>",
"       <tds valign=\"top\" width=\"33%\">",
"        <a class=\"tocItem\" href=\"UTD.htm?43/8/44160\">",
"         Digestive system",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?18/1/18462\">",
"         Ear, nose, and throat",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?15/14/15598\">",
"         Eyes and vision",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?36/43/37567\">",
"         General health",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?16/61/17361\">",
"         Heart and blood vessel disease",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?5/25/5534\">",
"         HIV and AIDS",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?10/37/10832\">",
"         Hormones",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?33/2/33826\">",
"         Infections and vaccines",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?18/20/18767\">",
"         Kidneys and urinary system",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?16/4/16462\">",
"         Liver disease",
"        </a>",
"        <br/>",
"       </tds>",
"       <tds valign=\"top\" width=\"33%\">",
"        <a class=\"tocItem\" href=\"UTD.htm?39/51/40767\">",
"         Lung disease",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?0/56/911\">",
"         Men's health issues",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?24/9/24734\">",
"         Mental health",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?28/37/29264\">",
"         Pregnancy and childbirth",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?42/61/43999\">",
"         Senior health",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?22/10/22703\">",
"         Skin, hair, and nails",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?38/54/39789\">",
"         Sleep",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?9/19/9534\">",
"         Surgery",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?13/0/13326\">",
"         Travel health",
"        </a>",
"        <br/>",
"        <a class=\"tocItem\" href=\"UTD.htm?35/7/35954\">",
"         Women's health issues",
"        </a>",
"        <br/>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-E3D58D7734-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f18_22_18798=[""].join("\n");
var outline_f18_22_18798=null;
var title_f18_22_18799="Event recorder PI";
var content_f18_22_18799=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F75670&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F75670&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cardiac event recorder",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 306px; height: 413px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An event recorder is a portable device patients can use to measure their heart rhythm for a short time. The patient must activate the recorder and hold it to the chest when they feel symptoms. It is useful for patients that have intermittent symptoms that may not be captured with other forms of testing.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_22_18799=[""].join("\n");
var outline_f18_22_18799=null;
